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ABSTRACT 
Large-Scale Analysis of Protein-Ligand Binding Sites Using 
the Binding MOAD Database. 
 
by 
 
Nickolay Khazanov 
 
 
Chair:  Heather A. Carlson  
 
 
Current structure-based drug design (SBDD) methods require understanding of 
general tends of protein-ligand interactions. Informative descriptors of ligand-binding 
sites provide powerful heuristics to improve SBDD methods designed to infer function 
from protein structure. These descriptors must have a solid statistical foundation for 
assessing general trends in large sets of protein-ligand complexes. This dissertation 
focuses on mining the Binding MOAD database of highly curated protein-ligand 
complexes to determine frequently observed patterns of binding-site composition. An 
extension to Binding MOAD’s framework is developed to store structural details of 
binding sites and facilitate large-scale analysis. This thesis uses the framework to 
address three topics. It first describes a strategy for determining over-representation of 
amino acids within ligand-binding sites, comparing the trends of residue propensity for 
binding sites of biologically relevant ligands to those of spurious molecules with no 
xvi 
known function. To determine the significance of these trends and to provide guidelines 
for residue-propensity studies, the effect of the data set size on the variation in 
propensity values is evaluated. Next, binding-site residue propensities are applied to 
improve the performance of a geometry-based, binding-site prediction algorithm. 
Propensity-based scores are found to perform comparably to the native score in 
successfully ranking correct predictions. For large proteins, propensity-based and 
consensus scores improve the scoring success. Finally, current protein-ligand scoring 
functions are evaluated using a new criterion: the ability to discern biologically relevant 
ligands from “opportunistic binders,”  molecules present in crystal structures due to 
their high concentrations in the crystallization medium. Four different scoring functions 
are evaluated against a diverse benchmark set. All are found to perform well for ranking 
biologically relevant sites over spurious ones, and all performed best when penalties for 
torsional strain of ligands were included. The final chapter describes a structural 
alignment method, termed HwRMSD, which can align proteins of very low sequence 
homology based on their structural similarity using a weighted structure superposition. 
The overall aims of the dissertation are to collect high-quality binding-site composition 
data within the largest available set of protein-ligand complexes and to evaluate the 
appropriate applications of this data to emerging methods for computational proteomics. 
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CHAPTER I  
 
Introduction and Background 
1.1 Overview 
Proteins are ubiquitous in the cellular environment and are essential for biochemical 
functions that sustain life. To accomplish their task, proteins interact with a variety of 
entities in the cell, some macro-molecular (DNA, RNA, membranes) and others smaller 
(catalytic substrates, nucleotides, peptides, and man-made chemicals).  The diverse 
interactions between proteins and their small molecule ligands are the focus of intense 
study, not only for elucidation of cellular mechanisms, but also for facilitating the 
design of drugs to modulate protein function in disease states. A significant portion of 
this design process is based upon the three dimensional structures of the protein and the 
ligand, in complex or separate.  
The challenge of structure-based drug design (SBDD) is to correctly predict which 
small molecule would bind to a specific protein and what impact it might have on its 
function. SBDD involves an intimate understanding of how a ligand interacts with its 
binding site on the protein surface and using that information to predict what other 
ligands can bind and how strong the binding will be. Screening large databases of 
potential lead compounds against a structure of a protein can speed drug development 
by focusing the more resource-intensive experiments on a narrow set of compounds 
most likely to have activity.   
In general, two major requirements for SBDD are the availability of a 3D structure 
of the desired protein target and the annotation of the ligand binding site(s) on that 
protein.  In the recent years, SBDD received a major boost as the number of known 
protein structures has grown exponentially, thanks in part to numerous structural 
genomics projects aimed at obtaining X-ray crystal structures of proteins with unknown 
or poorly understood function [1]. While some contain co-crystallized ligands, most are 
2 
un-liganded. This large number of “incomplete” protein structures has raised new 
challenges in predicting and characterizing protein-ligand interactions. One of the more 
fundamental challenges is the identification of pockets on the protein surface capable of 
binding a small molecule. This can be a relatively straightforward process if the protein 
in question is a member of a well-studied family because function and binding pockets 
can be identified through sequence homology to an existing protein structure. However, 
the aim of many of the structural genomics projects is to find new uncharacterized 
targets, so many of the proteins in the new structures may have low sequence homology 
to any other structure in the Protein Data Bank (PDB) [2]. In these cases, structure-
based methods need to be employed. Methods for determining the location of binding 
sites include computational and experimental fragment-based screening, identifying 
structural similarity to a known binding site, or using a structure-based prediction tool.  
Once a binding site is located, the subsequent challenge is to describe the functional 
significance and selectivity/specificity of the site for various small molecules.  While 
classical SBDD methods such as in silico screening can be used to determine possible 
binding partners, the existence of extensive databases of protein-ligand binding pockets 
motivates the development of comparative methods to leverage this structural data. One 
way to use this data is to derive a “druggability” or “bindability” score that is trained on 
existing protein-ligand structures. A druggability score can be used to rank identified 
pockets by how likely each is to bind a drug-like ligand. The ‘druggability’ index 
approach is relatively popular, but it has difficulty separating pockets known to bind 
drugs from pockets not suited to drug design, known to bind only small organic 
molecules. This is likely due to the high similarity of such sites and the limited dataset 
used to train the score [3]. Comparing one binding pocket to another to find significant 
similarities is a knowledge-based way to infer the ligands capable of binding to a pocket. 
The challenge faced by this approach is usually determining the significance of the 
similarity by estimating a cutoff value on a sufficiently diverse set of example 
complexes.  These knowledge-based approaches also have the potential to address 
significant challenges in the drug-design process, – such as predicting off-target effect 
of new drugs [4], finding secondary targets for existing drugs [5], and engineering novel 
proteins to bind specific ligands [6]. The development of such tools requires an intimate 
3 
understanding of the variation within binding pockets across the known “pocketome” 
and their relative importance in partitioning the vast many-to-many interaction network 
of proteins and small molecules.  
All of the above-mentioned challenges require methods that incorporate efficient yet 
informative descriptors of structural, physicochemical, and dynamic features of the 
protein surface. Also, they must have a solid statistical foundation for assessing 
similarities or differences between such regions. This dissertation focuses on mining the 
Binding MOAD database, a vast, curated set of protein-ligand complexes, for frequently 
observed patterns of binding-site composition with respect to ligand type. We then 
apply these patterns to the improvement of emerging binding-site prediction and 
comparison methods. After a short description of Binding MOAD and the extensions 
made to the database framework to facilitate binding-site analysis, the thesis addresses 
three topics. It first describes a strategy for determining over-representation of certain 
amino acids in ligand-binding sites. The significance of this over-representation is 
assessed by comparing binding pockets of biologically relevant ligands to those that 
bind spurious molecules with no known function. Significant trends in the propensities 
are described, and the effect of the data set size on the variation in propensity values is 
determined. Second, the propensities of residue occurrence are applied to improve the 
performance of a de novo binding-site prediction method. Propensity-based scores are 
used to rank predictions from the geometry-based SiteFinder algorithm. They are found 
to perform well on their own and in combination with the default SiteFinder score. The 
effect of predicted site size and protein size on prediction success is examined to 
identify cases where propensity-based scores are especially helpful. 
Finally, this dissertation describes an evaluation of current protein-ligand scoring 
functions with a new criterion – the ability to discern biologically relevant ligands from 
“opportunistic binders,” molecules present in many crystal structures due to their high 
concentrations in the crystallization medium. A diverse benchmark of both types of 
complexes is compiled from the PDB and evaluated with four different scoring 
functions representing different scoring approaches. Particularly challenging examples 
are examined, such as those where biologically relevant binding is weak or invalid 
ligands that mimic biologically relevant contacts in a known binding site. The final 
4 
chapter presents a new method for better structural alignment of two homologous 
proteins based on the weighted superposition (wRMSD) technique [7]. This new 
HwRMSD method performs comparably to established structural alignment methods 
and is effectively used on proteins pairs with large structural changes. While HwRMSD 
does not utilize binding-site information, it has potential applications to structural 
comparison of ligand-binding regions. The overall aims of the dissertation are to collect 
high-quality data to describe the composition of binding sites within the largest 
available set of protein-ligand complexes and to evaluate the appropriate applications of 
this data to emerging methods for computational proteomics.  
 
1.2 Understanding General Trends of Protein-Ligand binding  
The understanding of protein-ligand binding has come a long way since the 
formulation of the lock-and-key hypothesis in 1984 by Hermann Fischer, who 
suggested the binding of a substrate to an enzyme is analogous to a key being inserted 
into a lock. This model of shape complementarity between the ligand and the receptor 
has since expanded to incorporate the flexibility of the receptor. More dynamic models 
of binding include the zipper model, the induced-fit model, and the conformational-
selection model (reviewed in [8]). Considering that a majority of structural knowledge 
of proteins still comes from static structures obtained by x-ray crystallography [1] or 
homology modeling [9], it is still a challenge to identify binding regions that might only 
be present in certain protein conformations, yet are important for the function of the 
protein. Geometric complementarity is required but not sufficient for ligand binding 
[10]. Molecular recognition also relies on physicochemical complementarity – namely 
the various electrostatic, hydrogen-bonding, hydrophobic, and solvent-mediated 
interactions between the protein and the ligand. All of these features must combine to 
create an energetically favorable interaction for the ligand to enter and remain in the 
binding site long enough to affect protein function. Despite major efforts to develop 
computational methods that can describe these physicochemical interactions from “first 
principles” using sophisticated force-fields, a large portion of existing methods rely on 
knowledge-based or empirical approaches.  
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The knowledge-based methods are fast and efficient, but they suffer from over-
reliance on their training sets, which can limit their generalizability [11]. Empirical 
methods parameterize their energy-estimation functions with existing protein-ligand 
data, and thus, offer an intermediate approach. However, none of these methods have 
been very effective in predicting experimentally-determined ligand affinities [12], 
illustrating the challenges inherent in understanding the full range of factors governing 
protein-ligand binding.  
1.2.1 Binding-Site Shape 
Looking at the variation of shapes, sizes, and composition of protein-ligand binding 
sites and the ligands they bind, it is easy to see why finding a general method for 
predicting their location and binding partners is such a challenge. Recent studies of 
thousands of human protein-ligand complexes found a complicated relationship 
between the similarity of protein sequences and the similarity of their pockets and 
bound ligands [13-15]. By clustering the proteins, ligands, and pockets separately, one 
study found many examples of highly related proteins binding varied ligands. 
Conversely, many ligands similar in structure, as measured by Tanimoto similarity, 
have unrelated protein partners, as measured by sequence similarity [13]. Moreover, it 
has been observed that binding sites of two proteins can be similar despite having 
different global folds [16], which is likely a result of convergent evolution.  
The shapes of binding pockets range from small spherical invaginations to deep 
curved or linear clefts in the protein [17]. Catalytic sites are usually situated at the 
bottom of the deeper clefts, where hydrophobic residues can shield the catalytic 
residues from solvent while the latter perform the enzymatic reaction. However, other 
functional sites can vary greatly in size and depth. To complicate matters, the size of the 
binding site is not necessarily related to the size of the ligand it can accommodate [10, 
18], and several binding regions can exist in close proximity, forming a large swath of 
ligand-binding surface with complex geometry.  The average volume of a drug-binding 
pocket is between 600 - 900 Å
3
, depending on the method used to delineate pocket 
boundaries [19-21], while that of a drug-like ligand is around 400Å
3
. Since drug 
molecules are often designed to be as small as possible to improve their bioavailability, 
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this range of binding site and ligand volumes only increases when the full variety of 
biologically-relevant protein-ligand complexes is considered.  Despite the variation, 
some general trends have emerged from the recent studies. Ligands, and especially 
drugs, have been observed to bind into the largest and/or deepest concavity on the 
protein surface [18]. On average, that cavity might be three times as large as the ligand, 
indicating the presence of a large ”buffer” zone between the ligand and protein [10] and 
demonstrating the difficulty in defining the boundaries of what really constitutes the 
binding site.  
 
1.2.2 Binding-Site Composition 
Chemical complementarity may have general trends as well. In a study of ligand 
efficiency in enzymes and non-enzymes, high-affinity enzyme ligands were observed to 
be larger than those with low-affinity, indicating increasing ligand size can improve 
affinity. However, non-enzymes were observed to have high ligand efficiencies 
irrespective of ligand size, and the composition of their binding sites had greater 
influence upon modulating affinity [22]. Such relative trends between protein classes 
are helpful in guiding SBDD with a particular protein target in mind, but provide only 
broad-brushstroke insight into binding-site behavior. Many methods that delve into the 
details of the protein-ligand interactions have been developed to score potential matches 
between a specific ligand pose and its receptor [23-26]. These knowledge-based scoring 
functions look for general trends of atom-atom contacts between ligand and protein in 
large structure databases, and they reward frequently-seen interactions in the potential 
protein-ligand pair to be scored. Depending on the training set, the interaction trends 
captured by the function may not be generally transferable to a wide variety of proteins 
[27]. Moreover, the trends utilized by the scoring functions require the presence of both 
protein and ligand atoms in a structure. They are usually applied in cases where the 
relative location of the binding site has been narrowed down, and only the best binding 
mode is sought [28]. This limits their usefulness in understanding general trends of 
binding-site composition in the absence of a potential ligand.  
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Yet another class of studies has analyzed the composition of protein surfaces in 
general. This led to general insight that a mix of both hydrophobic and hydrophilic 
solvent-exposed residue exist on protein surfaces [29], and that there is limited 
correlation between residue hydrophobicity and its surface exposure patters [30] (i.e., its 
presence on the surface). Such insights further the understanding of the composition of 
protein surfaces, but they do not compare and contrast their findings with the regions of 
protein surface involved in ligand binding.  
With the advent of thousands of protein-ligand complexes in the PDB, analyses of 
composition and conservation of residues in ligand binding sites are becoming more 
common. Such studies take a more asymmetric view of the protein-ligand interactions, 
focusing on the trends in protein composition independently of the details of ligand 
interaction. The trends are often linked back to significant or frequently observed 
interactions, but they can also be used to contrast ligand-binding regions of the protein 
to the rest of the protein surface or assign some manner of scores to protein residues in a 
structure without co-crystallized ligand.  
One of the most detailed studies of ligand-interacting residues was carried out by 
Bartlett et al. on ~200 enzyme active sites [31]. A residue’s role in enzyme catalysis 
was confirmed by manual curation. His, Cys, Asp, and Arg were found to have the 
highest catalytic propensities (over-representation in catalytic site as compared to the 
rest of the protein). A variety of other detailed trends for the solvent exposure and 
biochemical function of the residues were also determined. The study provided a 
heuristic basis for predicting catalytic residues in enzymes, and it was the source for the 
Catalytic Site Atlas database. However, the focus on catalytic residues side-stepped the 
analysis of residues involved in non-catalytic interactions with the ligand. These 
residues likely provide energetically-favorable interactions that maintain the ligand in 
the correct binding mode while the catalytic residues perform their function; therefore, 
they are important to include in residue composition analysis.  
 A recent study by Davis and Sali examined the general residue composition of 
ligand-binding sites as compared to protein-protein binding sites and the protein surface 
with no known interactions [32]. They found residue composition in protein-protein 
binding sites resembles that of the general protein surface, while residues in protein-
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ligand binding sites had much different propensities. Residues involved in both protein 
and ligand binding (bi-functional) showed intermediate propensities. Largest 
propensities for ligand-binding sites were seen for Cys, Phe, His, Met, Trp, Val, and Ile 
residues. Cys, Ile, and Val were unique with respect to protein-protein or bi-functional 
positions. That study analyzed ~35,000 binding sites, but it was based on only ~1000 
domain families, which is a very redundant set of structures. 
A more focused study by Nayal and Honig extensively characterized the binding 
sites of 99 non-redundant, protein-ligand complexes as part of an effort to develop a 
binding-site detection algorithm [18]. Unfortunately, the authors focused on 
classification of binding sites as being drug-binding or not, and they did not report 
general trends of the binding pockets analyzed in the study. However, they found that 
Asn, Gln, and Glu were important residues in recognizing drug-binding sites among a 
set of sites binding various ligands.  Aside from these representative efforts, relatively 
few surveys of large sets of protein complexes have been completed [33-37], and the 
ever-growing number of raw structural data and binding-site characterization methods 
promise greater insights into the general theories governing protein-ligand complexes. 
These insights will undoubtedly lead to improvements in SBDD strategies that make 
use of these theories [36, 38]. 
1.3 Methods to Identify Binding Sites de novo 
Methods that aim to predict binding sites face several major challenges. Two of the 
largest are the change in the binding-site structure upon ligand binding (an implication 
of the induced-fit model of ligand binding) and the sheer variety of existing binding-site 
shapes and sizes needed to accommodate the various biologically-relevant ligands. 
Another challenge is detecting sites located at protein subunit interfaces, which are 
often omitted in the test sets used to develop and benchmark prediction methods. Even 
with a large and properly chosen evaluation set, there remains the challenge of precision 
and accuracy, i.e., identifying the precise region expected to bind a ligand without over-
predicting. Overpredicting is problematic because classifying the entire surface of a 
protein as a binding site would certainly result in a match, so evaluating the success of a 
prediction must be done carefully. The field as a whole still lacks gold-standard sets or 
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consistent metrics for calling “true” predictions. These challenges will need to be 
overcome for successful application of prediction methods in SBDD, which require a 
precise and accurate definition of the binding site to focus the search effort on relevant 
areas of the protein and reduce false-positive results.  
Three major classes of tools have emerged to address binding-site prediction: 1) 
those that use the geometry of the protein surface to identify large concavities 
resembling a binding site, 2) those that use probe-based methods to identify regions of 
the surface capable of making energetically favorable interactions with a potential 
ligand, and 3) those that use knowledge-based methods to search a protein structure 
against a database of known binding sites. Representative tools in these categories are 
discussed below and summarized in Table I-1. Additional tools exist that use more 
complex methods, such as molecular dynamics, to identify the binding regions, but they 
are outside the scope of the current discussion.  
Table I-1: Representative algorithms for binding site prediction.  
 
Pub Date 
(Latest) 
Type Server Download 
Open 
Source 
GRID 1985 Energy-based    
POCKET 1992 Geometric    
VOIDOO 1994 Geometric  ✓  
APROPOS 1996 Geometric    
PASS 2000 Geometric  ✓  
eF-Site 2002 Knowledge-based ✓   
Pocket-Finder 2005 Geometric ✓  ✓ 
PocketFinder 2005 Energy-based ✓ $  
SiteFinder 2005 Geometric  $  
Q-SiteFinder 2005 Energy-based ✓   
ProFunc 2005 Knowledge-based ✓   
ConSurf 2005 Knowledge-based ✓   
SiteEngine 2005 Knowledge-based ✓   
LIGSITEcsc 2006 Geometric/Genomic ✓ ✓ ✓ 
SURFNETConSurf 2006 Geometric/Genomic ✓ ✓ ✓ 
CAST(p) 2006 Geometric ✓   
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SCREEN 2006 Geometric  ✓  
Pocket-Picker 2007 Geometric  ✓ ✓ 
PHECOM 2007 Geometric    
SiteMap 2007 Combination  $  
CavBase 2007 Knowledge-based ✓   
PocketDepth 2008 Geometric ✓   
FINDSITE 2008 Knowledge-based ✓   
Fpocket 2009 Geometric ✓ ✓ ✓ 
McVol 2010 Geometric  ✓ ✓ 
PROSITE 2010 Knowledge-based ✓   
ProBiS 2010 Knowledge-based ✓   
 
1.3.1 Methods Primarily Using Geometry of Static 3D Protein Structures 
The earliest methods developed for prediction of surface pockets employed a grid-
based approach, scanning the protein along grid lines using a geometric probe and 
detecting the regions where grid points lay outside of protein atoms (Figure I-1). In 
POCKET [39], the specific pockets were defined by protein-solvent-protein events, 
which are characterized as a series of grid points along the scan axes that alternate 
between being “inside” the protein to “outside” of the protein. Since this approach is 
sensitive to the relative orientation of the protein to the grid axes, it was extended in 
LIGSITE [40] to include scans along grid diagonals. LIGSITE was tested on a set of 
only 10 proteins in its initial publication, but at the time, it was a state-of-the-art method 
in terms of accuracy and efficient implementation. Owing to its success, it was further 
extended to incorporate the Connolly protein surface [41] in order to count surface-
protein-surface events instead of protein-solvent-protein events. Recently, non-
structural information was incorporated by considering the conservation of residues in 
the identified pockets. [42]. The extended version is named LIGSITE
csc
. It was 
validated on a large set of 210 structures, which included a subset of matched apo and 
holo protein structures. It showed an improvement in top-ranked successful predictions 
from 67% to 75% as compared to LIGSITE. LIGSITE was also implemented as Pocket-
Finder for comparison to energy-based methods [43]. 
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Figure I-1: Illustration of several methods utilizing protein-structure geometry for binding-site 
identification. Each illustration is taken from the publication describing the respective algorithm. 
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LIGSTE served as a basis for the PocketPicker method, which used a finer grid 
representation and calculated an additional “buriedness” measure for grid points in the 
identified pockets [44]. The PocketPicker method performed worse (59% for top-hit 
success) than LIGSITE or LIGSITE
csc
 on the same test set of 210 complexes, a fact the 
authors attributed to the optimization of PocketPicker to identify smaller, more buried 
pockets useful for shape comparison. However, it did outperform alternative geometry-
based methods PASS and SURFNET (see below). Conceptually, grid-based methods 
have limits due to their sensitivity to grid size, protein orientation, and the inability to 
define a cavity “ceiling” to delineate the outer limit of a pocket. VOIDOO was an early 
method that sought to rectify the limitations of grid-based approaches by detecting 
cavities through the expansion of atomic van der Waals (vdW) boundaries [45]. The 
premise was that deep pockets can be delineated by progressively expanding the vdW 
radii of all protein atoms until invaginations on the surface of the protein get “pinched 
off” by the vdW surfaces colliding at the narrowest point, i.e. the “mouth” of the pocket 
(Figure I-1).  Although the method provided a way to outline the cavity and measure its 
volume independent of a grid, it could not detect shallow or broad pockets that cannot 
be closed off by increasing the vdW radii.  
A slightly different use of grids was recently proposed in the PocketDepth method 
[46]. It uses the fine grid of points placed on a protein to calculate pair-wise measures 
of depth between pairs of points flagged as being on the surface of the protein. The 
points are identified as being on the surface by considering the density of protein atoms 
in the vicinity of a point. Depth measurements passing through a protein atom are not 
considered. Subspaces of the grid are evaluated based on the density and magnitude of 
the depths measurement among the points in the subspace. Complex clustering and 
filtering steps allow the algorithm to identify grid subspaces that have large numbers of 
‘deep’ points in close spatial proximity, and thus delineate the predicted pocket shape 
based on these subspaces. The algorithm was extensively evaluated on a set of 1091 
proteins from the PDBBind database [47], where it achieved a success rate of 55% 
among its top-ranked predictions. This performance was similar to or better than 
LIGSITE
CSC
 and Q-SiteFinder methods, respectively, based on the benchmark datasets 
for those methods (see below). 
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An early, alternative geometry-based method was implemented in SURFNET [48], 
which used an algorithm that fits spheres of varying size between all pairs of relevant 
protein atoms to find the pocket-like cavities. The radius of a sphere placed between 
several atoms is iteratively reduced until no overlap with protein atoms is achieved 
(Figure I-1). All indentations on a protein are packed with spheres of radii varying from 
1 to 4 Å, defining the outlines and volumes of prospective binding sites. Ranking the 
pockets by size, SURFNET was found to correctly predict the ligand-binding pocket in 
83% of the top-ranked results for a set of 67 enzyme complexes [49]. In a more recent 
test on 210 bound complexes from Huang & Schroeder, SURFNET underperformed in 
relation to LIGSITE and PASS methods, achieving a success rate of only 42% for its 
top-ranked predictions [42]. SURFNET was later expanded to SURFNET-ConSurf, 
which incorporates evolutionary sequence information to trim the predicted pocket size 
based on the conservation rate of its component residues.  
The PASS method [50], whose top-ranked predictions achieved a performance of 
54% in the Huang et al. evaluation on 210 complexes, is another popular tool that uses a 
probe-packing algorithm to detect protein pockets. In this algorithm, probes are packed 
on the protein surface so that each probe touches a triplet of adjacent protein atoms. 
Probes that clash with protein atoms are then removed, and the remaining probes are 
filtered by their degree of burial, estimated from the count of protein within 8 Å of the 
probe.  Subsequent rounds of packing build up additional layers of probes until no more 
buried probes can be placed. The probes are clustered into “active site points” that 
define the predicted pockets. PASS was originally evaluated on 32 complexes, where its 
top-predicted pockets successfully identified 60% of the known sites, and on a set of 21 
apo structures, where the success rate was 57%. A more recent method, PHECOM, 
used two sets of large and small spheres to pack the protein surface, and determined 
pockets by identifying small spheres that packed between the surface and the large 
spheres [20]. Probe packing methods might have difficulty detecting wide cavities, 
which would require very large spheres to define, and would limit the accuracy of 
pocket-volume estimation based on sphere volumes.  
A series of algorithms utilize Voronoi diagrams [51] and Delaunay triangulation 
[52] for geometric surface representation. These techniques effectively “shrink wrap” 
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the protein surface in a mesh of triangles and allow for complex geometric algorithms to 
calculate various shape properties of this tiling. APROPOS [53], one of the earliest 
methods in this category, creates a Delaunay representation of the protein and then 
generates an α-shape, which is conceptually similar to rolling a probe with a radius α to 
erase edges of the Delaunay triangles. The vertices of the triangles are located at atomic 
centers and unaffected by the rolling-probe step. By varying the α parameter, a series of 
surfaces can be generated, with the most extreme value (α = ∞) generating a convex hull 
of the protein. Pockets of various sizes can be detected by comparing the shape of the 
convex hull to the alpha shapes generated by alpha values corresponding to the radii of 
an oxygen atom or a methyl group. The algorithm initially achieved a 95% success rate 
in its initial test on 200 monomer complexes, but it has not been extensively compared 
to other methods.  CAST is a similar method that combines the Delaunay representation 
with discrete flow theory to identify concave pockets [35]. It first identifies the alpha-
shape of the protein and defines Delaunay triangles with one or more omitted edges as 
“empty”. The neighboring empty triangles are then combined in the “discrete-flow” 
method to define continuous voids on the protein surface (Figure I-1). An obtuse empty 
triangle flows into its neighbor, while an acute empty triangle acts as a sink to collect 
the flow of its neighbors. If the flow is directed out of the protein the pocket is ignored, 
otherwise it is considered a putative binding site. The algorithm was tested on the 51 of 
the 67 proteins used by SURFNET, and it achieved a success rate of 74% (lower than 
SURFNET). However, the authors determined that the differences in nature of the 
pockets predicted by the two methods prevent fair comparison. The α-shape and secrete 
flow approaches might be limited in their applicability to very open pockets, since they 
are optimized to detect pockets whose “mouth” is smaller than the cross sections 
through the rest of the pocket [54]. Alpha-sphere methods, discussed below, are less 
sensitive to such pocket geometry.   
More recent methods utilizing a surface-based approach include Fpocket [55] and 
SiteFinder [56]. Both use the concept of α-spheres [54] andVoronoi tessellation of the 
protein. An alpha sphere is a sphere contacting four protein atoms but no internal atoms 
(Figure I-1). Centers of alpha spheres correspond to the vertices of the Voronoi 
tessellation of the protein, and both Fpocket and SiteFinder algorithms determine the set 
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of alpha spheres based on this tessellation. Since alpha-sphere radii scale with the 
curvature of the plane of the four atoms they contact, small alpha spheres are located in 
tightly packed areas of the protein while those with larger radii are located in cavities 
towards the surface. Thus, clusters of alpha spheres with a desired range of radii can be 
used to identify and define surface cavities. Fpocket clusters the spheres by proximity, 
density, and size. It then prunes uninteresting sphere clusters based on cluster size and 
some basic definitions of polarity with respect to the atoms the spheres touch. The sites 
are then ranked according to a scoring scheme that estimates the “bindability” of the site 
based on a set of geometric and physicochemical pocket descriptors. SiteFinder 
performs similar clustering and pruning based on the solvent exposure of the spheres 
and the hydrophobicity of the neighboring atoms. Clusters with at least one 
“hydrophobic” sphere are retained while the rest are discarded. Fpocket was tested on 
the smaller bound/unbound test set of structures used by PocketPicker (see above). It 
outperformed PocketPicker, LIGSITE
csc
, CAST, PASS, and SURFNET on the bound 
set of 48 structures, with an 83% success rate among its top-ranked predictions [55]. On 
the unbound set of the same proteins, it performed as well as PocketPicker, achieving a 
69% success rate. It slightly underperformed compared to LIGSITE
scs
 (71% success). In 
a recent large-scale comparison on a dataset of several thousand apo and holo structures, 
Fpocket performed similar into SiteFinder on the bound structure set, achieving top 
rank success of around 78%, compared to SiteFinder’s 77%. However, it significantly 
underperformed on the unbound set, where it achieved a success rate of only 42% 
versus 62% achieved by SiteFinder [57]. 
Another way of defining a protein surface is by a rolling-sphere approach. The 
SCREEN method uses differences in two molecular surface representations of the 
protein to define protein cavities [18]. First a “tight” molecular surface is constructed by 
rolling a small sphere (1.4Å in radius) over the whole protein. Then, a low-resolution 
envelope surface is constructed by rolling a sphere closer in size to a ligand molecule 
(5.0Å in radius). The depth of the molecular surface is then computed with respect to 
the envelope surface, and cavity surfaces are defined as contiguous regions of the 
molecular surface that are below a certain depth. A sophisticated clustering method then 
merges continuous cavities to produce well-delineated, compact, predicted pockets. 
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This is the extent of the geometric component of SCREEN, which was further used to 
train a classifier for predicting druggability of the sites based on an array of 
physicochemical proteins of the predicted pockets. 
Geometric methods are relatively simple and efficient, but they have no underlying 
physical meaning. The following section describes representative methods that apply a 
more physicochemical approach, or a combination of geometric and physical features, 
to scan the protein surface for potential ligand-binding sites. 
1.3.2 Methods Primarily Using Energetic Mapping of 3D Protein Structure  
Methods that evaluate the interaction energy between the protein and a chemical 
probe, fragment, or molecule, to determine favorable regions date back as early as 1985, 
when the GRID method was first published [58]. GRID calculates interaction energies 
between the protein atoms and probes placed on a grid superimposed on the protein. 
The interaction energy is composed of Lennard-Jones, Coulombic, and hydrogen-
bonding terms, and the probe identity can be varied to represent different chemical 
fragments. The method was designed to identify regions of interest on the protein but 
not necessarily predict binding sites; as such, it generates a map of the protein surface as 
opposed to a set of pocket predictions. Although used heavily and successfully in 
SBDD of individual protein targets [59], it has not been extensively evaluated as a 
binding-site prediction algorithm. Probe interaction energies have been successfully 
combined with some measure of protein geometry in the recently-developed Q-
SiteFinder [43]. The Q-SiteFinder algorithm relies on the GRID force field to calculate 
vdW interaction energies between the protein atoms and methyl probes placed on a fine 
grid. An interaction energy threshold is used to retain the most favorable probes. A 
clustering algorithm groups the probes according to their spatial proximity along the 
protein surface and uses the total interaction energy of the probes in a cluster to rank 
them relative to one another. The most favorably interacting clusters are presented as 
the predicted binding pockets. Q-SiteFinder was evaluated on a set of 134 proteins from 
the GOLD docking test set [60] and achieved a success rate of 71% in the top-ranked 
predicted sites [43]. The method also outperformed LIGSITE (as implemented in 
Pocket-Finder), which achieved a success rate of 48%. When evaluated on a set of 35 
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proteins with corresponding apo and holo structures, the Q-SiteFinder success rate in 
the top-ranked sites decreased from 80% in the bound structures to 51% in the unbound 
structures [43].  
Shortly after the publication of Q-SiteFinder, an alternative energy-based method 
was proposed in PocketFinder [13] (not to be confused with Pocket-Finder, an 
implementation of LIGSITE). Like previous grid-based methods, PocketFinder 
calculates a grid potential map of vdW interaction energies using an implementation of 
the Lennard-Jones potential. The method deviates from its predecessors by smoothing 
this potential map to emphasize continuous regions of highly favorable vdW potential 
and then contouring the map at a level sufficient to identify putative ligand envelopes. 
Small envelopes are pruned, and the rest are ranked by their volumes. PocketFinder was 
tested on the largest set of any other method (5,616 bound and even more corresponding 
un-bound structures). It was found to perform better in predicting sites from ligand-
bound structures than unbound structures. Since the authors chose to stratify their 
predictions by a site-coverage threshold, a direct measure of top-rank results is not 
available.  
A more sophisticated approach similar to GRID and Q-SiteFinder is implemented in 
SiteMap, part of the Schrödinger software suite [61]. SiteMap first identifies potential 
sites by placing a grid of probe points over the protein and retaining those that are 
located “outside” of the protein, have a certain degree of enclosure, and obtain 
favorable vdW interaction energy with the protein. An agglomerative clustering step 
then groups the points by proximity, and point groups are further merged if an un-
interrupted point-to-point traversal can be completed from one group to the other 
without encountering the protein. The predicted sites are then scored and ranked 
according to variety of aggregate physicochemical descriptors including size, enclosure, 
solvent exposure, tightness of non-bonded interactions, hydrophobicity, and hydrogen-
bonding potential.   
Energy-based methods tend to be much faster than geometric ones, but they are 
more sensitive to missing atoms and proper set-up of the protonation states and atom 
types of each protein [57]. Alternative energy-based methods include the fairly explicit 
and expensive computational solvent-mapping approaches [62, 63] and whole-protein 
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“blind docking” methods such as MEDock [64] or an AutoDock-based method by 
Hetenyi et al. [65]. The former involve simulation of the protein surrounded by a bath 
of organic solvent to identify solvent-binding hot-spots. The later are based on existing 
docking and molecular dynamics software. Thus, both are beyond the scope of this 
introduction. 
1.3.3 Methods Using Knowledge-Based Approaches to Identify Binding Sites  
Knowledge-based methods used to predict ligand binding sites are comparative by 
definition. They make use of existing binding-site data obtained from X-ray and NMR 
experiments, biochemical data from site-directed mutagenesis studies, and sequence 
information associated with these data sources. Comparison of global or local structure 
of a protein of unknown function against existing databases of binding sites is the 
primary method for inferring the presence and/or function of the binding site. Sequence 
conservation or estimation of favorable energetic potentials is sometimes used to 
supplements the structural match. Unlike geometry- or energy-based methods, which 
report rank-ordered predictions, knowledge-based methods search against a large 
database of a known size, and then estimate the absolute statistical significance of their 
predictions. However, the obvious limitation of these methods is the difficulty of 
working with proteins that show little structural or sequence similarity to existing 
protein families. The power of knowledge-based methods will continue to improve as 
current sources of protein-structure data continue to grow. 
There is an important distinction between predicting a binding site region on the 
surface of an uncharacterized protein and classifying the function of that region. 
Geometry-based and energy-based methods described in the previous sections focus on 
identifying the ligand-binding region, not on its classification. Although geometry-
based methods such as SCREEN [18] follow up the binding-site identification step with 
a classification step, this classification step often relies on broadly-applicable binding-
site properties to label the predicted regions as “druggable” or “bindable.” In contrast, 
knowledge-based prediction methods compare a potential binding region to sites of 
known function, and consequently, try to assign a more specific functional class to their 
queries. Some knowledge-based methods that are considered binding-site prediction 
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methods are actually binding site classification or comparison methods that rely on a 
geometry- or energy-based algorithm for predicting potential cavities to be used in 
querying known sites. For example, the popular Cavbase [66, 67] method actually relies 
on the geometry-based LIGSITE [68] cavity-prediction method to identify the potential 
pockets. The ProFunc [69] database uses the SURFNET [48] method to identify 
potential cavities. These predictions are then used for comparison to known ligand 
pockets using geometric and physicochemical criteria. The overview of the knowledge-
based methods below focuses on the predictive aspect of these approaches. Binding-site 
similarity assessment is a broader extension of these methods that is outside of the 
scope of this chapter. 
Evolutionary analysis can help identify patches of conserved residues on the protein 
surface that are essential to protein function. Conservation of residues in a family of 
proteins is obtained by a multiple-sequence alignment (MSAL), where family members 
are chosen by functional similarity, presence of a common ligand, or structural 
similarity. The Rate4Site method developed by Pupko et al. uses MSALs to estimate the 
rate of evolution among homologous proteins; it then maps the conservation data onto 
the 3D surface of the query protein [70]. Patches of conserved residues are assumed to 
have functional significance, but the interpretation of the specific binding-site location 
is left to the user. Bayesian inference used for the conservation calculations provides 
robust conservation scores that can differentiate highly conserved positions arising due 
to short divergence times between proteins, from less-conserved positions that deserve 
attention due to their relatively small changes across long phylogenetic lineages [71]. 
The ConSurf database uses the Rate4Site method to identify functionally important 
amino acids on a query protein surface by searching a large database of protein 
sequences to generate MSALs appropriate for estimating residue conservation. The self-
professed bottleneck of this class of methods [72, 73] is the availability of sufficient 
sequence data. Too little variation in the MSAL due to insufficient diversity or too few 
sequences (usually < 10) can severely undermine the meaningful interpretation of the 
evolutionary relationships [74].  
The PROSITE database also relies on sequence conservation to detect functionally 
important regions in proteins of unknown function [75]. It attempts to counteract the 
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problems of insufficient sequence homology or small family size by considering short 
(10-20 residues), conserved sequence motifs in addition to full-length sequence profiles. 
A query sequence can be analyzed for the presence of a motif even it has no significant 
pair-wise sequence homology to known proteins. The short motifs can be constructed 
from full length MSALs in functionally-related proteins, such as enzymes or proteins 
containing prosthetic groups. Due to their size, individual patterns are not sufficient to 
infer function, but requiring the presence of several linked patterns in a query protein 
can boost their predictive power. [76]. If a significant match is found, the functionally-
relevant residues can be identified. The exact functional relevance is dependent on the 
patterns used against the query. For example, patterns derived from nucleotide-binding 
sites will only be helpful in locating nucleotide-binding sites. Like any knowledge-
based method, PROSITE performance is dependent on the presence of sufficient 
sequence information in its parent database – SwissProt. The diversity of motifs that can 
be generated from SwissProt bounds the type of functional residues that can be detected 
by this method. 
When there is sufficient sequence homology between the query and a known protein 
structure, methods that combine the two sources of information might provide more 
effective functional site prediction than simple sequence comparison. FINDSITE is a 
method that can localize a ligand-binding site in a crystal structure or protein model by 
using a threading method commonly employed to build homology models of related 
proteins [77]. It can be used with query proteins that have < 35% sequence identity to 
the closest known reference structure, and it can tolerate differences of up to 10 Å 
RMSD between the query model and a known crystal structure.  
The ProFunc database provides multiple sources of evidence for inferring the 
function of an un-characterized protein; many of which can be used to localize the 
functional site. It combines the largest-available variety of knowledge-based, functional 
prediction methods to take full advantage of an equally diverse set of data sources 
containing protein-function information [69] (Figure I-2). For example, ProFunc uses 
sequence-based searches against PROSITE and other structure/function databases to 
find evolutionary relationships to known functional classes. It also performs geometric 
comparison of local atom environments directly to 3D atom templates generated from 
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known protein-ligand sites from the PDB[78]. The server uses the SURFNET program 
to generate query pockets to search against known structures and templates, and as such, 
does not constitute a stand-alone prediction method. However, the comprehensive 
combination of a multitude of search and comparison methods, make it a powerful 
knowledge-based tool for predicting functional sites in proteins.  
Figure I-2: Schematic of different methods used by the ProFunc server to predict protein 
functional sites and infer protein function in general. The right-most column lists 3D template 
methods used to match potential cavities to existing PDB entries. Figure taken from Laskowski et 
al. [69] 
 
Several knowledge-based methods are available that assume no sequence or fold 
similarity between the query and the known proteins. They solely rely on local structure 
similarity to locate potential ligand-binding sites. The algorithms at the heart of these 
methods can compare two sets of three-dimensional coordinates of atoms or residues to 
provide a measure of structural similarity between them. Since the location of a binding 
site on an un-characterized protein is not known, the methods need to employ clever 
optimization to search all possible regions of the query protein surface against the 
structures of known sites. As part of the optimization, matches of the sub-structure 
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searches are often accompanied by a statistical measure of confidence in order to return 
only the most meaningful results. The global search across the entire protein makes 
these methods distinct from knowledge-based approaches that use geometric or energy-
based methods to locate the potential pockets for use as structural queries. Of course, 
many of the methods can also be used as binding-site similarity tools to compare 
structural representations of known binding site, or predicted pockets. 
The eF-site database was one of the first methods developed to search the molecular 
surface (MS) of a protein surface for potential functional sites [79]. In addition to using 
a geometric representation of MS, eF-site also calculates the electrostatic potential of 
the MS using the Poisson-Boltzmann equation. A clique-detection algorithm based on 
graph theory is used to compare the geometry and electrostatics of the entire MS of a 
query protein to a database of known ligand-binding proteins collected from the Protein 
Data Bank (PDB) [80]. This algorithm recognizes the region of the MS that matches 
known ligand-binding surfaces. It can be used to locate the binding site and assign 
potential function. The eF-site method uses a Connoly surface representation of the 
protein for its algorithm. The SiteEngine server developed by Shulman-Peleg et al. uses 
an alternative representation to achieve a similar high-performance search of a protein’s 
surface against a database of known ligand pockets [81]. Physico-chemical 
pseudocenters of surface residues are used to abstract the protein surface and reduce the 
dimensionality of the surface-comparison problem. Then, a geometric hashing 
algorithm is used to compare triangles of pseudocenters between the query and the 
database proteins. Enforcing the matching of physicochemical labels improves the 
algorithm efficiency by reducing the search space. Clustering and scoring steps help 
identify the regions of the query with the most relevant matches to a database ligand site. 
Like the eF-site method, SiteEngine is available via a server [82] capable of quickly 
searching a custom query structure against a database of pre-hashed sites from the PDB.  
The recently-developed ProBiS algorithm [83], and its accompanying web server 
[84], employ yet another prediction method that detects structurally-conserved cliques 
of residues on the surface of a query protein. ProBiS represents the MS as a connected 
graph of functional groups derived from the surface residues. In searching a database of 
proteins, a maximum clique detection algorithm is used to detect subsets of functional 
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groups that share geometric and physico-chemical complementarity. This algorithm 
effectively performs many local structural alignments between cliques of functional 
groups across the entire database. The results of these local alignments are aggregated 
to identify regions of strong structural conservation within the query structure and to 
select the most appropriate matching structure for further structural alignment and 
functional inference. The algorithm is fast enough to search a query structure against a 
pre-computed database of protein structures on–demand.  
PINTS is another approach that uses a sophisticated algorithm to determine 
similarity between two sets of atoms regardless of the position of their residues in the 
sequence [85]. No information about the relationship between the atoms is needed aside 
from their 3D coordinates, and the search is not limited to protein surface atoms. A 
statistical model determines the significance of an RMSD between two sets of atoms 
and provides a confidence value that is dependent on the number and type of atoms, the 
obtained RMSD, and a background probability of a similar match against a large 
database of proteins [86]. This efficient algorithm can query a pattern of atoms against a 
database of protein structures in real-time, which allows searching an entire protein 
structure against the database without restricting the query to a small subset of atoms 
(although such restriction is also allowed).  
The SiteEngine, ProBiS, and PINTS methods described above rely on their ability to 
quickly perform many small (local) pair-wise structure comparisons and then “grow” 
the individual matches to include larger protein–surface regions. These larger regions 
can be further compared to the database or simply reported to the user as the potential 
matches. When presented with the challenge of searching a whole protein surface 
against a database of such proteins, breaking down the problem into smaller, more 
efficient pieces is necessary. However, all methods utilize heuristics that help them 
prioritize and streamline which local surface regions are compared, and more heuristics 
to decide how they are eventually combined to delineate a matching site. Since no 
assumption is made about the location of a binding site in the query protein a priori, 
these methods would benefit from any information that will help them with such 
prioritization [85]. Trends of general binding-site composition can provide such 
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heuristics, which can potentially improve the performance and accuracy of many of 
these methods.  
1.3.4 Evaluation of Binding-Site Prediction Methods: Test Sets and Performance 
Metrics 
The variety of proposed binding-site prediction methods is accompanied by a 
similar variety in metrics and datasets used for their evaluation. Most current methods 
have been developed in the past 10 years, and no gold standards have yet been 
established. Understandably, each publication proposing a new method aims to selects a 
bigger, better, and broader set of structures to highlight the strengths of their approach. 
Unfortunately, not many of these publications attempt to benchmark their tools on 
previously published datasets or to compare their novel method to existing ones. 
Notable exceptions to this are listed in Table I-2 in an attempt to highlight structure sets 
on which several methods have been evaluated. Many of these sets correspond to those 
discussed in the previous sections.  
Table I-2: Notable test sets for binding-site prediction algorithms 
Compiled 
By 
Used  
By 
Evaluated 
algorithms 
Basis Size 
Number of 
corresponding  
unbound 
structures 
Laskowski 
et al. 
(1995) [48] 
Liang et al. 
(1998) [35] 
SURFNET 
CAST PDB [2] 67 proteins -- 
Nissink et 
al. 
(2002)[60] 
Huang & 
Schroeder 
(2006) [42] 
Laurie & 
Jackson 
(2005) [43] Le 
Guillaux et al. 
(2009) [55] 
None in original 
paper 
original GOLD 
validation set 
[87] 
305 proteins 35 proteins 
Laurie & 
Jackson 
(2005) [43] 
Kalidas & 
Chandra 
(2008) [46] 
Q-SiteFinder 
LIGSITE (Pocket-
Finder)  
PocketDepth 
subset of 
Nissink et al. 
134 proteins 35 proteins 
An et al. 
(2005) [13] 
Schmidtke et 
al. (2010) [57] 
PocketFinder 
Fpocket 
SiteMap 
SiteFinder 
PDB 
4,711 proteins 
5,616 pockets 
11,510 apo 
pockets (> 1 per 
holo pocket) 
Huang & 
Schroeder 
(2006) [42] 
Weisel et al. 
(2007) [44] 
Kalidas & 
Chandra 
LIGSITE
(CSC) 
PASS 
CAST 
SURFNET 
subset of PLD 
[88] + 
subset of 
Nissink et al. 
210 proteins 48 proteins 
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(2008) [46] 
Le Guilloux et 
al. (2009) [55] 
PocketDepth 
PocketPicker 
Fpocket 
 
Because binding-site prediction tools locate multiple candidate pockets on the 
protein surface, they usually return a ranked list of candidates for evaluation by the user. 
The number of predictions can be anywhere from 10 to 30+ potential sites, but every 
method strives to place the most confident prediction among the top ranks. Examining 
the top ranks and visually comparing the location of the predicted pocket to the location 
of a co-crystallized ligand is sensible for a manual evaluation of several structures. A 
more systematic approach for determining a true pocket match is required for a large-
scale evaluation of an algorithm’s performance. Since every method is first 
benchmarked on known protein-ligand complexes, the proximity of a predicted pocket 
to the ligand is a common criterion. For example: the authors of PASS used a distance 
metric measured from a predicted active-site point (APS) to the nearest ligand atom (D-
near), and to the center of mass of the ligand (DCOM), to evaluate their results. An ASP 
was considered a “hit” if Dnear was < 4.0 Å. DCOM was used to assess the accuracy of the 
predictions with respect to varied ligand sizes [50]. Laurie and Jackson used a precision 
threshold to evaluate Q-SiteFinder, where “precision” was defined as the percentage of 
the probe sites in a predicted pocket within 1.6 Å of a ligand atom [43]. A prediction 
was considered a hit if the precision was > 25%. In comparing the Q-SiteFinder tool to 
LIGSITE (as implemented in Pocket-Finder), the metric gave the authors a common 
measure of prediction accuracy. However, methods that do not use probes or the 
concept of an ASP for their pocket definition cannot be effectively evaluated with this 
metric. The authors of PocketDepth used a volume overlap with respect to the ligand as 
a measure to define their successful predictions. If the predicted site volume overlaps 
the ligand volume by more than 10%, the prediction was considered a hit. PocketFinder 
also defines a cavity as a bounded volume, but the authors of this algorithm chose to 
evaluate its predictions by the overlap of protein atoms in the vicinity of the predicted 
pocket with those in the vicinity of the ligand [13]. They define the relative overlap 
(RO) as RO = (AL ∩ AE) / AL where AL is the solvent-accessible surface area of the 
protein atoms within 3.5 Å of the ligand, and AE is the solvent-accessible area of the 
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protein atoms within 3.5 Å of the predicted envelope.  A perfect prediction was 
considered RO = 1 and a failed prediction RO = 0, with predictions of RO > 0.5 being 
considered successful. This overlap criterion helped dissect the performance of 
PockerFinder with respect to the quality of its predictions. The disadvantage of this 
metric is that very large predicted pockets will achieve an RO = 1 while greatly over-
predicting the binding-site region (defining the whole protein surface as a predicted 
binding site, for example, would achieve an RO of 1). Thus, Schmidtke et al. introduced 
a mutual overlap (MO) metric to quantify fraction of the predicted pocket that overlaps 
with the predicted site [57]. It is defined as MO = (AL ∩ AE) / AE . Similarly to RO, an 
MO close or equal to 1 signifies a better match to the known ligand binding pocket. 
Since a small ligand can bind in a large pocket, an MO of 1 is not to be expected for 
every binding site, but very low values of MO can flag predicted sites that extend too 
far beyond the known pocket. Taking into account both RO and MO makes it possible 
to better assess the accuracy of a prediction, and the authors use both metrics to 
compare four different algorithms against each other and identify the methods prone to 
over-predicting the size of the binding site.  
Once a definition of a hit is determined, the algorithm’s success on a large test set 
can be quantified by counting the number of successful predictions with respect to the 
rank of those predictions. A “Top-Rank” success rate could be the percentage of the 
predicted pockets with rank 1 that were successful hits. Conversely, the percent of the 
successful predictions that are ranked 1 can be counted as the Top-Rank success rate. 
The two measures are similar but give slightly different information since more than 
one site on a protein can be a hit due to the presence of multiple ligands. Care should be 
taken when comparing the performance of different algorithms, as authors often select 
the metrics that work best with their particular algorithm and test set.  
1.4 Surface Area Calculations: NACCESS 
Methods designed to detect protein pockets are usually optimized to report 
geometric pocket-delineating features, such as volumes, or simply the member residues 
comprising the protein edge of the pocket. Many do not report individual residue 
properties, such as degree of solvent exposure or even molecular surface area (MSA). 
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Several methods have been established as gold standard approaches for such 
calculations during the early emergence of computational SBDD field. Lee and Richard 
formally defined the concept of the accessible surface area (ASA) in 1971 [89], and it 
was promptly implemented in an efficient “probe rolling” algorithm by Shrake and 
Rupley in 1973 [90]. The algorithm lays down a grid of points equidistant from each 
atom of the protein and then calculates the points that can be considered solvent 
accessible. Points are checked against the vdW radii of each neighboring atom to 
determine if they are “outside” the protein.  A similar check against the vdW radius plus 
a probe distance (usually 1.4Å, the radius of a water molecule) determines whether the 
point is solvent accessible. The surface points can then be used to calculate the ASA of 
each atom, and hence each protein residue. This method effectively represents a probe 
of a certain radius being rolled across the vdW surface of the atoms, with the probe 
center tracing out the ASA and the probe’s surface tracing the MSA. The algorithm 
depends on the choice of correct vdW and probe radii and the density of grid points, but 
it tends to produce an accurate ASA with a relatively efficient numerical method. This 
thesis uses NACCESS, a popular implementation of the Lee and Richard’s method by 
Hubbard and Thornton [91] to determine the ASA of each residue and define it as 
“surface” or “non-surface”. Alternative methods also exist for calculating ASA. The 
Connolly surface method, described earlier, is effectively the inverse of the Lee and 
Richard method, defining the surface from the point of view of the solvent rather than 
the protein atoms. Numerous algorithms have since attempted to improve the speed of 
these approaches and provide additional surface metrics, but the conceptual definition 
of ASA has remained relatively unchanged [92, 93].  
1.5 Scoring Protein-Ligand Binding 
A fundamental result of understanding protein-ligand binding is the ability to 
predicting a binding mode and affinity of a ligand to a specific protein. The task of 
molecular docking is to do just that – predict the structure of the protein-ligand complex 
starting with the knowledge of the protein and ligand structures on their own. Docking 
has two primarily challenges.  The first is to sample the conformational space of the 
protein-ligand complex to identify the possible binding modes of the ligand. The second 
28 
is to score the quality of these conformations relative to each other. The goal of a 
scoring function is to rank these different modes, either by estimating the true binding 
affinity of the ligand or by computing a relative score to differentiate the modes 
containing favorable protein-ligand interactions.  
The approaches to calculate an appropriate score come in three general classes. 
Force-field scoring functions like GOLD [94], DOCK [95], and AutoDock [96] use 
classical force fields like AMBER [97] or CHARMM [98] to obtain absolute binding 
energy values of the potential ligand poses. Empirical scoring functions decompose the 
energy functions found in the force-field methods into various classes of interactions, 
such as hydrogen bonding, ionic interactions, hydrophobic contacts, and penalties for 
entropic contributions. Although functional forms in empirical functions tend follow 
those in force-field based functions, they are usually simplified, and the relative weights 
of the interaction terms can be adjusted to fine-tune the scoring function performance 
using known binding data. The choice of which interaction terms to include and the 
relative weight of the terms can be an advantage by making the scoring functions more 
flexible, but it can also be a major hurdle in the development of a widely-applicable 
scoring method. Empirical scoring functions like F-Score [99] or X-Score [100] rely on 
large and diverse training sets with available binding data to appropriately parameterize 
their interaction terms.   
Finally, knowledge-based scoring functions use statistical analysis of large sets of 
protein-ligand complexes to derive potentials of mean force between a ligand and 
protein. Protein-ligand atom pairs from the PDB are used to obtain pairing preferences 
and estimate their likelihoods. This approach is based on the theory that a Boltzmann-
distribution rule for a single closed system held at fixed temperature is applicable to a 
database of structures [24]. The knowledge-based functions do not incorporate binding 
affinity data, which might make them more generally applicable due to the larger size of 
their training sets [24]. However, since these methods do not incorporate any first-
principle energy calculations, they must be used with caution when attempting to 
estimate absolute binding energies. Examples of knowledge-based scoring functions 
include DrugScore [23] and ITScore [24]. Some approaches use a “consensus” method 
to combine scores from different methods in an attempt to capture complementary 
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information inherent in the different classes of scoring functions. Scores in consensus 
methods may be combined using various schemes, such as voting, rank-voting, 
weighted-sum ranks, and other multivariate combination methods [101].   
Scoring functions can be evaluated on various criteria. A recent comparison of 11 
different scoring functions tested the ability of the functions to identify an 
experimentally observed ligand conformation from a series of permuted invalid 
conformations. Scoring functions from various classes performed equally well at 
identifying the conformation with F-Score, DrugScore, X-Score, and several others 
yielding success rates higher than the force-field based AutoDock [102]. Performance 
could be improved by combining several of the methods into a consensus scoring 
scheme. When the same functions were tasked with reproducing experimentally-
determined binding affinities for a series of protein-ligand complexes, only a few, 
including X-Score and DrugScore, were able to give correlation coefficients that are 
better than random [102]. A recent large-scale exercise aimed at the protein-ligand 
scoring community tested the ability of 19 different methods to reproduce absolute 
binding affinities in a set of 343 high-quality protein-ligand complexes [103]. The 
exercise showed that the highest performance achieved a correlation (R
2
) with 
experimental data of only 0.58. No family of methods was found to perform better than 
another, but subsets of complexes scored well/poorly by many methods were identified 
[12]. The difference between the sets of “easy” complexes and “hard” complexes were 
used to identify pitfalls common across all scoring approaches. These studies stress that 
despite significant progress, scoring functions used in molecular docking software 
remain an area with significant room for improvement [104, 105]. 
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CHAPTER II  
 
Updating and Extending the Binding MOAD Database 
 
2.1 Introduction 
Datasets of protein-ligand complexes with binding-affinity data were first used in 
the field of computational chemistry to develop scoring functions for small-molecule 
docking with the goal of improving the structure-based drug design (SBDD) process. In 
recent years, many sets of protein-ligand complexes have been accumulated in online 
databases to make them searchable, downloadable, and more useful to the scientific 
community. Some of the databases, like Binding MOAD, contain binding-affinity data 
for the complexes they collect; others focus on describing binding site properties or 
implement algorithms to assess binding site similarity. The largest and most relevant 
databases are outlined below, and their relative strengths and weaknesses with respect 
to Binding MOAD are highlighted. Our aim is to maintain Binding MOAD as the 
largest-possible collection of high-quality, protein-ligand complexes available from the 
Protein Data Bank (PDB) [2], augmented with the inclusion of binding-affinity data. 
Recently, we have undertaken an expansion of Binding MOAD to include information 
regarding which residues compose the individual binding sites. Also query tools have 
been developed for obtaining summary statistics of this data on large sets of protein-
ligand pairs. These extensions will make Binding MOAD an even more powerful tool 
for characterization of protein-ligand binding. 
The original release of Binding MOAD was created over 2001-2005, as described 
previously [106].  It has grown from 5331 protein-ligand complexes in its first release 
to its current collection of 14,720 complexes, with binding data available for 4782 
(32%) of these complexes [107, 108]. The current release contains 7,064 unique ligands 
annotated with their biological relevance, and it is grouped into 4,618 protein families at 
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90% sequence identity. This chapter details the current state of the Binding MOAD 
annual update process and describes an extension of the database architecture to store, 
analyze, and display residue composition in individual sites and sets of complexes.  
Other similar resources are described to provide a scope of the field and the impact of 
Binding MOAD. 
2.2 Protein-Ligand Databases  
Large, well-curated databases are essential for analyzing protein-ligand binding. 
They can be used for a myriad of applications, from developing and testing scoring 
functions for docking and screening to mining structural and physicochemical 
properties for classification, prediction, and comparison of protein-ligand interactions. 
Consequently, each database tries to provide a unique perspective on the way the data is 
assembled, curated, and presented. Below are details of several leading databases that 
contain binding affinity data and/or provide easily accessible data on the interacting 
residues of protein-ligand binding sites.  
BindingDB   
BindingDB was developed by Michael Gilson in 2001, and it is currently hosted at 
the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of 
California, San Diego [109]. The database contains over 781,000 high-quality binding 
data for 6,448 protein targets (some are isoforms or mutants), and over 342,000 
molecules. A significant portion of this data has been extracted from ChEMBL and 
PubChem databases. The data comes from isothermal calorimetry (ITC), Ki , EC50, and 
other experimental assays, all with annotated experimental conditions. BindingDB 
allows for deposition of novel binding data and has been growing at a steady pace. 
However, most complexes do not have associated crystal or NMR structures, as the 
focus is first and foremost on the binding data collection. Currently ~1500 BindingDB 
protein-ligand complexes can be un-ambiguously referenced to a PDB crystal structure 
(at 100% sequence identity). The database has excellent browse and search features and 
extensive cross-references. [url: http://www.bindingdb.org] 
PDBbind  
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PDBbind was originally developed hee at University of Michigan under Shaomeng 
Wang. It is currently maintained and developed by Renxiao Wang  at the Shanghai 
Institute of Organic Chemistry [110]. The latest PDBbind release contains structures 
and binding data for 7,986 complexes, including protein-nucleic acid, nucleic acid-
ligand, and protein-protein interactions. As in Binding MOAD, the binding data is 
collected from the primary publication of the respective crystal structure. In general, 
PDBbind is curated in a way similar to Binding MOAD, but it has some key differences. 
Unlike Binding MOAD, PDBbind does not have strict controls for protein quality, such 
as a threshold for electron density (crystal structures with resolution as large as 4.7Å are 
included). PDBbind limits its entries to complexes with only one ligand in the crystal 
structure, and it excludes any complexes that do not have binding data (e.g., the many 
structures with only simple cofactors bound are excluded). PDBbind is updated 
annually and provides a user-friendly interface for data search, browsing, and download. 
It is accessible to both academic and commercial users. [url: http://www.pdbbind-
cn.net/] 
Catalytic Site Atlas (CSA) 
The CSA is a comprehensive listing of protein residues with known catalytic 
function developed by Janet Thornton and hosted at the European Bioinformatics 
Institute [111]. The database currently contains 968 enzymes annotated based on 
evidence from the literature. A residue is listed only if the evidence shows a direct 
chemical function for that residue in the protein active site.  Additionally, CSA provides 
over 26,000 entries whose catalytic residues are inferred by strict PSI-BLAST 
alignment to the 968 curated entries. Since a protein structure is required to un-
ambiguously identify functional residues, all entries contain cross-references to their 
respective PDB entries. Extensive browsing and searching capabilities, as well as a 
downloadable file, are provided at the CSA website. Since CSA requires evidence of 
catalytic function on a per-residue basis, it represents a focused but limited view of the 
ligand binding site. Residues that might participate in important binding interactions but 
do not have a catalytic role are omitted. These excluded residues may help define the 
specificity of binding.[url: http://www.ebi.ac.uk/thornton-srv/databases/CSA/] 
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PDBeMotif (formerly MSDmotif & MSDsite)  
Originally developed by Kim Henrick, PDBeMotif is part of the PDBe (PDB 
Europe) suite of tools available at the European Bioinformatics Institute. PDBeMotif is 
less of a database and more of an interface, allowing one to search the full set of the 
structures available in the PDB with sequence, chemical structure, or 3D sub-structure 
[112]. In fact, the open source PDBeMotif tool can be freely downloaded and used on 
any set of public or private protein structures. The search capabilities allow one to 
examine characteristics of binding sites of single proteins or classes of proteins grouped 
by structural families (CATH, Pfam), functional families (EC, TIGR), or a number of 
other classification methods, such as genetic families or ProSite motifs.  Binding-site 
environmental characteristics include residue composition, conserved 3D structural 
features, various bond types (such as ionic, hydrogen bonds, or planar groups), and 
many others. They can be browsed per-structure or summarized for custom groups of 
proteins. PDBeMotif provides the most full-featured and fastest portal to the full variety 
of protein-ligand complexes present in the PDB. However, no quality control for protein 
structures is performed, and ligands are defined as any HETATM group, including 
modified amino acids that are part of the main protein chain. The burden of filtering the 
data to desired quality is left to user, although extensive search and filtering 
functionality is provided for this purpose. [url: http://www.ebi.ac.uk/pdbe-
site/pdbemotif/]  
FireDB  
FireDB is a database enumerating residues involved in ligand binding in protein 
structures available from the PDB [34]. FireDB was developed by Alfonso Valencia 
and is hosted at the Spanish National Cancer Research Center. The current release of 
the database contains over 170,000 unique protein chains and over 13,000 
accompanying molecular compounds. The ligand-binding residues are identified at 
several distance cutoffs from the ligand (3.5, 4.0, and 4.5Å), and functional annotations 
are transferred from the Catalytic Site Atlas (see above). The database also clusters 
protein sequences at 97% sequence identity and generates consensus lists of binding-
site residue contacts. The conservation of binding sites across all proteins is also 
considered, and tools are provided to explore evolutionary relationships of distantly 
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related proteins with conserved binding sites.  Some ligand filtering is performed to 
eliminate solvents, ions, DNA, RNA, peptides, and uncommonly large ligands (where 
the ligand is two-thirds the size of the protein). FireDB allows NMR structures and has 
no criteria for excluding low-quality protein structures. [url: 
http://firedb.bioinfo.cnio.es/Php/FireDB.php] 
POCKETOME 
The Pocketome is a collection of experimentally identified (i.e. crystal structure), 
small-molecule binding pockets that was developed by Ruben Abagyan. It is hosted at 
the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of 
California, San Diego. Each entry in the Pocketome corresponds to a small-molecule 
binding site in a protein that is represented by at least two PDB entries, , has been co-
crystallized with at least one drug-like small molecule, has an associated UniProt entry.. 
Unbound crystal structures are also included if they meet the quality criteria. The 
dataset was originally compiled to evaluate the PocketFinder binding-site prediction 
algorithm. It was also made available as a searchable online database. The database 
included more than 5500 bound structures and twice as many un-bound structures in its 
original form (not every holo structure has an apo structure), and it has been updated 
periodically to keep pace with the growth of the PDB. Currently, the online database 
contains 988 entries, which encompass more than 11,000 PDB structures. However, an 
objective analysis of the content is difficult because bulk download of the annotated 
database is not available. Multiple examples of the same binding site in different crystal 
structures are aligned and compared to each other to calculate pair-wise, pocket-ligand 
steric clashes, binding-site atom RMSD, and overall shape similarity of the pockets. For 
each entry, a residue contact map is provided summarizing ligand-contacting residues in 
all structures in the entry. Each entry can be visualized via the web browser or 
downloaded for local analysis using the Molsoft ActiveICM software [113]. [url: 
http://www.pocketome.org] 
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2.3 Binding MOAD Annual Update 
As the number of high-quality structures annually deposited to the PDB continues to 
grow (Figure II-1), a thorough and efficient annual-update process is crucial to keeping 
Binding MOAD up-to-date with the available data. During creation of Binding MOAD, 
care was taken to automate as many steps of the data processing and curation as 
possible. Still, many steps require manual interpretation of the data, and constant 
improvements in Binding MOAD’s primary data source – the PDB – require 
appropriate adjustments and corrections to the process. While the details of the Binding 
MOAD pipeline have been described elsewhere, the general outline along with 
improvements and extensions to the procedure is described below.  
Figure II-1: Annual growth of the PDB. Figure from rscb.org 
 
To ensure that every protein-ligand pair in Binding MOAD has an associated 
protein structure, the database is updated in a top-down approach, starting with all the 
protein structures submitted to the PDB over the previous calendar year (Figure II-2). 
Initial filtering of acceptable structures is performed by automated scripts, and any 
ambiguous cases are flagged for further manual examination. The manual-examination 
step also entails the look-up of any binding data available in the primary literature for 
the crystal structure.  After the manual curation has been completed, all proteins that 
have not been rejected are clustered into families with existing Binding MOAD entries, 
and a representative leader is chosen for each family. Once the families and leaders are 
determined, the annual update is complete, and the production server that drives the 
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Binding MOAD website is loaded with the new dataset. Below is a summary of the 
individual steps in the above process.  
Figure II-2: Annual update of the Binding MOAD database and description of the individual steps. 
 
Annual steps to update Binding MOAD: 
1. Use the PDB's list of obsolete entries to identify any 
existing structures in Binding MOAD that should be 
removed. 
2. The previous version of the PDB download is compared 
to the new download to identify all new structures that 
have been added to the PDB since the last version of 
Binding MOAD was created. Biounit files are 
downloaded for the new entries. 
3. Good and suspect protein-ligand complexes are identified 
in the new structures using our filtering scripts. 
4. Any new HETs must be classified as suitable ligands or 
added to the suspect, partial, or reject lists. 
5. Literature references are scraped as HTML from publisher 
websites and loaded into BUDA – a tool designed to 
facilitate manual look up of binding or kinetic values.  
6. Sequences are added to existing classes and protein 
families, but regrouping all sequences from scratch may 
be necessary to periodically confirm our protein classes 
and families. 
7. Each new structure is compared with the leader of its 
homologous protein family to determine if the new 
structure is a better representative of the family. Any new 
families are also evaluated to choose leaders. 
8. Updated data is loaded into the Binding MOAD database. 
 
2.3.1 Automatic Filtering Scripts 
Remediated biounit PDB files are retrieved from the RSCB website. The use of 
biounits instead of mmCIF format files that were initially used to create Binding 
MOAD was promted by the PDB’s commitment to the format and the 2006 remediation 
that fixed numerous issues in the biounit files. The biounit also provides the most 
biologically-appropriare structure of the protein, important when annotating the protein 
with binding data that was likely obtained using the biologically-relevant protein form. 
The biounit files are processed with a series of Perl scripts that use the Bioperl library 
parser to interpret the PDB format data. Ligands and protein atoms are identified using 
a combination of SEQRES and HETATM records. Multi-part ligands – those that 
contain more than one HET group – are identified by their spatial proximity, and every 
ligand is checked for covalency by measuring the distance to the closest protein atom. A 
multi-part name is constructed for a multi-part ligand based on its component HET 
groups. Any ligand within 2.1 – 2.4 Å of the protein is flagged as suspect and examined 
manually. Short contacts to metals are also examined manually to differentiate 
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coordinated ions in metal-containing enzymes from covalently bound metals, such as 
the iron present in heme groups.  Ligands are flagged as “suspect” according to their 
memberships in our list of unusual HET groups (Table II-1). 
Table II-1:Definition of unusual HET groups. For brevity, not all compounds are listed.  
Classification Ligand Types (Examples) 
Suspect Ligands 
(111) 
Sugars (glucose, galactose, fructose, xylose, sucrose, b-D-
xylopyranose,trehalose) 
Small organic molecules (phenol, benzene, toluene, t-butyl 
alcohol) 
Membrane components (phosphatidylethanolamine, palmitic 
acid, decanoic acid) 
Small metabolites that may be buffer components (citric acid, 
succinate, tartaric acid) 
Partial Ligands 
(78) 
Chemical groups (amino group, ethyl group, butyl group, 
methoxy, methyl amine) 
Inorganic centers of transition state or product mimics (aluminum 
fluorides, beryllium fluorides, boronic acids) 
Modifications to amino acids (oxygens of oxidized CYS, 
phosphate group on TYR) 
Rejected Ligands 
(511) 
Unknown or dummy groups (UNK, DUM, unknown nucleic 
acid, fragment of) 
Salts and buffers (Na
+
, K
+
, CI
-
, PO4
-3
 , CHAPS, TRIS, tetramethyl 
ammonium ion) 
Solvents (DMSO, hexane, acetone, hydrogen peroxide) 
Crystal additives and detergents (polyethylene glycol, 
oxtoxynol-10,dodecyl sulfate, methyl paraben, 2,3 
propanediol, pentaethylene glycol, cibacron blue) 
Metal complexes that associate to the protein surface and are used 
for phase resolution (terpyridine platinum, bis bipyridine 
imidazole osmium) 
Metal ions that are part of the protein (Mg
+2
, Zn
+2
, Mn
+2
, Fe
+2
, 
Fe
+3
) 
Catalytic centers that are part of the protein (4Fe-4S cluster, Ni-Fe 
active center) 
Heme groups (heme D, bateriochlorophyll, cobatamin, 
protoporphyrin IX) 
2.3.2 By-Hand Curation of the Data 
Literature citations for all structures passing the automatic filtering scripts are read 
to confirm the validity of the ligands and record the binding data, if present. Suspect 
ligands are also examined at this step. Suspect ligands may be valid in cases where they 
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are actually products or reactants of an enzyme or otherwise take part in protein 
function. Partial ligands are molecules that cannot be a ligand on their own and are 
often components of multi-part ligands. In rare cases, even the ligands on the rejected 
ligand list may be marked as valid. This usually occurs in case of crystal additives and 
detergents, which are sometimes present in the structure as an enzyme reactant or target 
of a transport protein, as opposed to simply being a component of the crystallization 
medium. The information in the literature citation is normally sufficient to determine 
whether the ligand is a biologically relevant molecule or should be considered invalid. 
The reasons for retaining a suspect, partial, or rejected ligand as a valid ligand are 
recorded in a comment field for future reference.   
We have recently incorporated a browser-based tool that uses natural language 
processing (NLP) to assist with locating binding data and annotating ligand validity. 
The tool, termed BUDA, was developed in collaboration with Torrey Path LLC 
(formerly Metamatics LLC), and it is now hosted locally as an integral part of the 
annual update process. Literature citations are given a score based on the probability of 
containing binding data, as determined by an NLP text-mining algorithm. Citations with 
higher scores are examined first. To aid the examination, words and sentences 
indicating the likely location of the binding constant are highlighted in an HTML 
version of the citation. Once a binding constant is identified, it is recorded right in the 
browser-based application. Ligands can also be toggled as valid or invalid, and 
comments supporting an annotation call can be associated with each protein-ligand pair. 
All information is immediately saved to a database and exported to Binding MOAD 
once all structures are processed. The BUDA application greatly speeds up the manual 
curation process by improving the search for binding data and reducing errors in 
formatting and spelling that are otherwise inherent in free-text entry (such as using a 
spreadsheet).  
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Figure II-3: Literature citation analysis tool (BUDA). Inset shows text highlighting that identified 
sentences likely to contain binding data. Data and ligand annotations are recorded in allocated 
fields and saved for eventual export to Binding MOAD. 
 
2.3.3 Grouping Proteins to Address Redundancy 
Redundancy of proteins present in the PDB is addressed at two levels in Binding 
MOAD. The majority of the proteins deposited in the PDB are enzymes, and enzyme 
classification (EC) codes are used to broadly group entries into functionally similar 
classes. Within these classes, and among the non-enzymes, proteins are grouped into 
homologous protein families based on sequence similarity (Figure II-2).  
For each Binding MOAD update cycle all proteins (newly filtered and those from 
previous years) are aligned by BLASTp [114]. A cutoff of 90% sequence identity is 
used to group entries into a family. Enzyme proteins that match entries in multiple EC 
classes are only assigned a single EC class (see [106] for clustering details) and are only 
present in a single family. For each family, a best representative “leader” structure is 
chosen. The leader is the structure with the tightest binding ligand. If a family has no 
entries with binding data, the following order of priorities is used for choosing a leader: 
1. best resolution, 2. wild-type structure over mutants, 3. most recent deposition date, 
and finally 4. when all the criteria are the same, the leader is chosen based on comments 
in the crystallography paper. 
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2.3.4 Importing SMILES and Ensuring Ligand-Name Consistency 
HET groups in the PDB are periodically remediated to eliminate redundant names 
or enforce a specific formatting for existing names. Since Binding MOAD only imports 
new structures during the annual update, outdated ligand HET names can accumulate in 
the database. As part of an effort in this thesis to examine protein-ligand binding sites, 
the consistency of ligand names in Binding MOAD needs to be ensured. An additional 
step was implemented in the 2008 Binding MOAD update to synchronize Binding 
MOAD ligand names with the most up-to-date HET group and to import standardized 
SMILES strings for identifying unique ligand structures. The Chemical Component 
Dictionary (CCD) [115] distributed by the PDB contains all the single-HET names and 
formulas present in the PDB. A current version of the CCD database (in SQL format) is 
downloaded, and every HET group name in Binding MOAD is checked against the 
database. Standard OpenEye SMILES strings for single HET groups are imported from 
the CCD directly into the Binding MOAD database to supplement ligand information 
already stored in Binding MOAD. A cross-reference list of obsolete HET codes and 
their superseding versions is compiled and saved separately from the database. Multi-
part ligands are also checked to make sure any component HETs have not been 
superseded. As opposed to the SMILES, the ligands names are not corrected in the 
Binding MOAD database itself. This would introduce inconsistency with respect to the 
biounit files that accompany the Binding MOAD database. Since previous years’ 
biounits are not re-downloaded during the annual update, they will not contain the 
updated HET group names. A Python script handles the SMILES import and the 
construction of the HET name cross-reference list.   
2.4 Extension of Binding MOAD for Binding Site Analysis 
Currently, the relational database and object model underlying the Binding MOAD 
database is optimized for serving binding data on individual protein-ligand pairings and 
the organization of that data with respect to protein families and Enzyme Classification 
(EC) classes. Every unique protein-ligand pair is associated with binding data, if 
available, and the protein and ligand are in turn linked to additional annotation, such as 
the 90% sequence identity bin for the protein and the type for the ligand (valid or 
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invalid). Associated structure data is also available in the form of the original PDB 
biounit containing the protein-ligand pair and a SMILES string encoding the 2D 
molecular structure for most ligands. Although the Binding MOAD curation pipeline 
performs many useful calculations on the biounit structures to identify multi-part, 
covalently attached, and suspect covalent ligands, no references between the ligand 
definition and the biounit structure are stored in the relational database. Since the 
biounit file may have multiple ligand locations, unconventional labeling of chains or 
residues, or other inconsistencies inherent in structural-data files, matching the ligand 
name provided by Binding MOAD to the atomic coordinates is not always a 
straightforward process. In order to perform the rigorous and efficient analysis of 
protein-ligand binding sites described in this thesis, an extension of the relational 
database was implemented to directly link existing Binding MOAD annotation data to 
structural data in the biounit files. Aside from being used for analysis of binding site 
propensities in this thesis, the current implementation of the extended database is 
undergoing internal testing and evaluation for eventual incorporation into the publicly 
accessible Binding MOAD website.  
2.4.1 Relational Database Object Model 
To comply with the current implementation of the Binding MOAD database, all 
extensions to the relational model were developed using MySQL Server conventions 
(version 5.1). The initial point of extension was the LigandSuperRelation table (Figure 
II-4A), which maintains a binding-pair relationship between a PDB ID and a ligand that 
is uniquely identified by its HET group name. The goal of the extension is to create a 
binding-site definition where ligand uniqueness is defined by the coordinates of the 
specific ligand residues in the structure file. This approach extends the protein-ligand 
pairs with specifics about the interacting residues and atoms. This implies that a many-
to-one relationship can exist between a structure-based binding site and a 
LigandSuperRelation binding pair. For example, multiple sulphate (SO4) molecules (a 
frequent invalid ligand) can be present in a PDB biounit structure, and each of the 
molecules will have a unique location on the protein surface and unique set of 
interacting binding-site residues. Meanwhile, only one LigandSuperRelation will exist 
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between the protein PDB ID and the ligand named SO4 in the current Binding MOAD 
architecture. Therefore, the extended schema introduces the BindingSite object, which 
represents a structurally-unique protein-ligand pairing (middle of Figure II-4B). Several 
tables record the residue-residue and atom-atom interactions between the ligand and 
protein and tie in the structural data into the binding-site definition. Finally, a set of 
tables models the structure-chain-residue-atom hierarchy of the PDB file and stores 
residue and atom identities. Additional residue-level and atom-level data, such as 
solvent-accessible area and atomic coordinates, are also stored. The full entity relation 
(ER) diagram of the database schema is presented at the end of this chapter in Figure 
II-7.  
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Figure II-4: Simplified entity relation diagram for the Binding MOAD relational database, 
illustrating the relationship between A) the protein, ligand, and binding-data annotations in the 
existing schema and B) the structure’s  residue, atom, protein-ligand interaction, and residue-count 
data in the extended schema. There is a one-to-many relationship between the central table in A 
(ligandsuperrelationejb) and central table in B (moabs_bindingsite). Some tables and fields omitted 
for clarity.  
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In the extended object model, all information regarding chain and residue identity is 
recorded for each protein in Binding MOAD as it occurs in the PDB biounit file(s). This 
information is stored only once for each protein, as it is independent from the binding-
site definition. Primary keys are generated for all the Chain, Residue, and Atom objects 
for unique identification that is independent of the chain, residue, or atoms IDs of the 
PDB format. A BindingSite object is defined relative to this structural information, and 
it does not store any of the structural data itself.  The BindingSite object serves to make 
two important conceptual relations that extend the protein-ligand pair defined by 
LigandSuperRelation: the first is to the chain in the biounit file that contains the ligand, 
and the second is to the set of protein residues that are members of the binding site. For 
one protein-ligand pair, there can be multiple ligand chains in the structure file that 
represent the ligand. In turn, for each of the ligand chains, its respective binding site 
residues on the protein are conditional on the interaction criteria between the ligand and 
protein atom. Depending on the intended data analysis, multiple criteria for defining a 
binding site may be used, and thus, multiple binding sites can be defined for each ligand 
chain, each with their own set of protein-ligand interactions. The ResidueRelation and 
AtomRelation objects (Protein-Ligand Contacts box in Figure II-4) store the 
relationships between Residue and Atom objects (Structure Data box in Figure II-4) that 
constitute the binding site specified by the BindingSite object. This relationship model 
is simple yet powerful. It keeps the primary structure data separate from the concept of 
a binding site, and it can be easily modified and extended with any novel binding-site 
definition criteria. Conversely, any update to chain or residue information in the biounit 
file that does not affect the atomic coordinates (a change in HET name or residue re-
indexing) can be propagated to the database without the need to update the binding-site 
definition tables.  
A major goal of this thesis work is to calculate propensities of residues in 
collections of binding sites. This requires the calculation of residue frequencies in 
binding sites and in the whole protein. The simple relational model described so far can 
be used to count the residues and calculate the relevant frequency and propensity 
statistics. However, even with improved speed of querying provided by indexing and 
query optimization, the retrieval of individual residues on-demand is prohibitively 
45 
expensive for a large set of structures. To improve queries of residue content for 
multiple structures, additional tables are provided for storing pre-calculated residue 
counts for each protein and each BindingSite object. These ProteinCount and 
BindingSiteCount objects store total residue counts for each of the 20 amino acids in 
individual fields and a vector array of these totals in a single field. This data has to be 
computed ahead of time, but it results in significant speedup when querying binding-site 
composition. Just like there can be multiple BindingSite objects for each ligand chain, 
there can be many ProteinCount or BindingSiteCount objects for different counting 
criteria. For example, a ProteinCount object can record the residue totals for the protein 
surface or the residue totals for the protein as a whole. For the same BindingSite object, 
there might be a BindingSiteCount object with totals of residues that only have side-
chain interactions with the ligand and one object with totals of residues that have 
backbone interactions. Propensities for a set of protein-ligand pairs of interest can 
quickly be computed from queries to the respective BindingSiteCount and ProteinCount 
objects, avoiding numerous small queries against the ResidueRelation and Residue 
tables. This is particularly important when analyzing the data may require inspection of 
multiple subsets or the assessment of certain criteria’s impact upon the resulting data 
(i.e., what happens if a parameter changes, or how do subsets compare to each other). 
This speedup is important, as the latter query would result in prohibitively long wait 
times for a web-facing implementation like BindingMOAD.org. While further 
optimization of these pre-calculated residue totals is possible, the current 
implementation strikes a balance between usability and speed that is sufficient for 
current analyses.   
2.4.2 Framework for Import, Processing, and Analysis of Binding Site Data 
The extended version of Binding MOAD with additional binding-site data was 
prototyped independently of the Binding MOAD update process, and it is currently 
implemented as a stand-alone application with a MySQL database backend and Python-
based Django web framework front-end (Figure II-5).  The first challenge in creating 
the database of binding-site information is populating the data in a manner consistent 
with existing Binding MOAD conventions. A series of Python scripts were developed 
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for loading the data into the extended relational database. The import scripts use the 
existing Binding MOAD SQL database to obtain the PDB biounit file name and the 
names of ligands present in the biounit; then it parses the biounit file (mmLib parser is 
used) to identify and load the ligand- and protein- residue information. The identified 
ligands are then extracted from the biounit files, and the un-liganded structure is 
processed by NACCESS [91] to calculate the solvent accessible surface area (SASA) of 
each residue. Then the scripts directly load the structure, binding site, and SASA data 
into a new database using MySQLdb Python libraries. The direct data load ensures that 
database object relations are kept consistent, and it eliminates extra steps of 
writing/loading data to/from flat files.   
Figure II-5: Implementation of the extended Binding MOAD database. Scripts are used to load the 
extended database. A Django-powered front end implements data analysis and display functions.  
 
As previously described, Binding MOAD uses a series of heuristics to ensure the 
definitions of the ligand names are as accurate as possible for multi-part and suspect 
ligands. However, since specific chain and residue names are not recorded, the binding 
site import scripts need to re-trace certain parts of the heuristic analysis to try and 
unambiguously match an existing ligand name to its corresponding HETATM records 
in the structure file. For a majority of single HET group ligands, this process is 
straightforward; a simple name match to a HETATM residue name is sufficient. If 
multiple heteroresidues with that name are found, each is recorded separately (chain 
names are kept if unique, or mapped to unique pseudo-chain names based on residue 
indices). Multi-part ligands can be problematic as the ordering of the HET groups in the 
ligand name might not match the order of the residues in the structure file. This is 
especially true for structures that have multiple-sugar ligands present. Sugar chains tend 
to be fragmented, and if the chain information in the biounit file does not uniquely 
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identify the various fragments, telling the individual (un-connected) fragments apart 
might be near-impossible by name alone. A series of heuristics attempts to match the 
multi-part ligand name to the corresponding set of HET groups in the biounit file. 
Binding-site data is only imported for un-ambiguously identified ligands to prevent 
inaccurate binding-site definition or inconsistencies with the name-based ligand 
definition in the existing Binding MOAD database. Additional biounit quality issues, 
such as erroneous residue indexing or partially-missing ligand data, can also prevent un-
ambiguous identification. As a result of these limitations, about 8% of protein-ligand 
pairs in Binding MOAD are not extended with structural binding-site data. We may see 
a slight decrease in this failure rate once the import of the binding sites is incorporated 
into the Binding MOAD update process and the heuristics for ligand identification are 
unified.  
With the ligand chain and residue(s) identified, binding-site residues in the protein 
are defined using a distance cutoff from the atoms in the ligand chain. ResidueRelation 
and AtomRelation records are populated with interacting residues and atoms, 
respectively. For an interacting residue, all protein-ligand atom pairs within the 
interaction distance are noted in the AtomRelation table, along with the absolute 
distances to the ligand atom. Since this distance information is retained, a post-
processing step can re-define binding sites with interaction cutoffs smaller than the 
distance used to populate the database. Currently, the atom information is stored only 
for the binding-site residues and the ligand molecule. Storing all the protein atoms in 
the database is possible, of course, but the extra data significantly increases the size of 
the database from several hundred megabytes to several gigabytes, with a deleterious 
effect on query performance and without benefit to the intended data analysis. 
The identified ligand chains are also used to create an un-liganded version of the 
biounit file, extracting all valid and invalid ligands that are not part of the protein.  The 
SASA of every residue in the un-liganded structure is then calculated by NACCESS 
[91], ignoring any heteroatoms and water molecules remaining in the structure. 
Absolute and relative SASA for each residue side chain and main chain is recorded in 
the database. The default definition of a surface residue in this thesis is ≥5Å2 of side-
chain or main-chain SASA, and the surface residues are flagged as such to avoid 
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querying the raw SASAs numbers when compiling lists of surface residues. However, 
as with binding site residues, storing the raw data allows for an easy re-classification of 
which residues are considered surface at a later time. 
The Python import scripts directly load all the data into the MySQL database, at 
which point the binding-site data is ready for mining. The development of the data 
model and the optimal query methods required multiple development/testing cycles, and 
the Python-based Django web framework was used as a prototype front-end for 
processing and querying the database. Django is an open-source project designed for 
quick development of web-based applications, but its strength lies in providing an 
object-oriented database interface that is optimized for querying, filtering, and 
otherwise manipulating a MySQL data source. In other words, the developer does not 
have to write the raw SQL queries for retrieving or writing data from/to the database, 
but instead, can use Python classes and Django’s programmer-friendly syntax to build 
complex and flexible queries in a fraction of the time. This simplifies application 
development by allowing the developer to concentrate perfecting the methodology 
behind the data-mining code. On the user-facing side of the application, a light-weight 
web server and a feature-rich webpage template system provided in Django allow for a 
quick mock-up of a user-friendly interface for executing queries and displaying the 
results of the data processing. This interface uses standard HTML fields for specifying 
queries and displaying raw data in report form, and it was supplemented with Google 
Charts components for graphical display of key results. A simple example of a query for 
residue propensities, and the query result, is provided in Figure II-6. Developing the 
binding-site analysis code as a web-based application helped guide the relational 
database design for eventual incorporation into the existing Binding MOAD database 
and web server. Moreover, it provided a convenient interface for the retrieval of the 
binding-site information prior to its incorporation into the Binding MOAD web server. 
This made the binding-site data available for internal use by any lab members, without 
requiring them to write their own scripts for accessing the relational database. 
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Figure II-6: Example of a query for calculating residue propensities for a set of binding sites (in this 
case all valid binding sites with side-chain contact residues in non-redundant proteins of the Ligase 
enzyme class) and the resulting graphical and raw-data output.  
Query Result 
 
 
2.4.3 Optimizing Data Mining for a Web Interface 
Incorporating binding-site data into the Binding MOAD database has several 
intended uses: 
1. Retrieve a single ligand binding site and its residue content. 
a. Visualize the binding-site residues.  
2. Query a group of ligand-binding sites for residue frequencies or propensities. 
3. Retrieve binding sites similar in residue composition to the query. 
The first use case is the simplest, and does not require extensive database querying. 
The use case in 1a is also straightforward, and currently, a Python script can be 
generated for visualization of any binding site in PyMol [116]. Use cases 2 and 3 
require querying large numbers of binding sites, several thousand in worst case 
scenarios, and thus require appropriate optimizations. The largest speed-up in querying 
binding-site residues can be achieved by pre-calculating residue count totals and storing 
them in the database. A series of pre-processing functions are used to accomplish this 
after the data import has been completed and before the database is deployed for 
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querying. As noted in Figure II-4, the extended database schema allocates several tables 
for pre-calculated binding-site data (ProteinCounts and BindingSiteCounts objects). The 
pre-processing functions iterate through all the proteins in the database and add their 
surface residues, storing the totals in the ProteinCounts table for each protein structure 
entry. Two ProteinCounts records are created for each protein, one for totals of surface 
residues with exposed side chains and one for residues with exposed main chains. 
Similarly, for each unique binding site in the database, the totals for side-chain and 
main-chain surface residues for the 20 standard amino acids are calculated and placed in 
the BindingSiteCounts table. This pre-calculated data makes it simple to retrieve the 
member residues of a binding site if the BindingSite primary key is known instead of 
executing a multi-table join query with BindingSite, ResidueRelation, and Residue 
tables. The binding-site similarity data for use case 3 is also pre-calculated, using 
Tanimoto similarity of the residue count vectors, and stored in a separate table for easy 
retrieval by BindingSite primary key. Additional efficiency of database queries could be 
achieved by optimizing the actual query commands used to retrieve the data, but Django 
already implements query optimization, and for our purposes, simply following the 
best-practice conventions of the Django query syntax is sufficient for ensuring query 
optimality.  
After the data has been retrieved from the database, the second major bottleneck to 
serving the result back to the user is the calculation of actual residue frequencies and 
propensities. This is an issue mainly for use case 2, where residue counts of several 
thousand binding sites need to be added and divided thousands of times for assessment 
of confidence intervals. Since it is impossible to pre-calculate frequencies for every 
desired subset of binding sites, the propensity calculations and the sampling need to be 
performed on the fly.  Luckily, the NumPy scientific computing library for Python 
provides a set of powerful vector-based numerical functions for quick calculations on 
massive amounts of data. NumPy functions are leveraged extensively for the propensity 
calculations, and they provide a major speed-up as compared to generic Python math 
libraries. Once the residue-count data is retrieved from the database, it is stored in a 
NumPy matrix, which can be easily sliced to produce sub-sampled of the data. This 
makes propensity calculation for sampling runs lightning-fast. In fact, the current rate-
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limiting step in calculating the propensities for large sets of binding sites is still the 
database-query step. All code dependent on the NumPy library is implemented in a 
separate Python module to facilitate possible future use with a non-Python web 
framework, such as the Java-based JBoss Application Server, the framework for the 
current Binding MOAD implementation.  
With currently implemented optimizations, worst-case queries for residue 
propensity data (5000+ proteins) take between 5 and 10 minutes to execute. While this 
processing time is still well above the less-than-a-minute wait time that most web users 
expect from a website, it can be further streamlined for a production version of the 
Binding MOAD server.  The overall goal of the optimizations developed as part of this 
thesis was to construct a relational schema and processing code that is consistent with 
current best-practices in database and code design. The current implementation of the 
extended Binding MOAD database allows for extremely flexible queries of the binding 
sites present in Binding MOAD, and it provides results within minutes. The loss of 
speed that comes from using a relational database instead of flat files is counterbalanced 
by the ease of formulating complex queries and the existence of a user-friendly front 
end for internal laboratory use. More importantly, the use of the relational database 
schema that extends Binding MOAD’s current relational object model will facilitate the 
incorporation of the binding-site data into the existing Binding MOAD web server.  
2.5 Future Directions for the Extension of Binding MOAD  
The extended relational database described above will be integrated into the Binding 
MOAD application server and web site before the next annual update process. The 
Python code used to calculate sampled residue frequencies and propensities can be re-
factored into Java code compatible with the Java Beans currently powering the Binding 
MOAD website, or it can be used as a standalone module, providing functionality 
through a Java linker function. No special webpage elements are needed to display the 
residue count or propensity on the Binding MOAD website, unless summary graphs are 
desired. Such graphs can be implemented using Google Graphs components or plotting 
libraries such as gnuplot or matplotlib, all of which can generate plots on-demand with 
the speed required for a web application. Under the JBoss framework, the Binding 
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MOAD server is rebuilt whenever the database or component code is updated. To 
improve performance, any graphics for individual binding sites (or even sets of binding 
sites) can be pre-generated during the rebuild.  
Incorporating binding-site residue data into the Binding MOAD web application 
will give users a wider set of tools for exploring the database. For example, a user may 
wish to view the residue content of binding sites in a particular protein family to 
ascertain the variation in the ligand-binding environment. This is similar to residue 
conservation information provided by the Pocketome and PDBeMotif databases, and it 
may be presented graphically or via raw statistics. The user would also be able to 
compare a binding site to others in the database using their composition, either by 
retrieving sites similar to a known site or similar to a desired query pattern. Comparing 
the composition of two sites can be reduced to a vector distance calculation, and 
familiar distance metrics such as Tanimoto or RMSD will provide intuitive and 
adjustable cutoffs for defining relevant matches.  
 A unique feature of the Binding MOAD binding-site set will be the ability to 
generate residue frequencies and propensities for an arbitrary set of protein-ligand sites. 
These residue statistics can be pre-computed for the protein families and EC classes that 
are already incorporated into Binding MOAD. They will also be available for any result 
set of a Binding MOAD query, which currently includes search parameters for HET 
groups, protein names, structure-resolution cutoffs, and presence of binding data. 
Additional search parameters for ligand validity and type of protein-ligand contacts will 
also be included for propensity queries. Sampling techniques used in this thesis will be 
applied to provide a user with statistical confidence of the obtained propensity values. 
The functionality to compare propensities from one query to the propensities from 
another query and test the statistical significance of the differences can also be easily 
implemented in the current framework. The combination of these search criteria and the 
ability to return summary data of residue content for any query will distinguish Binding 
MOAD from existing protein-ligand databases. 
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Figure II-7: Entity relationship diagram of the extension to the Binding MOAD relational object 
model. The schema is derived directly from the MySQL database. Tables that store the structural 
information are on the left. Tables that store the binding-site residue relationships are on the upper 
right. Tables that store pre-calculate residue-count data are on the lower right. The 
moabs_bindingsite table (middle of figure) provides a foreign key to the existing Binding MOAD 
schema. 
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CHAPTER III  
 
Exploring the Composition of Protein-Ligand Binding Sites on a Large 
Scale 
 
3.1 Introduction 
Understanding general properties of protein-ligand binding sites is of great 
importance if we are to gain insight into the functional diversity of the proteome. One of 
the most fundamental properties of the receptor surface is the set of amino acids 
available for interactions with ligands. In many protein families, this set is well known 
and structurally conserved due to the functional role of the residues, and several 
insightful studies have summarized catalytic residue content in sets of enzymes [31] 
[117, 118]. However, the more general trend of amino-acid distribution within binding 
sites across a variety of protein and ligand types is less understood; previous studies 
have explored limited sets of proteins [37] or interactions of specific interest [119]. 
With ever-increasing numbers of protein structures available and numerous databases 
dedicated to protein-ligand analysis [34, 47, 88, 107, 112], a wider view of the residue 
composition of binding sites is now possible and necessary. Establishing general trends 
of binding-site composition can help develop valuable tools for identifying a protein 
functional site without prior information about the protein’s sequence or structural 
homology. Such tools can be invaluable for the characterization of proteins of unknown 
function emerging from current structural genomics projects [120]. The recent use of 
binding-site composition to bolster methods for de novo prediction of binding sites [18, 
33, 121] [122] is an encouraging example of the utility of the general binding-site 
composition trends. 
To study the composition of ligand binding sites across the broadest set of available 
protein structures, we analyzed the propensity of residues in all the binding sites present 
in the Binding MOAD database - one of the largest sets of curated protein-ligand 
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complexes [107]. Our analysis summarizes surface composition of binding sites of 
biologically relevant ligands, such as natural reactants, drugs, and co-factors. We also 
show how composition of binding-site surfaces varies with number of structures 
analyzed; this measure of statistical significance is not presented to this extent in other 
studies to date. Another unique aspect of this study is our examination of the binding of 
spurious co-crystals, such as crystallization buffers, solvents, and stray ions, which 
exhibit markedly different trends than the binding of functional ligands.   
3.2 Methods 
3.2.1 Large, Non-Redundant Binding-Site Dataset 
We began by assembling a non-redundant set of 3295 protein-ligand structures, each 
representing a closely related protein family from the 2009 release of Binding MOAD. 
The non-redundant set of Binding MOAD is composed of families grouped by 90% 
sequence identity; the 3295 complexes embody the variation of the full set of 14,720 
complexes with 41,721 binding sites. A binding site was defined as the set of protein 
residues which have at least one non-hydrogen atom within 4.0 Å of a ligand’s non-
hydrogen atom. These residue interactions were then labeled as side chain (SC) or 
backbone-only (BB-only) depending upon which atoms participated in the interaction. 
A residue classified with a BB-only interaction did not have any side-chain atoms 
within the interaction distance. Residues were classified as SC if the interaction was 
solely through the side chain or through both its side chain and backbone atoms. 
Glycine residues are considered a special case, and their interactions are always 
classified as SC regardless of the absence of a side chain. A single protein residue could 
have interactions with more than one ligand, in which case the residue interactions were 
considered independent, and the residue was included in each ligand’s binding site. 
Since a ligand-based definition of the binding site was used, smaller ligands may not 
make contacts with all possible residues in a large binding site. Only the residues in 
contact with the ligand are part of the calculation of a site’s solvent-accessible surface 
area (SASA).  
In accordance with Binding MOAD annotation, each binding site was classified as 
“valid” or “invalid” depending on the biological relevance of the ligand [107]. Since all 
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structures in Binding MOAD must contain a valid ligand, the likelihood of an invalid 
ligand occupying a biologically relevant site is greatly reduced. While it is still possible, 
the rate of such occurrence is much less than using all the structures in the Protein Data 
Bank (PDB) [2]. For each protein structure, multiple sites of a unique ligand were 
analyzed for redundancy by comparing the counts of each residue. Binding MOAD uses 
biounit structures, which can contain multi-meric proteins composed of identical 
subunits. To avoid over-representing ligand sites of multi-meric proteins, only one site 
was retained when multiple sites with an identical ligand and identical binding -ite 
residues existed in the same structure.  
3.2.2 Surface Residue Definition 
Solvent accessibility of residues was calculated using the NACCESS program [91]. 
NACCESS rolls a probe with the diameter of a water molecule across the entire van der 
Waals (vdW) surface of the protein and uses the path traced by the probe’s center to 
calculate the SASA of each residue. It is important to note that this is different from the 
molecular surface area (MSA), which is the path traced by the probe’s surface. Known 
ligands were removed from the structure before the SASA calculation. The default 
probe size was used, and any waters, hydrogens, or remaining hetero-residues were 
ignored (also default behavior for NACCESS). The NACCESS value of abs_side was 
used to define surface residues for the SC set and abs_main to define surface residues 
for the BB-only set. These report the absolute areas (in Å
2
) of the residue side chain and 
backbone, respectively (calculated using default NACCESS atom types and vdW radii). 
Since NACCESS treats the Gly Cα as a side chain, the largest of the abs_main or 
abs_side values was used for that residue. SASA was calculated for all residues in a 
protein, which included any binding-site residues. 
We chose to use the common standard of ≥5Å2 SASA as the definition of a “surface” 
residue [123, 124]. However, we were concerned that this definition included only 84% 
of SC binding-site residues (data not shown), so we also examined the effect of 
lowering the minimum SASA cutoff to 0.5Å
2
 (Table III-1) to ensure we were not 
omitting significant parts of the binding site. Lowering the cutoff for the surface 
definition increased the total number of binding-site residues (SC and BB-only) so that 
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98% of the residues within interaction distance of the ligand were considered “surface”. 
However, the respective increase in total binding-site SASA was only 0.2%, a 
contribution so small that it is misleading to count residues. Furthermore, the 0.5-Å
2
 
definition led to inappropriate frequencies for amino acids on the surface of the protein 
(Figure III-1). Specifically, more hydrophilic residues such as Arg, Asp, Lys, and Glu 
have the highest surface frequencies with the 5-Å
2
 cutoff (>7%), which is in keeping 
with other studies [30]. Although the relatively hydrophobic Leu had high frequencies 
with both definitions, it is not appropriate that counting many small-SASA 
contributions (at 0.5-Å
2
 cutoff) should make it more frequent (7.8%) than Arg (6.1%) or 
Lys (7%). Including the inconsequential contributions of small-SASA residues when 
counting residue frequencies and propensities simply leads to erroneous conclusions.  
Figure III-1: Frequencies of solvent-accessible SC residues on the protein surface with a cutoff of 
SASA≥5Å2 (black bars) and SASA≥0.5Å2 (white bars). Residues are sorted by decreasing 
hydrophobicity. 
 
3.2.3 Residue Propensity Calculation 
In accordance with previous studies, we used residue propensity as a measure of 
residue over-representation to explore the binding-site composition [31] [117] [37] 
[121]. The cumulative propensity Pi for each amino acid i = Ala, Arg, Cys ...etc. was 
calculated by taking the ratio of the frequency of the amino acid in binding-sites Fi
BS
 
and its frequency on the protein surface Fi
PS
. The binding-site frequency was obtained 
by summing across the surfaces of all binding sites s =1...S in a binding-site class (SC 
or BB-only). The protein frequency Fi
PS
 was obtained by summing up the occurrence of 
the amino acid across the surfaces of all proteins p = 1...P, where P= 3295 in our case.  
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Equation 1: Propensity calculation. 
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The propensities were calculated separately for valid versus invalid binding sites, 
and SC versus BB-only sets. Propensities greater than 1.0 show over-representation of a 
residue in the binding sites relative to the entire protein surface, and values less than 1.0 
show underrepresentation. Since propensity is a ratio of ratios and unit changes in its 
value represent fold changes in frequency, we present the propensity values on log-
scaled axes.  
Note that the residue counts were summed across the set of structures or binding 
sites before division. This is necessary because calculating a propensity value for a 
single protein may result in division-by-zero errors when rare residues, such as cysteine, 
are absent on the protein surface. Per-protein propensities for rare residues can also 
result in extremely large propensity values due to division by a small protein-surface 
frequency, making summary results harder to interpret. Moreover, since the average 
size of a binding site is around 11 residues, many amino-acids are not represented in all 
sites and lead to zero per-protein propensities. In calculations of propensities for a set of 
binding sites, only proteins that contained at least one site of that type (SC or BB-only, 
valid or invalid) were included in the calculations.  
The BB-only interactions are relatively rare (Table III-1), and they are dominated by 
glycine (Figure III-2 and Figure III-3). Most residues with BB-only contacts to the 
ligand point their side chains ‘away’ from the ligand; otherwise, a side-chain atom 
would likely be within the interaction distance, and the residue would be classified as 
having SC contacts. Additionally, since BB-only contacts represent equivalent atom 
types from residue to residue, they are not expected to provide diverse interaction 
environments based on residue type. For all these reasons, we focus our results and 
discussion on residues in the SC category. 
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Figure III-2: Relative frequency of sc-only, BB-only or both (SC+BB) interactions per residue. The 
residues with “SC” interactions in our analysis combine the sc-only and “SC+BB” contacts 
(blue+yellow).  Residues ordered by increasing BB-only frequency. Here, all Gly interactions are 
shown as BB-only to show its overall contribution to BB-only contacts.  
 
Figure III-3: Frequencies of BB-only residue contacts on binding site, sorted by increasing 
frequency of on the protein surface. Surface residues with ≥5Å2 backbone SASA are shown. Gly 
interactions are shown as BB-only to stress that it constitutes the vast majority of such contacts.  
 
3.3 Results and Discussion 
The set of 3295 structures yielded 7712 valid binding sites and 4909 invalid binding 
sites (Table III-1), which together represent a comprehensive set of protein-ligand 
variety present in the PDB. After taking into account site redundancy and eliminating 
incredibly small binding sites (those that could not accommodate a solvent probe atom 
and thus did not have “exposed” residues), there were 5562 valid and 3552 invalid sites. 
Roughly a third the 3295 structures had invalid binding sites in addition to one or more 
valid site, consistent with the higher number of invalid ligands per structure than valid 
in the structures where invalid ligands do occur. On average, valid binding sites were 6 
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times larger in terms of number of residues and 2 times larger by surface area that 
invalid ones. This is expected because valid ligands in our set tend to be larger and 
more buried than invalid ones. However, it means that the number of binding-site 
residues available for frequency and propensity calculations is different between valid 
and invalid sites.  
Table III-1: Summary data of structures from the 2009 Binding MOAD release used in the 
propensity calculations. Enzyme class memberships determined based on EC annotations from the 
PDB. All SASA areas calculated by NACCESS. 
 
Structures Sites 
 SASA 
Cutoff 
(Å2) 
Non-
Redundant 
Sites 
Residues Per 
Site 
Avg. (Median)  
SASA per site 
Avg. (Median) 
Å2 
Protein:Site  
# Residues 
Valid 
3295 
7712 
SC 
5.0 5562 11.4 (11) 433 (399) 10:1 
0.5 5514 13.2 (12) 441 (406) 10:1 
BB-
only 
5.0 3213 2.4 (2) 35 (28) 39:1 
0.5 3943 3.7 (3) 34 (26) 37:1 
Invalid 4909 
SC 
5.0 3461 3.6 (3) 194 (178) 50:1 
0.5 3581 4.1 (4) 195 (178) 51:1 
BB-
only 
5.0 1358 1.6 (1) 25 (21) 143:1 
0.5 1739 1.9(2) 22 (16) 165:1 
         
Valid  
Only 
Enzymes 
2354 6063 SC 5.0 4301 11.7 (11) 434 (399) 10:1 
Valid 
 Non-
Enzymes 
835 1597 SC 5.0 1261 10.3 (10) 431 (401) 11:1 
 
3.3.1 Residue Frequencies and Propensities 
Most proteins exist in aqueous environments, such as that of a cell. Therefore, it is 
generally accepted that the solvated outer surface of the protein is composed of amino 
acids that tend to be hydrophilic in nature. Conversely, the core of the protein is more 
hydrophobic, a factor that contributes to the proper folding and stability of proteins [125, 
126]. For example, hydrophobic residues tend to bury larger areas of their side chains 
upon protein folding than hydrophilic ones [29]. However, the composition of the 
solvent-exposed protein surface is not uniformly hydrophilic in nature [29], and the 
correlation between residue hydrophobicity and solvent-exposure is limited [30]. Since 
binding sites are a part of a protein’s surface, the comparative analysis of binding site 
composition must be performed with respect to the composition of the entire surface.  
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In our analysis, charged and polar residues make up the largest portion of protein 
surfaces (black bars in Figure III-4A), but surprisingly, Ala and Leu are more prevalent 
than the more hydrophilic Thr and Ser. All four of these residues are frequent in 
sequence. Less-frequent hydrophobic residues such as Met, Phe, Trp, and Cys have low 
surface frequencies. If we relax the surface definition to include less-solvent-accessible 
residues, (Figure III-1) very hydrophobic amino acids like Ile, Val, and Leu increase in 
their relative surface frequency. However, as discussed previously, their contribution in 
terms of fraction of overall surface area would be miniscule. Gly, which is common in 
protein sequence, has a surface frequency comparable to the more hydrophilic Asn and 
Pro.  
Figure III-4: A) Frequencies of solvent-accessible side chains on the protein surface and in binding 
sites with SASA cutoff ≥ 5Å2. B) Median propensity of residues in ligand binding sites of valid and 
invalid ligands, analyzed across all proteins. Residues in A and B are ordered by increasing 
frequency on surface. C) Ratio of residue propensity for valid versus invalid binding sites. Residues 
ordered by decreasing ratio. Error bars in B and C indicate 95
th
 percentiles of 10,000 leave-10%-
out samples.  
A 
 B
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Residue propensities presented in Figure III-4 B and C, present the propensity of 
residues to appear in protein surface regions involved in ligand binding. Pro, Glu, Gln, 
Lys, and Ala disfavor binding sites (propensities of 0.46 – 0.76). Arg, Thr, Val, Leu, 
Ser, and Asn have propensities within ±0.2 of 1.0, showing that these are relatively 
unbiased in their contributions to binding sites versus the rest of the protein surface 
(Figure III-4B). Though Arg, Leu, and Asp have the first, third, and fourth largest 
contributions to binding sites (Figure III-4A) their relative propensities are ~1 because 
of their equally high prevalence on the entire protein surface. Larger propensities for 
binding sites occur when a residue is frequently observed in binding sites, but is rare on 
the general surface. Cys, Trp, Met, His, Phe, Ile, and Tyr all have low protein surface 
frequencies (left side of Figure III-4A) and show propensities of ≥ 1.4 (left side of 
Figure III-4B). Tyr and Phe are excellent examples. They are the second and seventh 
most common resides in binding sites, respectively, but they are rare on the protein 
surface. These residues are bulky and aromatic, so their exposure to solvent is rather 
unfavorable.  It is reasonable that evolution is judicious in their use, placing them where 
they are most needed for a functional role, such as conservation in binding sites [117] 
[119] [30]. Trp also has a high propensity for binding sites and similar physical 
properties, but its exceptional propensity actually reflects its rarity on the protein 
surface (< 2% of all SC contacts). The same pattern is seen for Cys, which is even rarer 
on the surface (< 1% of SC contacts). Gly is notable because backbones are rare on 
protein surfaces (about 17% of the total protein surface area), but when they are present, 
they are overwhelmingly Gly. Gly backbones account for 13% of all backbone protein 
surface area (data not shown) and they are highly biased to be located in binding sites. 
Gly backbones account for ~50% of BB-only interactions in valid binding sites. 
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However, when considered along with other SC interactions, as it is in our analysis, Gly 
does not show a large propensity for binding-site regions. Overall, our propensities for 
valid binding sites agree well with previously published propensities from a set of 
~35,000 redundant ligand-binding sites [32] (R
2
=0.81) and those from a smaller set of 
41 drug-binding sites [121] (R
2
=0.79). Propensities for invalid sites were less well 
correlated with these data (R
2
=0.27 and R
2
=0.61, respectively).  
3.3.2 Comparison of Frequencies and Propensities in Invalid versus Valid Sites 
A unique aspect of this study is our ability to compare the binding-site interaction 
patterns for valid ligands to those in sites of spurious additives. This provides a type of 
“experimental control” which is usually not possible in analyses of binding-site 
databases. The issue at hand is not necessarily the recognition of additives themselves, 
but instead, with how valid and invalid binding differs. Figure III-4C demonstrates the 
propensities for valid and invalid binding sites, ordered by the ratio between of the two. 
This data emphasizes our caution in over-interpreting the high propensities of Cys and 
Trp. They do not show any significant bias for valid ligands. One could argue that Trp, 
Cys, or any other residue may be inherently “sticky” for small molecules, so they are 
meaningful for biological insights regardless of the presence of valid versus invalid 
ligands. However, we find that there are residues which show a significant bias between 
the classes. This significance was confirmed by randomly shuffling valid and invalid 
labels 1000 times (maintaining their relative proportion) and re-calculating the 
propensities and ratios each time. All residues had an average ratio of 1 across the 
shuffled sets. The maximum and minimum of the shuffled ratios was 1.2 and 0.8 
respectively, both for Cys, with all other residues having considerably narrower 
minimum and maximum values (data not shown). We therefore consider propensity 
ratios >1.2 and < 0.8 as significant trends. 
Ala, Ile, Met, and Val are the most biased toward biologically relevant binding sites 
over indiscriminant associations (ratio > 1.4), followed by a second tier of Phe, Cys, 
Leu, Gly, and Thr (ratio > 1.2). Conversely, His, Pro, Gln, Glu, Lys, and Arg show a 
bias towards invalid binding sites (ratio < 0.8), although all but His and Arg have 
propensity for the surface rather than binding sites. Considering Arg has among the 
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highest catalytic propensities [31], it should be present in many valid binding sites, but 
we do not see strong correlations between binding site propensity (valid or invalid) and 
catalytic propensity (data not shown) or large differences in propensity values when 
enzymes are considered separately from non-enzymes (Figure III-7). Instead, looking at 
the distribution of Arg interactions in binding sites of invalid ligands (Table III-3) 
demonstrates that they make up most SC interactions in 11 of the top 20 ligand sites and 
are present at high rates (> 15% of SC interactions) in sites of small, charged molecules, 
such as sulfate (SO4), phosphate (PO4), acetate (ACY), and chloride (CL) ions. They 
are also especially frequent in citrate (CIT) sites, which appear on both valid and invalid 
lists, depending on the function of the bound protein. Of the residues that show valid to 
invalid ratios of > 1.2, only Ile, Met, Phe, and Cys show a propensity for binding sites 
versus the protein surface.  
Table III-2: Composition of binding sites with respect to bound ligand for the top 20 valid ligands. Ligand listed in 
decreasing fraction of 5562 binding sites. Most frequently interacting residue for each ligand is in bold. 
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NAD 4.49 5.90 4.75 6.12 7.01 1.56 2.14 3.43 7.49 3.60 8.33 6.82 4.01 1.87 4.58 4.51 5.98 7.94 1.44 4.80 7.73 
FAD 3.90 6.77 7.09 4.02 4.47 1.91 3.51 4.28 7.33 4.72 6.79 6.21 3.98 1.42 4.65 4.00 6.91 7.79 3.42 6.28 4.44 
ADP 3.09 4.48 10.46 5.43 5.37 0.50 2.35 3.36 11.42 2.80 4.98 5.20 9.96 1.85 4.14 2.74 5.76 8.67 0.78 5.04 4.70 
NAP 2.97 6.37 8.97 5.68 4.02 0.59 2.25 2.01 9.93 3.01 6.78 5.99 5.64 2.01 2.25 4.12 8.76 8.65 0.97 5.78 6.23 
FMN 2.34 5.09 10.99 7.17 2.43 1.39 3.88 2.14 9.14 5.73 4.34 4.63 4.51 3.18 3.30 2.89 8.21 6.94 3.18 6.54 4.34 
ATP 1.80 2.76 12.20 4.26 6.27 0.17 2.42 7.52 10.78 2.26 4.43 5.51 12.03 1.92 5.43 0.75 5.35 8.02 1.42 2.26 4.26 
GDP 1.73 3.17 4.39 3.98 11.44 2.96 1.74 3.17 8.27 1.43 1.94 8.27 19.10 0.31 4.60 1.63 8.17 10.52 - 1.94 2.96 
GLC 1.55 3.95 9.65 6.58 12.94 0.22 6.14 7.46 3.07 7.46 2.41 1.10 2.63 2.19 7.46 0.88 1.75 1.54 11.40 10.53 0.66 
NDP 1.37 6.19 9.32 4.66 3.83 1.18 2.30 2.85 9.32 2.85 5.29 5.85 5.78 2.64 1.32 2.85 10.44 8.35 1.74 7.38 5.85 
SAH 1.20 5.07 2.97 3.21 10.51 1.85 2.10 4.45 11.50 2.35 5.07 8.16 1.98 4.45 7.91 2.97 6.06 3.83 4.20 7.29 4.08 
ANP 1.10 4.90 7.48 6.62 7.23 - 3.43 4.04 10.54 1.84 6.37 4.78 9.56 2.21 4.53 1.84 5.51 7.97 0.98 4.29 5.88 
COA 0.97 8.85 7.51 3.35 2.95 0.80 4.29 0.94 7.24 4.29 4.56 8.45 8.98 4.29 6.84 2.55 6.43 4.16 1.88 5.36 6.30 
NAG 0.81 2.34 6.54 19.16 9.35 3.74 4.21 3.74 4.21 1.40 2.80 4.21 2.34 1.87 3.27 1.40 2.34 5.61 14.49 4.67 2.34 
CIT 0.79 3.04 16.22 7.77 4.73 0.34 2.03 3.04 6.76 11.15 4.73 3.72 6.42 2.03 2.70 3.38 7.77 4.73 2.03 5.74 1.69 
AMP 0.77 4.48 10.70 2.74 5.72 1.74 3.73 5.97 6.97 5.97 5.97 4.98 5.97 1.49 6.72 1.74 5.97 7.71 1.00 6.47 3.98 
NAI 0.76 7.79 3.89 6.17 7.38 0.13 2.28 2.55 8.72 2.15 9.40 8.99 4.83 2.68 1.88 3.49 7.38 6.31 0.67 4.30 8.99 
MAN 0.72 5.91 - 18.72 16.75 - 9.36 1.97 5.91 2.46 - 5.42 3.45 - 1.48 2.46 1.97 3.94 5.42 12.32 2.46 
SAM 0.67 5.20 4.98 3.62 11.09 0.45 3.85 6.11 8.82 5.43 5.20 7.24 2.71 2.26 7.92 4.07 4.98 3.85 2.04 7.01 3.17 
GNP 0.65 4.22 0.84 2.95 8.44 1.90 2.11 1.27 12.66 0.84 1.27 8.02 18.78 0.42 5.49 3.16 8.86 14.14 - 3.16 1.48 
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Table III-3: Composition of binding sites with respect to bound ligand for the top 20 invalid ligands. Ligands listed in 
decreasing fraction of 3461 binding sites. Most frequently interacting residue for each ligand is in bold. 
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SO4 26.09 2.22 24.72 4.85 4.02 0.69 4.05 5.37 4.88 8.03 1.35 2.74 10.42 1.28 1.84 2.98 7.24 5.89 1.87 4.05 1.52 
GOL 16.93 3.03 11.63 4.95 7.53 0.31 4.55 7.89 5.17 4.55 4.10 5.35 7.35 1.29 4.95 3.39 4.95 4.68 3.88 6.68 3.79 
EDO 9.91 3.37 10.50 6.50 6.35 0.78 5.09 6.50 4.23 3.68 5.25 6.58 6.74 1.18 5.88 4.08 4.23 4.86 4.47 6.58 3.13 
CL 6.79 2.42 15.80 7.62 3.90 1.67 2.79 3.16 6.69 10.04 1.86 5.39 10.04 1.12 2.79 4.83 5.39 5.39 1.86 4.09 3.16 
PO4 5.46 2.22 18.03 4.30 7.21 0.97 3.74 6.38 9.71 9.02 0.97 1.53 10.68 0.69 2.36 1.80 8.74 4.58 0.69 4.58 1.80 
ACT 3.24 1.81 13.18 3.10 3.62 1.55 4.39 6.20 2.58 9.30 4.65 6.20 8.79 2.07 5.94 1.81 5.94 3.36 2.58 7.75 5.17 
MPD 2.25 3.26 8.31 5.34 8.31 - 3.56 6.53 4.15 2.67 5.04 8.31 3.26 2.67 6.82 6.53 4.75 3.26 3.56 9.50 4.15 
EGL 1.85 1.55 11.92 5.70 7.25 - 4.15 5.18 1.55 6.22 2.59 8.81 7.77 1.55 6.22 6.74 2.59 7.25 1.55 6.74 4.66 
FMT 1.56 3.80 13.92 8.23 11.39 - 2.53 3.80 5.70 5.06 1.90 3.16 8.86 1.27 0.63 2.53 5.70 9.49 4.43 3.80 3.80 
TRS 1.16 2.11 5.79 6.32 9.47 1.05 5.79 3.16 8.95 4.21 4.74 7.37 5.79 1.58 2.63 4.21 2.11 4.74 6.32 6.84 6.84 
ACY 1.10 1.87 18.69 5.61 9.35 - 1.87 2.80 6.54 3.74 2.80 3.74 8.41 2.80 5.61 3.74 8.41 6.54 0.93 5.61 0.93 
PEG 0.98 7.08 9.73 2.65 10.62 0.88 1.77 8.85 7.96 4.42 - 12.39 3.54 1.77 2.65 4.42 4.42 2.65 3.54 7.08 3.54 
IPA 0.81 3.23 11.83 5.38 3.23 3.23 1.08 - 2.15 6.45 7.53 11.83 - 4.30 8.60 3.23 8.60 2.15 2.15 7.53 7.53 
BOG 0.78 1.37 6.85 1.37 2.05 - 0.68 4.11 3.42 2.74 11.64 19.86 3.42 2.05 13.70 3.42 2.05 3.42 5.48 4.79 7.53 
IOD 0.75 2.13 12.77 4.26 2.13 2.13 2.13 - 2.13 4.26 2.13 6.38 12.77 2.13 2.13 6.38 8.51 10.64 8.51 6.38 2.13 
EOH 0.64 3.45 8.62 5.17 6.90 5.17 5.17 5.17 6.90 6.90 5.17 10.34 - - 1.72 - 5.17 5.17 5.17 12.07 1.72 
BR 0.58 - 6.98 6.98 - - 6.98 6.98 4.65 6.98 9.30 2.33 4.65 2.33 9.30 18.60 - 2.33 - 6.98 4.65 
MES 0.55 4.71 9.41 4.71 3.53 - 5.88 8.24 2.35 4.71 2.35 10.59 5.88 1.18 5.88 7.06 8.24 2.35 5.88 4.71 2.35 
MG 0.52 - 10.00 6.67 53.33 - 3.33 20.00 - 3.33 - - - - - - - 3.33 - - - 
 
In solution, all charged side chains may be expected to attract small polar ligands 
classified as invalid in our dataset. However, we see higher frequencies for positively 
charged residues (Arg, Lys) than for negatively charged ones (Glu, Asp) in invalid 
binding sites. It is unusual that Glu and Asp are under-represented in invalid binding 
sites because an abundance of positively charged ions are present in buffers just like 
negative ions. Asp and Glu are indeed frequent in Mg
+2
 sites, where they comprise 22 of 
30 residues across 18 sites. However, the binding of positive ions is not observed often 
in our dataset; Mg
+2
, Na
+
, and Ca
+2
, and are 20
th
 and 23
rd
 and 26
th
 highest occurring 
invalid ligands by frequency, and together they represent less than 0.8% of all invalid 
binding sites. This is in contrast to Cl
-
, I
-
, and Br
-
, which all make the top 20 list and 
comprise ~8% of invalid sites (Table III-3). The higher desolvation cost of a positive 
ion might make such binding interaction less frequent, and, thus, less likely to appear in 
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protein crystal structures (outside of functional active sites where they frequently appear 
as co-factors).  
3.3.3 Assessment of Ligand Bias on Propensity Values 
There is a significant bias in the PDB among the valid ligands (abundance of 
nucleosides) and invalid ones (common buffer molecules). To measure the bias 
introduced by preponderance of such ligands, we recalculated propensities while 
leaving out any binding sites containing the most frequent 20 ligands. Omission of the 
most frequent valid ligands (~32% of the set) slightly raised propensities of Trp, Phe, 
His, Met, and Glu and lowered those of Ser, Ala, and Pro (Figure III-5A). However, the 
omission had little effect overall. In contrast, propensities for invalid binding sites were 
significantly affected by the removal of the 20 most frequent invalids, which account 
for about 82% of invalid sites (Figure III-5B). The propensities for Trp, Phe, Met, and 
Tyr rose sharply while propensities for Arg and Lys fell, indicating a respective increase 
and decrease in frequencies of these residues in the remaining binding sites (protein 
surface frequencies remained the same, data not shown). 
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Figure III-5: Propensities of residue SC interactions in valid sites, with and without the top 20 
ligands by frequency. A) Propensities in valid sites. B) Propensities in invalid sites. The error bars 
represent 95
th
 percentile bounds based on leave-10%-out clustering within each set. Residues are 
ordered by increasing frequency on protein surface.  
A
 
B
 
 
These changes highlight the dependence of the propensities upon the size of the 
dataset and the variety of ligands it contains. While the propensities calculated for valid 
binding sites represent a broad array of ligands, invalid propensities are dominated by 
interactions that are made to the most frequent ligands, namely – sulfate, glycerol, 
ethylene glycol, and phosphate. This bias is inherent in protein crystallographic data and 
should be kept in mind when performing broad statistical analysis of residue 
interactions. Moreover, the large changes in propensities for the reduced set of invalid 
binding sites are hard to interpret, since subsets of such small size (352 structures 
remained) have large variation in the leave-10%-out cross-validation. As we see in 
Table III-4, random subsets from such a small set result in high standard deviations, 
even if all ligands are allowed, indicating that a sufficiently large set of sites has not 
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been sampled to produce confident propensity estimates. This exposes a caveat of any 
frequency- or propensity-based protein analysis with small sets of proteins: variation of 
binding-site frequencies in small sets of structures can have large effects on propensities 
(see below). Such comparison should only be done in the context of overall residue 
frequencies and with the knowledge of the uncertainty inherent to the small dataset.  
3.3.4 Influence of the Size of the Datasets on Propensity Confidence 
To assess the statistical significance of the data, propensity calculations for each set 
of binding sites were carried out 10,000 times, each time leaving out a random 10% of 
the proteins (i.e., retaining ~3000 structures at random). For each residue, the median of 
the 10,000 propensity values is reported, and the 95
th
 percentile bounds are used for the 
error bars. To assess the dependence upon the size of the dataset, a separate series of 
calculations were conducted using the procedure above. Progressively larger sets of 
proteins were randomly chosen from the set of 3295 structures, and propensities were 
calculated for that set without additional leave-10%-out sampling. The set size was 
incremented in intervals of 1% of the full structure set and 100 samples were taken at 
each percentage points, resulting in a total of 10,000 values. Frequencies and 
propensities were calculated for each sample (Figure III-6). Additionally, propensity 
medians, standard deviation, and 95
th
 percentiles for six representative residues were 
calculated from 10,000 random samples at four different set sizes: 100, 500, 1000, and 
2000 structures (Table III-4).  
The variation in SC frequencies and propensities were thus assessed by sampling 
random sets of varying numbers of structures (Figure III-6) 100 times each. For clarity, 
we focused on 6 representative residues: Lys and Glu as the most frequent on protein 
surface, Val and Asn as moderately frequent, and Cys and Trp as the least frequent. The 
protein surface contains the most residues by number, and the residue frequencies 
converge to within ±0.5% variation once ~ 500 or more structures are sampled (Figure 
III-6A). The binding sites are much smaller than the protein surface, so a larger number 
of structures are needed to achieve convergence of ±0.5% variation: ~1500 structures 
for valid sites (Figure III-6B) and ~2500 structures for invalid sites (Figure III-6C). The 
propensity values fluctuate in proportion to the frequencies (Figure III-6D) and 
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converge around ~1000 structures in a dataset. Standard deviations of propensities for 
Lys and Glu in valid and invalid binding sites are below 0.1, even in subsets as small as 
500 structures (Table III-4). The propensities of rare residues do not converge to such 
small standard deviation until sets as large as 2000 structures are sampled, especially in 
the case of propensities for invalid sites.  Convergence to mean values of the underlying 
population is guaranteed as the sample set size approaches the size of the full set; 
however, the rate of this convergence indicates whether relatively small subsets 
sufficiently sample the full population means. When constructing a dataset for 
computing propensities, a balance is required between eliminating redundant or poor 
quality structures and maintaining a sufficient set size. Based on our results, a set of at 
least 1000 structures is required to confidently measure general binding-site 
propensities for valid ligands and 2500 for invalid ligands. Of course, this figure is 
based on a random and non-redundant protein set. Frequencies and propensities for a set 
of related proteins (for example, those from the same structural fold family) may show 
such convergence with fewer structures. We recommend that any propensities 
calculated on a limited set of structures should be assessed by comparison to the best-
available general propensities (such as ones presented here) and by taking into account 
the variation in random subsets of similar size. 
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Figure III-6: A) Protein surface, B) valid binding-site, and C) invalid binding-site frequencies, and 
D) valid binding-site propensities of six residues. Values for subsets of the protein structure set, 
from 1% to 99% of the full set, are shown with 100 samples at each percent point. 
Sampled Frequency and Propensity of Surface Residues 
  
A B 
  
C D 
 Table III-4: Propensity median, standard deviation, and 95
th
 percentile bounds for 6 
representative residues in sampled subsets of protein structures. All values based on 10,000 random 
samples from the full protein set.   
Propensity median and standard deviation (with 95
th
 percentile bounds) of Representative Residues 
 
100 Structures 500 Structures 1000 Structures 2000 Structures 
Valid Invalid Valid Invalid Valid Invalid Valid Invalid 
F
re
q
u
e
n
t LYS 
0.64, 0.08 
(0.48/0.82) 
0.91, 0.21 
(0.55/1.38) 
0.64, 0.03 
(0.57/0.71) 
0.91, 0.08 
(0.75/1.09) 
0.64, 0.02 
(0.60/0.68) 
0.91, 0.06 
(0.81/1.03) 
0.64, 0.01 
(0.62/0.66) 
0.91, 0.03 
(0.86/0.97) 
GLU 
0.48, 0.07 
(0.34/0.62) 
0.67, 0.16 
(0.38/1.01) 
0.48, 0.03 
(0.42/0.54) 
0.66, 0.07 
(0.54/0.80) 
0.48, 0.02 
(0.44/0.52) 
0.67, 0.04 
(0.58/0.76) 
0.48, 0.01 
(0.46/0.50) 
0.67, 0.02 
(0.62/0.71) 
M
o
d
e
ra
te
 VAL 
1.01, 0.14 
(0.75/1.30) 
0.66, 0.24 
(0.26/1.19) 
1.01, 0.06 
(0.90/1.12) 
0.68, 0.10 
(0.49/0.88) 
1.01, 0.04 
(0.94/1.08) 
0.68, 0.06 
(0.55/0.81) 
1.01, 0.02 
(0.97/1.05) 
0.68, 0.03 
(0.61/0.75) 
ASN 
0.94, 0.13 
(0.71/1.22) 
0.96, 0.26 
(0.52/1.57) 
0.95, 0.05 
(0.85/1.05) 
0.99, 0.11 
(0.79/1.22) 
0.95, 0.03 
(0.88/1.01) 
0.99, 0.07 
(0.86/1.13) 
0.95, 0.02 
(0.91/0.98) 
0.99, 0.04 
(0.92/1.06) 
In
fr
e
q
u
e
n
t 
CYS 
1.86, 0.52 
(0.96/3.00) 
1.46, 1.13 
(0.00/4.52) 
1.87, 0.21 
(1.48/2.29) 
1.62, 0.47 
(0.89/2.71) 
1.87, 0.14 
(1.61/2.15) 
1.66, 0.30 
(1.13/2.29) 
1.87, 0.07 
(1.73/2.01) 
1.67, 0.16 
(1.35/1.97) 
TRP 
2.26, 0.41 
(1.53/3.13) 
2.20, 0.84 
(0.77/4.06) 
2.27, 0.16 
(1.96/2.60) 
2.28, 0.34 
(1.64/2.98) 
2.27, 0.11 
(2.07/2.49) 
2.29, 0.22 
(1.87/2.72) 
2.27, 0.06 
(2.16/2.38) 
2.29, 0.12 
(2.06/2.52) 
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As an example, we looked at the propensities in enzyme and non-enzyme valid 
ligand binding sites, which have been previously shown to differ in their ligand 
efficiencies [22].  Figure III-7 shows the propensities along with red lines indicating the 
95
th
 percentile bounds of valid propensities from random sets of structures sampled 
10,000 times from the full dataset (as presented in Table III-4). For enzymes, sets of 
2500 structures were sampled, while for the smaller non-enzyme set only 1000 
structures were sampled. The leave-10%-out sampling used during the propensity 
calculations provides a measure of stability for the propensity values. In contrast, the 
sampling of random structures provides a bound for propensity values that can be 
expected by chance. Therefore, for enzyme or non-enzyme propensities to be 
considered different from the general (randomly observed) valid binding-site 
propensities, their ±95
th
 percentile range must be outside the 95
th 
percentile range of 
propensities obtained from random structure sets of the same size. The asterisks in 
Figure III-7 mark residues that fulfill this criterion. This is the strictest-possible 
criterion, because only minimal overlaps of the median distributions can still be 
considered statistically significant. The average values of random sampling will be 
enzyme-biased because Binding MOAD and the PDB are themselves enzyme-biased. 
Therefore, exceptional propensity trends for non-enzyme may be more likely.  
The set of enzyme structures makes up more than two-thirds of the structure set 
used to compute propensities in this study. Binding-site propensities computed on this 
number of structures are very close to general propensity trends seen across all valid 
binding sites. Accordingly, the variation of propensities in corresponding random 
samples is very low. In enzyme binding sites, Ile and Ser have median propensities 
higher than random, and Leu and Trp lower ones. The set of non-enzymes has nine 
residues that have propensities significantly different than those seen at random. Leu, 
Lys, Phe, Trp, and Tyr have significantly higher binding-site propensities than those 
seen in sets of random structures, and Glu, Gly, Ile, and Ser have lower-than-random 
propensities. In a recent study comparing residue composition of enzyme and non-
enzyme sites, Leu, Met, Trp and Tyr have been shown to have much higher frequencies 
in binding sites of high-affinity non-enzyme proteins than in enzyme high-affinity 
binding sites [22]. Combined with our propensity observations, the presence of Leu, Trp, 
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and Tyr residues in binding sites without enzymatic function may be a distinguishing 
trend. Although Met propensity is higher in non-enzyme sites, it is within random 
sampling error. The Carlson et al. study also observed relatively low non-enzyme 
binding-site frequencies for Val, Ile, Asp, and Gly. Our propensities for Ile and Gly are 
consistent with their findings, but Asp has no propensity trend among enzymes versus 
non-enzymes, aside from its low propensity for binding sites in general. The elevated 
propensity of Lys and Phe and lower propensities for Glu and Ser for non-enzyme sites 
are unique trends observed in the current study.  
As smaller sets of structures are used for calculating propensity values, there is a 
greater chance of seeing values that deviate from general binding-site propensity trends. 
However, the 95
th
 percentile margins of error from randomly sampled sets of similar 
size will also change, becoming wider, especially for less-frequent residues. Therefore, 
it is important to conduct comparisons to randomly-sampled propensity values as 
suggested herein, to distinguish set-specific trends from the overall propensity trends in 
the currently available data. 
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Figure III-7: Propensities in A) enzyme and B) non-enzyme valid binding sites The black error bars 
represent 95
th
 percentile bounds based on leave-10%-out clustering. For context, red lines 
represent 95
th
 percentile bounds of propensities from 10,000 random samples of A) 2500 random, 
diverse proteins and B) 1000 random, diverse proteins (as seen in Table III-4). Stars indicate 
residues whose median propensity value (±leave-10%-out 95
th
 percentile error) falls outside of the 
95
th
 percentiles of the randomly-sampled propensities.  
 
3.4 Conclusion 
Our study highlights the differences in side-chain interactions with valid and invalid 
ligands and the frequency of residues taking part in these interactions, in contrast to the 
surface composition of the whole protein. Most importantly, the relative propensity of 
valid versus invalid binding sites should help to improve methods for identifying 
binding sites in proteins of unknown functions and other proteomic methods where 
understanding of general composition of protein-ligand binding sites is required. Better 
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understanding of these interactions, and how they differ across binding sites, can help 
focus statistical analysis of broad sets of protein surfaces toward the most biologically 
relevant ligands. It also exposes the variation in residue frequencies on the protein and 
binding-site surfaces in randomly chosen sets of proteins. Given how this variation can 
affect the interpretation of frequency- and propensity-based analysis of protein surfaces, 
we recommend that at least 1000 diverse protein complexes are needed for significant 
general conclusions for biologically relevant valid binding sites. When calculating 
propensities for smaller sets of structures, such as proteins of a functional family or 
similar ligand-binding sites, it is important to compare them to those of randomly 
sampled sets of structures. This can help determine how significant the trends are with 
respect to the variety of protein-ligand sites currently available in databases such as 
BindingMOAD.   
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CHAPTER IV  
 
Propensity-Based Scores to Improve a Binding-Site Prediction 
Algorithm 
4.1  Introduction: 
Proteins are the workhorses of the biochemical world, and they perform their 
functions through interactions with macromolecules (e.g. other proteins, DNA, RNA) or 
small molecule ligands (e.g. reactants, co-factors, or signaling molecules). The 
bewildering variety of protein functions are all mediated through contact between the 
protein surface and the interacting molecule, giving rise to an equivalent variety of 
protein interaction sites, each specialized to bind certain ligands and perform a certain 
function. Understanding how the protein binding surfaces allow for specificity and 
selectivity of their binding partners is crucial for such endeavors as characterizing 
protein function and developing drugs to target specific protein binding events and 
modulate the protein function. Identification of these binding sites on the protein is a 
critical goal of SBDD. Due to the increasing amount of un-characterized protein 
structures deposited in structure databases, such as those coming from large structural 
genomics projects [127], the need for tools to effectively predict un-known binding sites 
is pressing [120].   
A large fraction of drugs are developed to target protein binding sites that bind small 
molecules. Those sites are usually smaller than protein-protein binding sites, and 
therefore present a smaller target area for the rational design of drug molecules with 
good pharmacokinetic properties. Current SBDD methods rely on existing protein 
structures to inform the drug design process. The growing number of structures of 
proteins co-crystallized with small molecule ligands in the PDB [2] has motivated the 
rise in systematic study of the common features of the surface responsible for molecular 
interaction between proteins and ligands [13] [128] [10] [129]. Ligands bind to their 
binding sites in lieu of the rest of the protein for several reasons: including geometric 
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complementarity, physicochemical complementarity, and other energetically favorable 
effects. None of these factors alone can account for the overall specificity or selectivity 
of the binding site [13] [130]. However, in general, we can expect the site of ligand 
binding to be different in composition and/or geometry from the rest of the protein in 
order to allow the interactions necessary for diffusion-mediated ligand binding.  
The differences between protein-ligand sites and the rest of the protein have been 
exploited to construct many algorithms for the prediction of binding sites. These can be 
classified into three broad categories – those utilizing the protein geometry for their 
predictions, those utilizing energy-based descriptions of the protein surface, and those 
using knowledge-based methods to compare protein surface features to known binding 
sites (reviewed in [3] [36] [11]). The knowledge-based methods can perform well when 
the protein of interest has homologs or orthologs in existing databases or a similar 
ligand-binding mode can be identified, but they do not encompass information that can 
be generalized across many proteins. Ligand cross-reactivity with several proteins, for 
example, can occur without significant similarity in their binding sites. The geometric 
methods rely on the general observation that the largest and/or deepest cavity on the 
protein surface is one that is likely to bind a ligand [48] [53]. The energy-based methods 
use known physicochemical forces of atom-atom interactions, such as vdW interactions, 
hydrophobicity, or hydrogen-bonding potentials of the protein surface atoms, usually by 
measuring those forces with respect to probes or molecule fragments [58] [43]. Current 
state-of-the-art methods achieve success rates of up to 95% on holo structures, and most 
perform worse when tested on apo structures of the corresponding proteins[57]. 
However, the test sets for these methods often contain many redundant protein 
structures, which may inflate the performance data.  
In recent years, prediction methods have started to combine measures of geometry 
with energy-based or genome-based information to increase their predictive power [42] 
[131] [132] [133]. Several methods measure evolutionary conservation by using 
multiple alignments in a family of proteins to identify residues that appear in the 
binding sites of multiple family members. This approach is especially powerful in 
selectively predicting the functional class of binding sites, especially if only sub-
sequences of ligand-binding residues are aligned [134]. However, it is dependent on the 
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size of the available protein families, and does not capture cases of convergent 
evolution, where seemingly un-related proteins evolve binding sites that bind a similar 
set of ligands. Alignment-independent analysis of binding-site residue conservation also 
shows preferences of certain residues for binding surfaces as opposed to the rest of the 
ligand surface [32, 33] . Similarly, an analysis of atom triplet propensities for binding 
surfaces showed they can be used to predict protein-ligand sites by delineating protein 
surfaces that contain atom triplets biased towards binding sites [122]. However, to our 
knowledge, none of the methods have utilized general trends of residue composition to 
help improve their predictions.  
In this study, we obtain the propensities of amino acids within ligand binding sites 
in a large set of non-redundant protein-ligand complexes available in the Binding 
MOAD database. We then use the propensity measurements to improve the rank-
scoring performance of a binding-site prediction algorithm. Since residue composition 
of the binding site reflects the atom types available for energetic interactions with the 
ligand, we choose a binding site prediction method that utilizes protein surface 
geometry, instead of potential surface interaction energy, for predicting potential 
binding pockets. The geometric properties of the protein surface captured by such a 
method will be complementary to our residue propensity information. Specifically, we 
employ the SiteFinder method implemented in the Molecular Operating Environment 
(MOE) software suite. Despite rough estimates of hydrophobicity in its cavity selection 
algorithm, SiteFinder is still considered a primarily geometry-based method [57]. 
SiteFinder locates a series of large concave pockets on the protein surface, and ranks 
these pockets according to a scoring scheme that incorporates size and hydrophobicity 
of the pocket.   
A recently conducted study used the pockets predicted by SiteFinder predictions and 
a rank-score based on a protein-ligand binding index (similar to residue propensities) to 
predict known drug-binding pockets in a set of crystal structures [121] and homology 
models [135]. Our study distinguishes itself in the quality, size and diversity of the 
training set used to calculate the residue propensities, the assessment of residue pair 
propensity values in addition to single residues, and the use of a consensus score to 
combine propensity-based scores with those of SiteFinder. While Soga et al. 
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demonstrate that a propensity-based score can be used to successfully rank-order 
predicted sites, we perform a more thorough comparison of various scoring schemes 
and reveal the factors behind the high success rates of propensity-based scores. We also 
demonstrate certain cases where a consensus score (combination of SiteFinder and 
propensity-based score) may be more helpful in ranking successful SiteFinder 
prediction highly.  
4.2 Methods: 
4.2.1 SiteFinder 
SiteFinder is implemented in the MOE software package from the Chemical 
Computing Group (CCG) [56] and belongs to the class of binding site identification 
algorithms that rely primarily on the geometry of the protein surface to predict ligand-
binding cavities. To identify a potential predicted site, SiteFinder first uses Delaunay 
triangulation [52] to obtain a set of vertices that each correspond to plane of a Voronoi 
tessellation of the protein (a dual graph of the Voronoi tesselation) [51]. A set of 
spheres with varied radii, called the alpha-spheres (Figure IV-1), are then associated 
with the triangulated points, such that each alpha-sphere touches three protein atoms 
and has no internal atoms [54]. SiteFinder prunes this set of α-spheres based on their 
size and solvent exposure, eliminating those that are too buried or too exposed, and then 
labels the α-spheres as hydrophobic or hydrophilic based on the local atom environment 
near the sphere. The α-spheres are clustered into cavities, which consist of more than 
one α-sphere, and contain at least one hydrophobic sphere. The relative rank of these 
predicted cavities is determined by a score representing the number of hydrophobic 
atoms in contact with the α-spheres, which normally scales with cavity size. Using this 
algorithm, SiteFinder locates cavities of various shapes and sizes with a dense 
hydrophobic character. 
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Figure IV-1: Example of an alpha sphere. The alpha sphere is displayed in red, and the three 
contacted atoms (2D) are in black. Figure taken from Schmidtke et al. [57] 
 
4.2.2 Running SiteFinder with Optimized Parameters: 
One of the pitfalls of the ‘out-of-the-box’ SiteFinder algorithm is the relatively large 
size of its predicted binding pockets [57]. This can result in deceptively large success 
rates, as the large swaths of protein surface covered by the predicted pockets have a 
greater chance of including a known site. However, SiteFinder remains one of the top 
current geometric prediction algorithms, and its implementation in MOE makes it 
relatively simple to use on a large set of structures. Schmidtke et al. recently performed 
a systematic scan of SiteFinder parameters to find the optimal balance between 
predicted site size and prediction success [57]. We therefore use SiteFinder with 
optimized parameters of da_dist = 4.0, connect_dist = 4.6 Å, and site_minrad = 1.8 Å. 
SiteFinder was executed with a modified version of a batch_sitefinder SVL script 
distributed by CCG, and the member residues of the predicted binding sites were output 
to flat files for further processing. The member residues were identified by SiteFinder as 
those in the immediate vicinity of the binding-site spheres delineating a predicted 
pocket.  
4.2.3 Prediction Set (structures from 2003 and earlier): 
The evaluation is comprised of binding sites from 1080 non-redundant proteins 
from the Binding MOAD database that have been published in the PDB prior to 2003. 
We chose to use this date cutoff to approximate the set used by An et al. for their  
analysis of the “pocketome” [13]. Our set of proteins is smaller than the 5000+ 
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structures in the pocketome because we limit it to proteins that appear in Binding 
MOAD, and we have removed redundancy. The non-redundant set is grouped by 90% 
sequence identity. Any ligands listed in Binding MOAD are considered to represent 
“known” binding sites. Ligands were also classified as “valid” or “invalid” according to 
Binding MOAD annotations. Valid ligands include any biologically relevant co-
crystallized molecules known to play a role in the protein function. These include a 
wide variety of natural products, as well as drugs and other human-made molecules. 
Conversely, any “opportunistic” co-crystals not directly involved in protein function, 
such as buffers, solvents or other crystallographic additives, were classified as invalid. 
Only valid ligand binding sites were considered as known sites. To ensure that we 
match any and all possible correct predictions, any redundant ligand sites within a 
protein were considered. Known binding sites were defined by residues with at least one 
side-chain atom within 4.0 Å of the ligand. If more than one ligand was present within 
the cutoff distance from a residue, it was included in the binding site definition of both 
ligands.  
Before processing with SiteFinder, the biounit files for these structures were 
obtained from Binding MOAD and processed to remove any HETATM records 
corresponding to the known ligands. Solvent atoms and salts are ignored by SiteFinder. 
Other HETATM records in the biounit, such as modified residues were retained for 
completeness. The stripped proteins were loaded into MOE and processed by SiteFinder 
with optimized parameters noted above.  
4.2.4 Determining a correctly predicted binding site: 
The SiteFinder algorithm explicitly outputs the residues that belong to the surface 
patches outlined by the alpha spheres in the predicted cavity. The identities of the 
residues in the predicted and known sites were used to determine the quality and 
success of the prediction. Since the binding-site prediction and the known-site 
extraction were performed on the same biounit, and our definition used for a binding 
site is residue-based, the identity of the residues and their parent protein chain in the 
predicted and known sites is sufficient to determine correspondence. For each protein, 
residues in each predicted site were matched to those in known binding sites. For each 
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predicted/known site pair the extent of the match was quantified as follows. A relative 
overlap (RO) was defined as Nm/Nk, where Nm is the number of matched residues, and 
Nk is the number of residues in the known site. Predicting all the residues of a known 
site would thus result in an RO of 1, and an RO of 0 would signify no match (Figure 
IV-2).  A large predicted site will thus have a higher probability of matching a known 
pocket. Since a predicted pocket that covers the entire protein surface and achieves an 
RO of 1 is not very valuable in a real-world application, we also compute the mutual 
overlap (MO) of the predicted and know sites. MO is defined as Nm/Np, where Np is the 
size of the predicted site, and MO values closer to 1 indicate a more accurate prediction, 
namely one that contains only residues of the known binding site. Schmidtke et al. 
recently showed that SiteFinder is one of the methods prone to generate large predicted 
sites with a relatively low MO [136], and that this criterion is valuable for assessing the 
quality of a prediction.  
Figure IV-2: Graphical illustration of the RO and MO criteria used for assessing a successful 
binding-site prediction.  
 
Each predicted pocket in a protein is evaluated by calculating an RO and MO with 
respect to each of the known sites in the protein.  A given predicted site with an RO > 
0.5 is considered a correct prediction. If the predicted pocket contains matches to more 
than one known site, as can be the case when there are two known binding sites close to 
each other in a single large cavity, we choose the site with the largest MO as the best 
match. Since SiteFinder sometimes generates several dozen predicted sites per protein, 
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there is often more than one correctly predicted site for protein structures that contain 
more than one ligand. Therefore, for certain parts of the analysis we limit ourselves to 
structures with only one bound ligand.    
4.2.5 Propensity Set (structures between 2004-2009)  
Residue propensities used for scoring the predicted binding sites were independently 
calculated from a non-redundant subset of the Binding MOAD database that included 
2123 structures released in the PDB between 2004 and 2009. This set is completely 
independent of the prediction set described above. To avoid biasing propensities on 
multimers, we omit redundant sites within a structure, i.e., those that have the same 
ligand and same binding site residues, such as equivalent sites in a multi-meric protein. 
Surface-based propensities of individual residue side chains were calculated via the 
following propensity formula (also described in Chapter 2): 
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Where Pi is the propensity of amino acid i (I = Ala, Arg…) and Fi
BS
 and Fi
PS
  are the 
surface frequencies of the amino acid i in the binding sites or protein surface. The 
frequencies are calculated by summing over all occurrences of an amino acid in binding 
sites ( siN ) or on the protein surface (
p
iN  ) in a set of structures.  
Propensity of a pair of co-occurring residues to appear in binding sites is calculated 
in a similar manner [137]. The propensity of two co-occurring amino acids i and j is: 
     
    
  
    
    
where     
   and     
  are concurrence frequencies of two amino acids in the binding sites 
or the protein surfaces respectively. The binding site concurrence frequency     
   is 
determined by summing the occurrence of each pair of amino acids over the set of 
binding sites, and dividing by the total number of amino-acid pairs in that set: 
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If    is the number of residue of type x in a binding site s, then the concurrence of 
residues i and j in a binding site    
               , and  
 
 
       . The frequency 
of protein surface concurrence was calculated assuming that the occurrences of amino 
acids i and j are independent: 
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Propensities  were calculated separately by ligand class, resulting in four propensity 
sets: Valid or PairValid – based on residue frequencies in biologically relevant valid 
binding sites, and Invalid or PairInvalid – based on residue frequencies in spurious 
binding sites. The ligand class was based on annotation from Binding MOAD. Care was 
taken to ensure that only reasonable invalid ligands were retained for the propensity 
calculation. For example, covalently attached ligands, heme groups and unknown 
ligands (UNK, UNX, etc) were excluded from the invalid set. Metal ions that were not 
covalently attached (between 2 and 3 Å from the protein surface) were examined 
manually, and those involved in ligand coordination were excluded. All retained invalid 
ligands are thus known molecules that are not covalently attached, and to our 
knowledge, are not involved in facilitating the biological functionality of the protein. 
The valid ligand set was not filtered for specific ligand classes and includes many 
ligand types, from natural small molecules to drugs and small peptides.  
Propensity values of the Protein Ligand Binding (PLB) index were obtained from 
Soga et al. for comparative analysis [121].  
4.2.6 Calculation of Raw and Consensus Scores 
A series of propensity-based scores were calculated for each pocket predicted by 
SiteFinder for comparison to, and combination with, the default SiteFinder 
hydrophobicity score. Single and residue-pair propensities from valid and invalid sites 
constitute a set of four scores. A score based on the PLB index and one based on size 
were also calculated. For each predicted site, scores based on single-residue 
propensities were calculated using the equations below, where pi is the propensity of 
residue of type i (20 different types of amino acids) and n is the number of residues of 
that type present in the predicted pocket.  
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For calculation of pair propensities, the equation is extended to: 
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where Nij was defined as         when     and  
 
 
  when    , and  Pij is the 
propensity of i and j  calculated previously. Log-based scores were also explored to 
emphasize the differences in propensity values and avoid additive scores that scaled 
with the size of the score binding site. We do not use log scores for our analysis unless 
otherwise stated.  
To calculate a consensus or combination score the propensity scores and the 
SiteFinder scores were first converted to normalized scores (z-scores) according to the 
standard formula,  
          
   
 
  
where x is the score for a given site, μ is the mean score for all sites in the protein, and σ 
is the standard deviation for all score in the protein. A simple addition of the SiteFinder 
z-score and a propensity z-score gave the combined score for a predicted site. For each 
protein, the relative ranks for all the predicted sites were calculated by sorting the z-
scores from highest to lowest. Rank for each score type was calculated separately. In all, 
10 different rankings were calculated in addition to the default SiteFinder score: Size-
based, PLB-based, Valid, Invalid, PairValid, PairInvalid, CombinedValid, 
CombinedInvalid, CombinedPairValid and CombinedPairInvalid rank. A rank based on 
the PLB index from Soga et al. was calculated, using propensity values obtained from 
the publication.  
4.3 Results 
4.3.1 Propensities 
The propensity set contained 2123 structures, all deposited from 2004-2009 in the 
PDB. This set includes 2471 valid binding sites, and 1084 invalid binding sites. 
Propensities for the 20 standard amino acids were calculated for the structures from 
2003 and earlier, and the structures from 2004-2009, simply to show that one set is not 
grossly different from the other (Figure IV-3). However, only the propensities from the 
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2004-2009 propensity set were used to calculate scores of the site-prediction because it 
is inappropriate to train data to reproduce the answer one wishes to find. The 
propensities for valid binding sites were largely comparable across the two sets, with 
some small differences in the rarely occurring residues, such as Trp, His, Cys, and Met. 
The residues with the largest valid binding site propensities - those over-represented in 
the valid binding sites – are Trp, Cys, His, Met, Phe, and Tyr. Conversely, Ala, Gln, 
Glu, Lys, and Pro have low propensities, indicating their under-representation in the 
valid ligand sites relative to the rest of the protein surface. The propensities derived 
from the propensity set showed some differences between the valid and the invalid 
binding site sets. The largest relative difference was observed in Ala, Arg, Asn, Trp, 
Tyr, and Val. The former three residues have higher propensity in invalid binding sites, 
while the latter three have higher propensities in the valid binding sites. The more 
hydrophobic Ala, Trp, and Val, have binding site propensities above 1, while Arg, Asn, 
and Tyr have propensities near or below 1 in both types of binding sites. No single 
residue shows a change from a high binding-site propensity (>>1) to a very low binding 
site propensity (<<1), or vice versa, when valid sites are compared to invalid (Ile shows 
the strongest such trend).  This indicates that despite variability of residues present on 
the binding surfaces of a protein, the variation in residue frequencies between a ligand-
binding surface and a non-binding surface is greater than that between the valid versus 
invalid ligand-binding surface. Despite this trend, we still hypothesize that valid 
binding-site residue propensities can be more successful than those of invalid binding 
sites in scoring binding site predictions. After all, it is important to locate biologically 
relevant binding sites and reduce the chance of highly ranking surface pockets that are 
closer in character to a non-functional binding region for invalid ligands. Pair-wise 
residue propensities derived from the propensity set are presented in Figure IV-4. The 
trends in pair-wise propensities follow some of the trends of single propensities, 
especially for infrequently occurring residues. 
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Figure IV-3: Residue propensities derived from the prediction set (white) and propensity set (white) 
of valid ligand binding sites A) and invalid ligand binding sites B). Error bars represent 95% 
quartiles of leave-10%-out cross-validation sampling. 
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Figure IV-4: Residue propensities derived from the propensity set of valid ligand binding sites A) 
and invalid ligand binding sites B). Higher values highlighted in red, lower values in blue. 
A ALA ARG ASN ASP CYS GLN GLU GLY HIS ILE LEU LYS MET PHE PRO SER THR TRP TYR VAL 
ALA 1.51 0.70 0.71 0.56 1.34 0.46 0.28 1.10 1.00 1.22 0.90 0.46 1.23 1.22 0.37 0.70 0.83 1.21 1.27 0.93 
ARG 
 
2.07 0.95 0.76 1.57 0.67 0.51 1.15 1.69 1.30 0.90 0.67 1.54 1.69 0.42 1.01 1.11 1.94 1.94 0.96 
ASN 
  
2.47 0.67 1.49 0.58 0.42 1.09 1.41 1.28 0.79 0.58 1.41 1.47 0.43 0.95 0.96 1.88 1.77 0.88 
ASP 
   
1.33 1.29 0.43 0.30 1.05 1.03 1.15 0.67 0.54 0.94 1.12 0.35 0.71 0.83 1.42 1.28 0.71 
CYS 
    
35.13 1.00 0.74 1.99 2.84 2.59 2.05 1.10 3.24 3.27 0.87 1.83 2.22 3.76 3.05 1.87 
GLN 
     
1.73 0.27 0.74 0.90 0.82 0.64 0.37 1.03 1.07 0.25 0.63 0.69 1.40 1.21 0.60 
GLU 
      
0.65 0.50 0.80 0.60 0.39 0.28 0.65 0.81 0.17 0.39 0.43 1.22 0.88 0.41 
GLY 
       
3.07 1.54 2.10 1.17 0.85 1.73 1.66 0.68 1.28 1.49 1.73 1.84 1.31 
HIS 
        
7.36 1.89 1.43 0.77 2.29 2.67 0.59 1.35 1.40 3.45 2.95 1.30 
ILE 
         
5.08 1.59 0.77 2.53 2.62 0.78 1.35 1.55 2.18 2.36 1.71 
LEU 
          
2.06 0.61 2.01 1.99 0.45 0.96 1.07 1.83 1.79 1.28 
LYS 
           
1.02 0.81 0.92 0.26 0.67 0.80 1.01 1.08 0.59 
MET 
            
13.38 3.73 0.62 1.37 1.57 3.15 2.74 1.79 
PHE 
             
7.45 0.75 1.49 1.58 3.89 3.23 1.88 
PRO 
              
1.01 0.45 0.50 0.75 0.71 0.54 
SER 
               
2.11 1.05 1.93 1.74 0.95 
THR 
                
2.42 1.79 1.82 1.11 
TRP 
                 
19.16 5.41 1.76 
TYR 
                  
7.55 1.85 
VAL 
                   
2.83 
 
B ALA ARG ASN ASP CYS GLN GLU GLY HIS ILE LEU LYS MET PHE PRO SER THR TRP TYR VAL 
ALA 2.54 0.83 0.41 0.21 1.60 0.37 0.24 0.67 0.80 0.85 0.86 0.25 0.84 1.34 0.32 0.55 0.64 1.67 0.97 0.61 
ARG 
 
6.68 0.91 0.67 2.25 0.87 0.55 1.00 2.39 1.01 1.01 0.79 1.19 1.74 0.44 1.20 0.94 2.44 1.85 0.75 
ASN 
  
5.38 0.32 1.51 0.52 0.33 0.60 1.13 0.67 0.60 0.52 1.09 0.88 0.38 0.52 0.60 1.41 1.18 0.43 
ASP 
   
2.68 0.54 0.25 0.28 0.46 0.77 0.30 0.32 0.48 0.41 0.48 0.25 0.44 0.40 0.80 0.76 0.31 
CYS 
    
89.28 2.00 1.13 1.23 3.51 2.44 2.25 0.96 4.24 4.68 1.28 1.38 2.11 8.53 2.48 1.68 
GLN 
     
4.94 0.28 0.39 1.41 0.76 0.70 0.36 0.77 1.27 0.33 0.52 0.50 1.68 0.97 0.55 
GLU 
      
1.92 0.47 0.64 0.49 0.41 0.32 0.73 0.69 0.20 0.30 0.29 1.30 0.69 0.32 
GLY 
       
5.44 1.42 0.78 0.74 0.68 1.17 1.28 0.45 0.75 0.58 1.37 1.41 0.59 
HIS 
        
21.93 1.84 1.98 1.16 2.04 3.00 0.73 1.47 1.43 3.33 2.85 1.08 
ILE 
         
7.66 1.71 0.50 2.72 2.98 0.47 0.81 0.92 3.18 1.89 1.33 
LEU 
          
3.63 0.44 1.72 2.31 0.48 0.73 0.81 2.28 1.63 0.85 
LYS 
           
3.01 0.62 0.76 0.26 0.49 0.42 0.96 0.93 0.31 
MET 
            
19.97 4.14 0.65 1.10 0.87 6.04 3.51 1.72 
PHE 
             
13.84 0.90 1.49 1.47 5.27 3.45 1.77 
PRO 
              
2.61 0.30 0.31 0.60 0.63 0.32 
SER 
               
4.71 0.79 1.64 0.97 0.63 
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THR 
                
4.28 1.51 0.91 0.46 
TRP 
                 
43.10 4.35 2.24 
TYR 
                  
11.39 1.34 
VAL 
                   
4.13 
 
4.3.2 SiteFinder Prediction Success 
The SiteFinder algorithm predicted 29,157 pockets in the 1080 structures from 2003 
and earlier. An average of ~27 predictions per protein were found, with an average 
prediction size of 20 residues (median size 10 residues). Of the 1080 structures, 1072 
(99%) contained one or more correct (RO > 0.5) predictions, and 1850 of the known 
binding sites were matched by at least one prediction. If the rank of the correctly 
predicted sites is not considered, this represents a 75% overall success rate (1850 
/2471); 1317 of these predictions were ranked among the top 3 in their respective 
protein by SiteFinder - a 53% top-3 success rate overall. The SiteFinder top-ranked 
prediction success is 67% with the limitation that only one correct prediction per protein 
is required even if there are multiple known ligand sites a protein. This optimistic rate 
climbs to 89% if the top-3 ranked predictions are considered.  
Over a quarter of the structures in the prediction set had more than 3 bound ligands 
(Figure IV-5A), so 100% success in top-3 ranked sites is impossible in this dataset. We 
thus limited our further comparative analysis to the 422 proteins with only one co-
crystallized ligand (Figure IV-5B). This limits the assumptions about the correct 
number of expected true-positive results when calculating a success rates, and it 
simplifies the interpretation. SiteFinder correctly identified 60.4% of the known ligand 
sites as a top-ranked prediction (Table IV-1), with an average RO of 0.99 and average 
MO of 0.30. The success rate in the top-3 ranked sites was 87.9%, picking up an 
additional 100 correctly-identified predictions. These success rates are lower than those 
determined for SiteFinder by Schmidtke et al. in their prediction exercise with the 
pocketome dataset. In that study, 77% and 96% predictions ranked in the top-1 and top-
3, respectively. The pocketome set is much larger (> 5000 structures) and includes 
redundant proteins, which may result in higher success rates. The relative improvement 
in performance between the top-ranked and the top-3 ranks is comparable to their 
results. 
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Figure IV-5: A) Fractions of structures in the full prediction set with respect to the number of co-
crystallized ligands. B) Structures with one co-crystallized ligand, binned by heavy atom count and 
showing proportions of structures with various number of protein chains within bin.  
 
A 
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4.3.3 Relative Success of Raw Scores 
We compared the default SiteFinder rank score to ranks based on the size of the 
predicted site, the Protein-Ligand Binding (PLB) Index score of Soga et al. [121], and 
our propensity-based scores. We also compared to various combinations with the 
SiteFinder score. As can be seen from Table IV-1, all scores had similar success among 
their highest ranked sites. The highest success rate for the top-3 ranked sites was 
achieved by the z-score combination of SiteFinder and Valid propensity scores (91.3%). 
In fact, all scores performed better than the 87.9% top-3 success rate of the SiteFinder 
score alone, although the margin of the improvements was slim. Size alone, as 
measured by the number of residues in the predicted site, performed as well as any of 
the scoring schemes. It even out-performed the SiteFinder score in both top-ranked and 
top-3 ranked predictions. Many site-prediction methods like SiteFinder are of course 
based on the premise that the largest cavity on the protein is the true binding site, and 
due to the additive nature of the scoring metrics, additive scores have a high correlation 
with the size of the predicted site. Still, it is important to have a metric that performs 
better than a simple residue count.   
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Table IV-1: Success rate of predictions in proteins with one co-crystallized ligand, and success rate 
for the same proteins if binned by protein size.    
 
Success for One-ligand 
Proteins  
Success Rates for One-ligand Proteins Binned by Size 
(# atoms) 
Scores Top rank Top 3 
 
1K 2K 3K 4K 5K 6K 7K 
SiteFinder Score 60.4% 87.9% 
Top 
Rank 
78.6% 79.7% 69.4% 71.1% 40.9% 28.0% 50.0% 
   
Top 3 92.9 91.3 88.7 95.2 81.8 86.0 79.2 
Size 59.2 88.8 
        
PLB Index[135] 62.4 91.1 
        
Propensity Scores: 
         
Valid 62.6 90.9 
Top 
Rank 
82.1 79.7 74.2 73.5 52.3 24.0 54.2 
   
Top 3 96.4 91.3 91.9 94.0 93.2 90.0 95.8 
Invalid 62.0 91.1 
        
PairValid 63.1 91.1 
        
PairInvalid 62.0 90.6 
        
Combination Scores: 
        
SiteFinder & Valid 62.7 90.9 
Top 
Rank 
82.1 79.7 74.2 75.9 47.7 24.0 54.2 
   
Top 3 92.9 92.8 91.9 94.0 93.2 90.0 95.8 
SiteFinder & Invalid 62.9 90.6 
        
SiteFinder & Pair 
Valid 
62.7 91.3 
        
SiteFinder & Pair 
Invalid 
62.9 91.1 
        
SiteFinder & log Valid -- -- 
Top 
Rank 
67.9 69.6 61.3 67.5 65.9 82.0 62.5 
   
Top 3 96.4 87.0 88.7 90.4 84.1 90.0 75.0 
SiteFinder & log 
Invalid 
  
Top 
Rank 
71.4 56.5 51.6 54.2 47.7 80.0 37.5 
   Top 3 92.9 81.2 75.8 73.5 68.2 88.0 62.5 
 
We expected scores based on Valid propensities to perform better than those based 
on Invalid propensities, since all known ligands sites in the prediction set are valid 
biologically relevant co-crystals, and their sites should be preferentially weighted by a 
score derived from such ligand sites. However, the Valid score does no better than the 
Invalid score, and it does not constitute a significant advantage. A Pearson correlation 
of 1 between the two scores confirms their strong linear relationship (Table IV-2). The 
PLB index is also highly correlated with our propensity-based scores, and it has almost 
identical success rates. Any differences in actual values of residue propensities was 
inconsequential with respect to prediction success, and all three of the above-mentioned 
scores have Pearson correlations of 1 with predicted binding-site size. Scores based on 
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residue-pair propensities are less correlated with other scores because, like the number 
of residue pairs, the score grows exponentially with the size of the predicted site. 
However, the different score distribution does not translate into a difference in 
prediction success, and the ranks of the pair-wise scores are highly correlated to the 
single-residue scores and place almost exactly the same number of correctly matched 
predictions among their top ranks (Table IV-1).Due to the high correlation between the 
Valid scores and other propensity-based scores, we focus the following results and 
discussion on the SiteFinder, size, and Valid scoring schemes, addressing the remaining 
scores as needed when differences are observed.   
Table IV-2: Pearson correlations among the various scoring schemes.  
Pearson 
Correlation of 
Propensities 
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SitFinder 0.98 0.98 0.98 0.98 0.80 0.80 
Size 
 
1.00 1.00 1.00 0.77 0.78 
PLB 
  
1.00 1.00 0.75 0.76 
Valid 
   
1.00 0.76 0.76 
Invalid 
    
0.76 0.76 
PairValid 
     
1.00 
PairInvalid 
      
4.3.4 Prediction Success and Protein Size 
Size of the predicted binding sites dominates the prediction success in our set of 
single-site proteins. The matching prediction size largely does not correspond to the 
actual size of the known binding site, indicating poor precision (Pearson correlation = 
0.14). It is only somewhat correlated with the protein size (Pearson correlation = 0.56). 
SiteFinder generates anywhere from a few to several dozen predicted sites for every 
protein. Overall, the median size of these predicted sites is consistently ~10±2 residues. 
However, the number of predicted sites per protein is proportional to protein size 
(Pearson correlation = 0.89), and the mean size of these prediction also increases with 
increasing protein size. Due to the dominating effect of size of the predicted site size on 
the success rate, all additive scoring schemes will agree on the largest of the predictions 
92 
as the top-ranked one, when a protein contains a few extremely large predictions 
followed by a number of much smaller pocket candidates. In an additive score, where 
each residue is multiplied by its respective propensity, size can be thought of as a score 
with propensity of 1 for each residue. The dominating effect of size implies that in most 
cases, the contribution to a propensity-based score by residue propensity values that do 
not equal 1 is not large enough to counteract the difference in size between the largest 
predictions and their smaller, but possibly relevant, alternatives. Because predicted 
pocket size is such a good indicator of a correct prediction for a majority of cases, any 
attempt to normalize a propensity-based score to remove the size effect would 
significantly lower success rate. After all, there are a larger number of smaller predicted 
pockets for a protein than big ones, and most of them will not overlap with a known site.  
Protein size is well known for any system where the binding site is unknown. 
Normally only sequence and structure information are available for such a system. 
Barring any sequence or structural similarity to known proteins, which can shed a light 
on the potential protein function, the shape and size of the protein are two factors that 
may indicate the success of a binding-site prediction algorithm. Protein size is also the 
one factor that correlates with number of predictions per protein, their average size, and 
the MO values of the matches (Figure IV-5B). To better understand the cases where 
protein size might have a varied influence on the success of SiteFinder, we chose to 
look at a breakdown of our one-ligand protein set by their weight. We binned proteins 
by size ranging from 1,000 to 8,000 heavy atoms (Figure IV-5B). There were 360 
proteins in this range, with the remaining 62 proteins having > 8000 atoms. We only 
looked at the seven sets of smallest proteins (Figure IV-6), because there were too few 
proteins per bin to establish accurate success rates for proteins with > 8000 atoms 
(Figure IV-8). To better appreciate the differences in success rates within and across 
bins, we sampled the set of 422 proteins 1000 times, each time discarding a random 
10% of the data and repeating the binning and success-rate calculations. The error bars 
in Figure IV-6 indicate the standard deviation of these samples for the SiteFinder and 
Valid scores. Valid scores improved the success of the top-ranked predictions in the 
3000 and 5000 atom bins by 4.8% and 11.4%, respectively. These differences are 
greater in magnitude than the sum of the standard deviation from sampling. For the top-
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3 ranks, Valid scores significantly improved on SiteFinder in the 3000, 5000 and 7000 
atom bins by 11.4%, 4%, and 16.7%, respectively. 
Figure IV-6: Prediction success of various scores as a function of protein size. Structures with one 
ligand are binned by number of heavy atoms. Success rates are calculated separately for each bin. 
Median MO values for prediction matches in each bin are also shown. Error bars show standard 
deviation for SiteFinder and Valid scores in 1000 rounds of leave-10%-out sampling of the full set 
of 422 proteins.  
 
A clear trend among top-ranked predictions is the lower success rate for larger 
proteins.  Performance of the SiteFinder score dropped off starting at proteins of 4000 
atoms in size, and a sharp dip was observed for all scores in the 6000 atom bin (6000-
7000 atoms). Drop-off in performance with size was not evident when the top-3 ranked 
predictions were considered. The top-3 ranks recapitulate the lack of performance seen 
in the top-ranked predictions, and we can surmise that SiteFinder generates very large 
and thus, highly-ranked sites for large proteins. While the largest prediction may not 
necessarily be correct, the second or third largest likely is. This is consistent with the 
trends for larger and more numerous SiteFinder predictions with increasing protein size. 
It may also reflect the multi-meric composition of proteins in the higher size bins, 
where two or more chains may have reasonable binding sites, but only one contains a 
ligand bound in the crystal structure (these would be classified as having only one 
known site in our data set).  
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It is curious that proteins in the 6000 bin were poor targets for prediction, especially 
among the top-ranked predicted sites. This poor performance can be attributed to a 
disproportionate number of antibodies present in this bin.  Of the 50 structures in the bin, 
31 are antibody variants. This is 70% of all antibodies present in the 422 structures of 
the one-ligand set. Although 28 of the 31 (41 of the 45 in the full set) antibody proteins 
in the bin have a matching prediction within the top-3 ranks, only 14 of them are ranked 
as the top prediction. Antibody complexes are composed of a “light” chain and a “heavy” 
chain. They have a large central cavity at the junction of these chains. This partially 
hydrophobic cavity is detected by SiteFinder as the top-ranked pocket in lieu of the 
antigen-binding sites at the “ends” of the immunoglobulin domains that usually contain 
the co-crystallized ligand. Although we use a non-redundant protein set to eliminate 
multiple proteins with similar structures, the antibody family has high sequence 
variability with relatively similar tertiary structure, and thus it introduces some bias into 
the dataset.    
4.3.5 Relative Success of Consensus Scores 
We examined the effectiveness of consensus scoring by adding the z-scores of a 
propensity-based score to the SiteFinder score for each predicted site and then re-
ranking the predictions by the combined z-scores. Due to the previously-mentioned 
influence of predicted site size on the success rate, combination scores did not perform 
much better than the individual scores alone (ComboValid in Figure IV-7). Therefore, 
we examined the combination of the SiteFinder score with a non-additive, propensity-
based scoring scheme in which the number of residues is multiplied by the log of the 
propensity of that residue, instead of the raw propensity value (see Methods). 
Propensities of < 1.0 will generate negative log values, so the final score will not always 
be additive with respect to the number of residues in a site. Using the log version of a 
propensity-based score on its own results in very poor performance because some large 
sites may have low z-scores in contrast to smaller sites (data not shown). However, in 
combination with the size-dependent SiteFinder score, the log score may provide 
complimentary information that reflects the composition of the binding site rather than 
its size. In Figure IV-7, we see that the combination of SiteFinder score with a log Valid 
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propensity score (ComboLogValid) has high top-rank success rates in proteins over 
5000 atoms in size, improving the success rate of SiteFinder alone by 25%, 54%, and 
12.5% in the three largest protein bins (Table IV-1 and Figure IV-7). The advantage of 
the consensus score is not observed in the success rates of the top-3 ranked predictions. 
This indicates that log-based scores can re-rank a slightly smaller correct pocket from 
second or third place to top rank, but they are less effective at re-ranking smaller correct 
predictions that may be present further down in the prediction list. With size of the 
predicted site having a diminished influence, consensus scores based on Valid 
propensities significantly outperform those based on Invalid propensity values (Table 
IV-1). The consensus score of SiteFinder and the log of Invalid propensities has top-
rank success rates 10% lower on average than those of the Valid log-based consensus 
score. Consensus scores calculated for log values of PairValid and PairInvalid 
propensities still retain some size dependence, and they perform with intermediate 
success between that of SiteFinder alone and consensus scores based on log values of 
single-residue propensities. Unfortunately, using any consensus score also reduces the 
success rate of the SiteFinder score for structures smaller than 5000 atoms in size, both 
in the top-ranked, and the top-3 ranked predictions. 
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Figure IV-7: Prediction success using consensus scores, reported as a function of protein size. 
Structures with one ligand are binned by number of heavy atoms. Success rates are calculated 
separately for each bin. Error bars show standard deviation for SiteFinder scores in 1000 rounds of 
leave-10%-out sampling of the full set of 422 proteins.  
 
Figure IV-8: Prediction success, reported as a function of protein size. Structures with one ligand 
are binned by number of heavy atoms. Success rates are calculated separately for each bin. 
Number of structures in each bin is also shown. Error bars show standard deviation for SiteFinder 
and Valid scores in 1000 rounds of leave-10%-out sampling of the full set of 422 proteins. 
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4.4 Conclusion 
We tested the success of the SiteFinder algorithm to predict binding sites over a set 
1080 diverse proteins, and a subset of 422 proteins with only one ligand-binding site. 
The default SiteFinder score were compared to size-based scores based on residue 
propensities derived from an independent training set of thousands of diverse protein-
ligand complexes. Propensity-based scores were found to rank binding-site predictions 
as well as, or better than, the SiteFinder score. However, we found that the size of the 
predicted binding sites alone can account for most of the successful matches, and the 
success of any additive rank score that scales with prediction size will be driven by the 
size component. This accounts for high success rates of propensity based scores 
presented in this study and previous publications [121] [135].  We found that the top-
rank success rate of SiteFinder predictions drops off as the size of the protein increases, 
and certain protein classes, such as antibody proteins, are especially challenging for this 
prediction method. The propensity scores perform better in placing correctly predicted 
sites at the top for proteins over 5000 atoms in size, and a consensus score combining 
the additive SiteFinder score and a non-additive propensity score can rescue poor 
success rates. While the confirmation of overall success of SiteFinder on a large, 
diverse set of proteins is encouraging, the dominance of predicted site size in 
successfully ranking correct predictions indicates room for improvement in scoring the 
potential pockets generated by geometry-based binding site prediction methods. 
 98 
CHAPTER V  
 
Can Scoring Functions Distinguish Biologically Relevant Binding from 
Irrelevant, Opportunistic Binding? 
5.1 Introduction 
Databases of protein-ligand structures are important tools for studying principles of 
molecular recognition. Our resource, Binding MOAD, has helped yield new insight into 
protein-ligand binding, ranging from fundamental differences between enzymes and 
non-enzymes[22] to residue propensities in binding sites. Binding MOAD is valuable 
not only for generating new knowledge, but also as a yardstick for testing current 
understanding and hypotheses. It can serve as gold standard collection of known 
protein-ligand structures for evaluating and improving algorithms used in molecular 
docking. Here, we demonstrate its use in creating a new test set to evaluate scoring 
functions, one that poses a new question, “can scoring functions distinguish biologically 
relevant binding from irrelevant, opportunistic binding across diverse proteins?”  
Molecular docking has become an increasingly important computational tool in 
modern structure-based drug design (see refs [138], [139], [140], [141], [142], [143] for 
review). Given the three-dimensional structure of a protein, the process starts with 
sampling possible ligand orientations and conformations (referred to as modes) at the 
selected site of the protein target and then ranks these modes according to their scores 
calculated with a scoring function. The development of accurate scoring functions to 
evaluate putative modes is a critical and challenging element in molecular docking. For 
years, different scoring functions have been developed that boast different 
computational speeds and accuracy. Roughly, these scoring functions can be grouped 
into three categories according to their derivation: force-field based, empirical, and 
knowledge based.  
Force-field-based scoring functions are fully or partially evaluated on a set of force-
field parameters derived from both experimental work and quantum mechanical 
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calculations to describe the interactions among atoms.[144] [98] When considering the 
multitude of ways that explicit water molecules can compliment binding (see ref [145] 
and references therein), conformational sampling and force-field based scoring 
functions are computationally too expensive to be used in virtual database screening. As 
an alternative, the solvent effect can be implicitly considered by the Poisson-Boltzmann 
model (e.g., [146], [147], [148],[149]) or generalized-Born model (see [150] for review) 
in post-docking scoring (e.g.,[151], [152], [153]). The most simplified method for 
modeling the solvent effect is to use a distance-dependent dielectric constant to 
calculate the electrostatic interaction energy term [154], which can be directly used to 
speed the docking process at the expense of accuracy. 
A second category is empirical scoring functions whose parameters are derived by 
reproducing the binding affinities of a training set of protein-ligand complexes with 
known three-dimensional structures (e.g., [155], [156], [157], [158], [159]). Compared 
to force-field-based scoring functions, empirical scoring functions score protein-ligand 
complexes quicker because of their relatively simple energy terms. The generality of an 
empirical scoring function is typically restricted by the composition of its training set.  
The third kind of scoring functions are the knowledge-based scoring functions [160], 
[161], in which an inverse Boltzmann relationship is used to determine pair-wise energy 
potentials, directly converted from the occurrence frequencies between atom pairs in a 
database of protein-ligand structures[25, 162-168]. The derived pair potentials try to 
embody all the effects that govern ligand binding such as electrostatic interactions, van 
der Waals interactions, hydrophobic effect, desolvation penalties, etc. Knowledge-based 
scoring functions have a good balance between accuracy and speed. Compared to 
empirical scoring functions, knowledge-base scoring functions can be more general as a 
result of larger and more diverse training sets of protein-ligand structures available from 
the Protein Data Bank (PDB) because any structure can be used even if binding affinity 
data is unknown [2]. The pair-potential feature of the knowledge-based scoring 
functions also makes the scoring process as fast as the empirical scoring functions. 
Currently, there are three common criteria that are used to evaluate a scoring 
function.[167] The first criterion is binding-mode prediction, how closely a predicted 
ligand-binding mode resembles the experimental structure. The second criterion is 
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binding-affinity prediction, whether or not the scoring function can rank order 
compounds by affinity or reproduce the experimentally determined binding data. The 
third criterion is enrichment in virtual database screening, whether or not the true 
inhibitors/binders can be ranked at the top of a large database of ligands according to 
their binding scores for a protein target. Most current scoring functions perform 
satisfactorily in one or two criteria [102]; however, it is challenging for a scoring 
function to perform well in all three. [167] 
One common feature for the three above criteria is that they are designed to evaluate 
a scoring function on a single protein-ligand complex or a specific binding site, target 
without considering the biological types of the bound ligand. With the rapid 
development of proteomics projects, more and more protein-ligand structures are being 
determined experimentally and deposited in the PDB. It is noticeable that many bound 
ligands in the PDB are biologically irrelevant; typical examples include additive 
molecules such as detergents for crystallization purposes or buffer molecules. The 
presence of these molecules bound to protein surfaces usually results from their high 
concentrations rather than from tight binding interactions (a case referred to as 
“opportunistic binders” or “invalid ligands”) [106, 108]. Whether a scoring function is 
able to discern invalid ligands from weakly-bound, biologically relevant ligands is a 
new criterion proposed in the present work. It is desirable to extend scoring functions to 
evaluate protein binding sites for the determination of function or druggability of a 
pocket. This goal requires scoring functions to be able to discern biologically relevant 
binding events from opportunistic ones over a wide range of proteins. This can be 
particularly challenging if the biologically relevant binding is weak. An important 
counter issue is “appropriate failures” when additives in a valid binding site should 
score well if they are chemically similar to the biologically relevant ligand. 
In this work, a diverse benchmark of valid and invalid protein-ligand complexes 
from the PDB is presented. Four different scoring functions, representing different 
categories, are used to test this new benchmark. The influence of including entropic 
penalties for rotatable bonds in ligands was also examined. 
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5.2 Methods 
We selected four scoring functions to test our new benchmark. They include the 
empirical scoring function X-Score [100], a force field-based scoring function in DOCK 
4.0 [154] [95], a semi-empirical force-field-based scoring function in AutoDock 4.0 [96, 
169], and the knowledge-based scoring function ITScore in MDock [167] [170]. 
X-Score 
The empirical scoring function X-Score includes three individual scoring functions 
of HSScore, HPScore, and HMScore [100]. The van der Waals energy term (VDW) is 
calculated by a Lennard-Jones 8-4 potential, the hydrogen-bonding term (HB) is 
obtained from the hydrogen bonds between protein and ligand, and the rotor term (RT) 
stands for the number of effective rotatable bonds in the ligand molecule. The HS, HP, 
and HM terms calculate the buried, hydrophobic molecular surface of the ligand, the 
pair-wise hydrophobic atom-contact potential, and the microscopic match of 
hydrophobic ligand atoms to the binding pocket, respectively. The coefficients in the 
scoring functions were obtained by fitting the binding affinities of 200 protein-ligand 
complexes with known structures [100]. In the present study, we used the average of the 
scores from the three scoring functions in Eq. (1) to represent the X-Score of a protein-
ligand complex. 
 
HSScore = CVDW,1 VDW+CH-bond,1 HB+Chydrophobic,1 HS+Crotor,1 Ntor+C0,1 
HPScore = CVDW,2 VDW+CH-bond,2 HB+Chydrophobic,2 HP+Crotor,2 Ntor+C0,2  (1) 
HMScore = CVDW,3 VDW+CH-bond,3 HB+Chydrophobic,3 HM+Crotor,3 Ntor+C0,3 
AutoDock 
The scoring function in AutoDock 4.0 is a semi-empirical, force-field based scoring 
function which includes five energy terms [96, 169] 
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where the first two energy terms are classic VDW and electrostatic interactions and have 
the same forms as the force-field scoring function in DOCK 4.0. [95, 154] The third term 
stands for the contribution from hydrogen bonds between protein and ligand. The fourth 
term considers the loss of torsional entropy of a ligand upon binding in which Ntor is the 
number of rotatable bonds in the molecule. The last term describes the solvation effect. 
The weighting coefficients for the five energy terms were obtained by fitting the known 
binding constants of 188 protein-ligand complexes [169]. 
DOCK 
The scoring function in DOCK 4.0 [95] represents a typical force-field-based 
scoring function whose energy parameters are taken from the Amber force field [154]. 
This scoring function includes VDW and electrostatic interaction energy components 
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where rij stands for the distance of protein atom i and ligand atom j, Ai j and Bi j are the 
VDW parameters, and qi and qj are the atomic charges. The effect of solvent is implicitly 
considered by using a distance-dependent dielectric constant ε(rij). 
ITScore 
ITScore is an iterative knowledge-based scoring function developed using a training 
database of 781 protein-ligand complexes structures from the PDB [167], representing a 
set of effective pair potentials resulting from the overall effects of all binding factors. 
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The binding score is calculated by summing all the atomic pairs between protein atom i 
and ligand atom j as 

ji
ijITScore ruE
,
)(                (4) 
where r is the distance between the atom pair i and j. The effective pair potentials uij(r) 
are iteratively derived until they can discriminate the native structures from decoys for 
99% of the protein-ligand complexes in the training set. The ITScore scoring function 
has been implemented in MDock, a program for docking against an ensemble of protein 
structures. [170] 
5.2.1 Scoring and Adding Torsional Entropic Penalties 
X-Score and AutoDock contain terms that penalize a score for each rotatable bond 
in a ligand on the basis that restricting each torsion carries an entropic cost. Similar 
terms are not included in DOCK or ITScore. The additive nature of both DOCK and 
ITScore inherently bias large ligands to score well (a well-known limitation of many 
scoring methods). This caveat can be particularly problematic in our study because 
several additives in the invalid set are large detergents.  
To investigate the effect of incorporating penalties for torsional entropy of the 
ligands, we calculated two set of binding scores with and without a torsional ligand 
terms. To remove the torsional term from X-Score and AutoDock, we simply set the 
coefficients Crotor and Wtor to zero in Eqs. (1) and (2). These are referred to as X-Score-tor 
and AutoDock-tor, respectively. To add a torsional term to DOCK and ITScore in a 
straight forward way, we added wtor  and Ntor to Eqs. (3) and (4) where Ntor is calculated 
by X-Score (its count of rotatable bound count) and wtor (a scaling factor for the 
torsional penalty) was simply set to 1 for this work. These are referred to as DOCK+tor 
and ITScore+tor. This was chosen for simplicity. Furthermore, we did not wish to 
unfairly bias the performance of DOCK and ITScore by explicitly fitting new 
parameters for this purpose. 
5.2.2 Receiver Operating Characteristic Curves 
The performance of the scoring functions was evaluated by comparing the rank 
ordering of real ligands (true positive valids) versus invalids (false positives) with the 
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receiver operator characteristic (ROC) curves. A perfect scoring method would rank 
order all valids before invalids, achieving a curve that starts at the origin (0,0), goes 
straight up to the left-hand corner of the ROC plot (1,0), and then across (1,1). A 
scoring method with no predictive power would equally rank valids and invalids, 
achieving a line with slope = 1 starting at the origin (0,0) and connecting to (1,1). Area 
under the curve (AUC) provides a quantitative measure for comparison for ROC curves. 
A perfect scoring function would have a ROC curve with an AUC of 1.0, while the 
poorer scoring function described above would score an AUC of 0.5, no better than 
random assignment. The ROCS package in R was used for calculation of the ROC 
curves.  
5.2.3 The Test Set: Valids and Invalids. 
The test set contains crystal structures of protein-ligand that are classified as valid or 
invalid based on biological relevance of the ligand. The subset of 177 valid hits contains 
complexes where the ligand is a biologically relevant molecule such as a natural 
substrate or a known inhibitor (Table V-1). The subset of 71 invalids contains 
complexes where the ligand is an extraneous molecule such as a buffer, detergent, or 
solvent (Table V-2).  It is important to note that the invalids in this study are not 
computationally derived binding modes like those often used to evaluate docking and 
scoring; rather the invalids are obtained from existing crystal structures that represent 
non-functional binding events. Both types of complexes are observed protein-ligand 
binding events, but the ligands in the structures chosen as invalids are instances of 
opportunistic binding, often occurring as a result of over-abundance of the ligand in the 
crystallization medium. All structural data for the valid set was obtained from the 
Binding MOAD biounit files. Structures for the invalid complexes not available in 
Binding MOAD (due to absence of valid ligands) were obtained from the PDB. 
Table V-1: Set of valid complexes. 
PDB HET Affinity PDB HET Affinity PDB HET Affinity 
1A5B IGP  1OIT HDT IC50 <  0.0030 uM 2BU2 TF1  
1A6V NPC  1OUW MLT  2BVE PH5 IC50=215 uM 
1AI4 HAA ki= 3.3 mM 1P0B PQ0  2C25 SIA  
1AJN AAN ki=2.32 mM 1P0M CHT  2CA8 GSW kd=22 uM 
1B42 M1A kd=97.9 uM 1P28 HBS kd=3.8 uM 2CAQ GSW kd=285 uM 
1B74 DGN Ki=50 mM 1P6B EBP  2CBU CTS kd=2.1 uM 
1BEU IPL  1PA9 CSN ki=25 uM 2CCG TMP  
1BGG GCO  1PZP FTA ki=480 uM 2CER PGI ki=0.6 nM 
1BR6 PT1 ki =  0.6 mM 1Q8U H52 kd = 1.1 uM 2D5C SKM  
1C7R PA5  1QA0 270  2DDQ HRB  
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1C9C PP3  1QIZ RCO  2E7F C2F kd=0.79 uM 
1CA7 ENO  1R4S MUA  2ENB PTP  
1CEA ACA kd~11 uM 1RDY F6P  2EXM ZIP  
1CEB AMH ki~1 uM 1RGK 2AM kd=49 uM 2FA1 BDF  
1D1Q 4NP  1ROB C2P  2FZG EOB IC50=86 uM 
1D8C SOR  1SD3 SYM  2G5F PYR  
1DL7 NCH kd=0.32 uM 1SUX BTS  2G7Q AHL  
1DPM EBP  1TH6 OIN  2GA4 1PS  
1E1X NW1 ki=1.3 uM 1TVP CBI  2GN2 C5P  
1E3V DXC kd = 45.74 uM 1U0G E4P  2GNH H52 ki=149 nM 
1E4N HBO   1U1W 3HA kd=1.4 uM 2GZ8 F3F IC50=3 uM 
1ENU APZ  ki=8.3 mM 1U2O NEC  2HAI PFI IC50=0.53 uM 
1FDS EST  1UF7 CDV   2HDQ C21 ki=40 mM 
1G86 NEQ  1UTM PEA kd=0.971 uM 2HDR 4A3 Ki=19 mM 
1GII 1PU  1UTO PEA kd=5 mM 2HDU F12 ki=5 mM 
1GW9 LXC  1UUX PPI  2HHA 3TP IC50=0.122uM 
1H1H A2P ki~6.5 uM 1UWC FER  2HUI GLV  
1H7F C5P  1UYQ NFG  2I5X UA5  
1HG2 IP2  1UZU INR ki=13.8 uM 2I6P 4NP  
1IEX TCB  1V2G OCA  2IUQ TSS  
1IG0 VIB  1V48 HA1 ki=16 nM 2J75 NOY  
1IS4 LAT  1VJ5 CIU IC50=0.12 uM 2J7B NTZ ki=174 nM 
1JGM PEL  1VYQ DUX ki=4.98 uM 2J7C IDE ki=10.7 nM 
1JVU C2P  1VYZ N5B IC50=290 nM 2J7D GI1 ki=160 nM 
1K1P MEL  1W3O PYR  2J7G GI4 ki=136 nM 
1KCC GTR  1W4Q UMF ki=5.89 uM 2O9R TCB ki=21 mM 
1L8B MGP kd=0.14 uM 1W61 PYC  2OU0 MR3 kd=592 uM 
1LO0 BC1  1W6F ISZ  2OVD DAO  
1LP6 C5P  1W8M E1P ki=25 mM 2OVW CBI  
1LPD ADE  1W8O LBT  2OWZ F6P  
1LT6 GAA  1WMA AB3 IC50=788 nM 2OYM MNI ki=10 uM 
1MEN GAR  1X2B STX  2PBW DOQ ki=5.56 nM 
1MFI FHC ki=2.6 uM 1XFG HGA  2PLK P3D  
1MMY G6D  1XUA HHA  2Q89 6CS kd=0.5 uM 
1MOO 4MZ  1Y20 1AC ki=4.8 uM 2R5N RP5 kd=700 uM 
1MRD IDP  1YC4 43P kd=0.28 uM 2UW3 GVG ic50=80 uM 
1MSA MMA  1YL1 ETF  2Z26 DOR  
1ND0 DP4  1YQC GLV  3FIT FRU  
1NHK CMP  1ZC9 PMP kd=0.6 mM 3KIV ACA kd=20 uM 
1NJR XYL  1ZI3 NLC  3LKF POC  
1NO6 794  1ZO8 SNO  3MCT 3MC kd=85.5 uM 
1NXJ GLV  1ZR8 AJM  3PAX 3MB IC50=10 uM 
1O0O A2P ki=8 uM 1ZWP NIM  3SLI SKD  
1O4N OXD IC50 > 40 mM 2ACK EDR  43CA NPO kd<1 uM 
1O71 POC  2AJV COC  4ERK OLO ic50=27 uM 
1O9O MLM  2B56 U5P  4RHN RIB  
1OBA CHT kd = 3.6 mM 2BKL ZAH  4SLI CNP  
1OFZ AFL  2BKV PGA  5EUG URA  
1OI6 TMP  2BS7 CBS  5GPB GPM  
 
Table V-2: Set of invalid complexes 
PDB HET  PDB HET  PDB HET 
1APM OCT   1S2U PEG   2G4Y  TAR  
1D2M  SO4   1SHV MA4   2GFC  OCT  
1D5R TLA   1T7L  MRY   2GON  FLC  
1D6F B3P   1T7V  P6G   2GW5 IPA  
1D6J  TLA   1TAQ  BGL   2HI9  GOL  
1EM2  TAR   1TP7  DMX   2I3A BTB  
1FZV MPD   1TTO TRS   2I5P  GLC  
1H53  PO4   1U3A  PE5   2INU  2PO  
1HH8  FLC   1URM  BEZ   2J8X URE  
1HVV  TAR   1XEZ  BOG   2NR9  PA6  
1IZ2 SUM   1YBK  BEQ   2NUD  TRS  
1JJ0  SUC   1YXS IMD   2O02  BEZ  
1JLU  OCT   1ZDY T3A   2OQA  PG4  
1KWN  TAR   1ZGN  MES   2OR7 ACT  
1LIH PHN   1ZR3 MES   2P4B BOG  
1M27  FLC   2A0Q  NDG   2PGB  NAG  
1MRZ  CIT   2APV  MLA   2Q9H  ACY  
1N2F DTT   2B4P  MLI   2RA5  SRT  
1OLL EDO   2BEX  GOL   2SHP  CAT  
1PK3 BME   2C56  SUC   2Z9J  DMS  
1PPA ANL   2CJP PG4   8CHO P4C  
1Q61 MG8   2E50 TRE     
1QST EPE   2FAF  EPE     
1RJM EP1   2FUF  FLC     
1RTV  SRT   2G47 DIO     
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The valid set was chosen from Binding MOAD, a database of high-quality, protein-
ligand structures with annotated ligands [106]. Structures were filtered to have the 
following criteria: contain as few ligands as possible (preferably only the valid ligand of 
interest), have no other ligands or co-factor molecules anywhere within 12Å of the 
ligand of interest, and be crystallized in the biologically relevant pH range of 6-8. All 
structures in Binding MOAD have at least 2.5Å resolution and no covalently attached 
ligands.  
The invalid set was chosen by filtering the PDB for protein-ligand structures that 
met the same structural quality criteria as the valids, but did not meet the validity 
criteria as defined in Binding MOAD [106]. Ions, nucleic acids, and multi-part ligands 
were not considered as candidate ligands in either set. The two sets were further refined 
by clustering  based on chemical similarity and then selecting pairs of similar ligands 
that were in different sets (valid vs. invalid). Preferentially, only one such pair from 
every cluster was chosen in order to maintain variety of ligands in the test set. 
Clustering was performed using the QuaSAR function in MOE, based on 
physicochemical descriptors – solubility (logS), hydrophobicity (SlogP), weight, and 
buried surface area (BSA). Solubility, hydrophobicity, weight and primary components 
(PCA) were calculated with MOE [56]; buried surface area was calculated with 
NACCESS [91]. Affinity data are available for 38% of the valid hits.  
 In order to ensure a fair distribution of valids and invalids across chemical space, 
the final sets were reviewed for even distribution of logS, SlogP, weight, and BSA 
values. The histograms in Figure V-1 through Figure V-4 compare the valid and invalid 
ligands based on these criteria. Since BSA is proportional to the number of protein-
ligand contacts, and ultimately to the docking score, it was of great importance to select 
complexes with similar degrees of ligand burial in both valid and invalid subsets. Figure 
V-1 shows that the distribution of BSA between the two sets is slightly un-even, with 
valid ligands on average being more buried. Still ~50% of the invalids have BSA above 
200 Å where ~75% of the valid hits lie. Also, both valid and invalid examples can be 
found throughout the BSA range. An exception is a highly buried, invalid polyethylene 
glycol molecule (1U3A) which was selected because it clustered with a valid ligand 
based on other descriptors. Such trade-offs were essential to maintain comparable 
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distributions of the various descriptors and minimize any selection bias inherent in 
construction of such test sets. The ROC curve of the various descriptors in Figure V-5 
shows the relative classification power of the various descriptors. BSA, weight, and the 
first principal component (PCA1) are the most discriminating. Each has an AUC around 
0.65. While higher than the unbiased AUC = 0.5 that we had aimed for, the set is much 
more evenly distributes than the full set of valid hits and invalids in MOAD (data not 
shown). 
Figure V-1: Buried Surface Area (BSA) distribution for valids and invalids. 
  
Figure V-2: Size distribution for valids and invalids 
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Figure V-3: Solubility (logS) distribution for valids and invalids 
  
 
Figure V-4: Hydrophobicity (SlogP) distribution for valids and invalids. 
  
 
5.2.4 Preparing and Scoring the Complexes 
 The scoring of all the complexes was done with ligands in their original 
crystallographic coordinates to avoid any bias from the various docking routines, which 
makes all differences in the ROC plots come solely from the scoring of the exact same 
poses. The complexes were prepared using Chimera software from UCSF [171]by 
removing water molecules and metal ions from the structures. Hydrogens and charges 
were added to both the protein and ligand of the complex with the former assigned 
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Amber charges and the latter Gasteiger [172]. Once prepared, the binding energy score 
for each complex was calculated using X-Score, DOCK 4.0, MDock and AutoDock 4.0.  
It is important to note that the scoring with X-Score, DOCK, and ITScore were 
performed “blindly” as part of collaboration with the Zou lab. The Carlson group 
provided the Zou lab with the full list of 248 complexes, without noting which were 
valids and which were invalids. The Zou group scored the full list with and without 
torsional entropy penalties for the ligands (X-Score, DOCK+tor, ITScore+tor, X-Score-
tor, DOCK, ITscore). Classification and the resulting ROC plots were calculated by the 
Carlson lab to reveal the performance. Scoring with AutoDock (and AutoDock-tor) was 
performed by the Carlson lab.  
 
5.3 Results and Discussion 
The test set is composed of 177 valid valids and 71 invalids. Although there is no 
ligand that is present in both sets, the molecules in the two sets are nevertheless very 
similar chemically. As Figure V-5 shows, the sets were chosen so that the two classes 
could not be easily distinguished by their molecular weight, logS, SlogP, BSA, or the 
PCA1 of these properties. Weight and BSA were top classifiers with AUCs of 0.67 and 
0.68 respectively. Bias between weight and affinity is known, but these AUCs are still 
significantly lower than the AUC of the scoring functions (0.73-0.84 in Figure V-6 - 
Figure V-9). Most of the biologically relevant ligands in protein-ligand crystal 
structures are well buried [173], and tight-binding ligands have, on average, more BSA 
than weakly bound ligands.[174] Thus, similar BSA between the two sets is especially 
important as it is directly proportional to the number of contacts that contribute to the 
scores. Even despite our effort to achieve similar BSA distributions across the two sets, 
this descriptor remains the strongest naïve discriminator between the valids and invalids. 
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Figure V-5: ROC plot showing performance of physicochemical descriptors as classifiers: 
Molecular Weight (MW), logS, SlogP, Buried Surface Area (BSA), percent Exposed Surface Area 
(%ESA), and the principal component (PCA1). Areas under the curve (AUC) are noted in 
parenthesis in the legend. 
 
 
5.3.1 Analysis of Scoring Functions 
We were delighted that X-Score, AutoDock, DOCK, and ITScore all performed 
well, preferentially distinguishing valids over invalids and at a higher rate than MW or 
BSA (Table V-3 and Figure V-10). This is very promising for extending current scoring 
functions to new uses in structural proteomics like predicting druggability or function of 
a protein. ITScore with a torsional entropy penalty included, performed best, especially 
in the all-important, low-false-positive segment at the beginning of the curve. BSA 
significantly underperforms for more than half of the valid ligands (<0.5 true positives), 
its presence in the ROC plot of Figure V-10 emphasizes that all the scoring functions 
are out-performing a mere count of contacts in evaluating the ligands. The performance 
111 
of the scoring functions is even more encouraging if one considers that they are 
optimized to provide a measure of protein-ligand affinity, whereas our valids and 
invalids were chosen on the basis of biological validity. Not all of the valid ligands are 
tight binders. An underlying assumption of this study is that the ligands classified in 
Binding MOAD as invalid are weaker binders. Though this assumption is quite 
reasonable, a direct comparison between experimental affinity values and the calculated 
scores for valid versus invalid ligands is currently impossible because affinities are 
typically not measured for these chance binding events. Therefore, it is encouraging to 
see that a measure of affinity can differentiate well between valid- and invalid-ligand 
binding.  
Table V-3: Number of invalids in the top ranked results of the scoring functions.  
 AUC Top 10% ranked Top 25% ranked Top 50% ranked 
AutoDock (w/tor) 0.78 0 out of 25 2 out of 62 11 out of 125 
DOCK (+tor) 0.79 0 out of 25 3 out of 62 6 out of 125 
ITScore (+tor) 0.84 0 out of 25 0 out of 62 6 out of 125 
X-Score (w/tor) 0.81 0 out of 25 3 out of 62 13 out of 125 
Cumulative Rank  0 out of 25 0 out of 62 10 out of 125 
 
Figure V-6: ROC plot of ITScore performance 
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Figure V-7: ROC plot of DOCK4 performance 
 
Figure V-8 – ROC plot of X-Score performance 
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Figure V-9 - ROC plot of AutoDock4 performance 
 
Figure V-10 - ROC plot of Scoring Function Performance 
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5.3.2 Torsional Entropy 
 Although valids were ranked over invalids whether or not torsional entropy terms 
were included, it is important to note that adding the penalty significantly increased  the 
true positive rate in the highest ranked ligands (Figure V-6 – Figure V-9). This 
improvement was seen for all scoring functions. Including the torsional term in ITScore 
and DOCK improved performance (AUC increase of .03 and .04 respectively), and 
removing the term from X-Score and AutoDock degraded performance (AUC decrease 
of .05 for both). Of course removing a term from a scoring function should degrade its 
performance, but it was interesting to see that the torsional term resulted in relatively 
similar contributions in performance for all the scoring functions in terms of AUC. 
Furthermore the contribution of the torsional term seems to be essential for improved 
performance in the most critical region of the ROC plot – the lower left corner where 
the highest-ranked compounds are represented. 
 A closer look at the scores by ITScore with and without torsional penalty shows 
that the largest changes in score occurred for several of the invalid complexes (1U3A 
and 1T7V), ranking them much lower when the term was included (59 vs. 167 and 70 
vs. 140 respectively). The ligands in both of these molecules are polyethylene glycols, 
long chain-like molecules that are not biologically important for these proteins. These 
ligands are large and extremely flexible, with 23 and 17 rotatable bonds, respectively. 
The ligands’ large size results in a good contact score, even with modest burial, and the 
penalty term is essential to account for the high conformational entropy loss for the 
ligand when the torsions become restricted. 
 The method for including a torsional penalty to ITScore and DOCK was 
somewhat naïve for this study. It is reasonable to assume that performance would be 
further improved by properly fitting these terms into DOCK and ITScore functions. 
While knowledge potentials like ITScore aim to represent all physical contributions to 
binding, they are still restricted by any limitations of their training set. ITScore’s 
training set is much larger than those of other functions, but torsional entropic penalties 
of the ligand will not be well represented unless the set includes ligands with many 
rotatable bonds. Pair-wise potentials are iteratively trained by identifying native poses 
over incorrect poses, but docking ligands with many rotatable bonds is inherently 
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difficult because of their large conformational space. This predicament has severely 
restricted the ability of pair-wise potentials to account for the torsional penalty well at 
this time. In order to improve performance, the most appropriate approach will be to 
iteratively fit a new term as a corrective measure when training the pair-potential. 
5.3.3 Top-Scoring Complexes 
A set of valids was consistently ranked highly by at least several of the scoring 
functions (Table V-4). Although several valids were ranked in the top ten by 3 out of 
the 4 scoring functions, most non-unique top valids were highly ranked by 2 out of 4 
functions. These common top-valids were most similar between functions that included 
the torsional penalty in their original formulation (AutoDock and X-Score) or had the 
penalty added (ITScore+tor and DOCK+tor). This might indicate certain scoring bias 
for certain ligands in our implementation of the torsional penalty for ITScore+tor and 
DOCK+tor. However, such bias does not undermine the usefulness of the torsional 
penalty in separating valids from invalids.  
The common top-ranked valids range from enzymes such as hydrolases (2CER, 
1VJ5, 1NO6, 1K1P), transferases (1C9C), and kinases (1OIT) to RNA binding proteins 
(1L8B) and immune system proteins (1LO0). Most of the valid ligands are either 
inhibitors, reaction intermediates designed to study enzyme function, or the enzyme 
substrates (EST in 1FDS). In one case, the ligand is a modified cofactor (PP3 in 1C9C) 
bound in the cofactor binding site. Most importantly, each of the valids is a biologically 
relevant ligand that makes important contacts with the protein in the active site.  
One valid ranked highly by three of the four functions is the phenethyl-substituted 
glucoimidazole (PGI), a transition-state mimic and a potent inhibitor of beta-
glycosidase (2CER) with a Ki of 0.6 nM [175]. The multiple hydroxyl groups of the 
ligand form numerous bonds within the active site to residues Glu 432, Gln 18, Trp 433, 
His 150, Asn 205 and Glu 387. However, no interactions are seen for the phenethyl 
group. The structure’s authors argue that entropic contributions, perhaps attributable to 
desolvation, are responsible for the high affinity of this inhibitor. The inhibitor is one of 
the strongest known for this family of proteins.  
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Another valid ranked in the top 10 by the majority of the functions is CIU, a potent 
alkylurea inhibitor of human epoxide hydrolase, bound to its target (1VJ5) with an IC50 
value of 0.12 μM[176]. The urea oxygen forms stabilizing hydrogen bonds to Tyr 381 
and Tyr 465 and the NH group form bonds with Asp 333. Additional favorable VDW 
interactions utilize a smattering of residues across the active site.  
Structure 1C9C contains an aspartate aminotransferase complexed with a substrate 
analogue (pyridocal 5’-phosphate linked with an alanine, PP3) that was used to study 
active site-loop motion. It was ranked as a top valid by both ITScore+tor and 
DOCK4+tor. Highly buried (%ESA ~ 6%) and armed with phosphate and carboxylate 
groups, the ligand forms favorable ionic interactions with Arg 266 and Arg 386, as well 
as polar interactions with Asn 194, Asp 222, and several other active site residues [177]. 
The ligand also has relatively few rotatable bonds, reducing the torsional entropy. 
Curiously, X-Score and AutoDock ranked this ligand 17
th
 and 53
rd
, respectively. 
 1OIT is an X-ray structure containing a selective inhibitor of cyclin-dependent 
kinase 2 (CDK2), identified through high-throughput screening and structure-activity-
based optimization. The ligand, a 2-anilino imidazo[1,2-a]-pyridine, is one of the 
stronger binders in the valid set, with an IC50 of < 3 nM. The pyrimidine core of the 
molecule forms stabilizing hydrogen bonds to the protein backbone, while the 
hydrophobic anilino ring lies in a hydrophobic path of residues whose desolvation 
contributes to the high binding constant and likely to the CDK2 specificity of this 
inhibitor [178]. Additional bonds with Asp 86 further stabilize the compound. In this 
instance, the protein-ligand complex was ranked in the top-10 by X-Score and 
AutoDock, while ITScore+tor and DOCK4+tor ranked the complex lower as 31
st
 and 
11
th
, respectively.  
Despite some correlation between AutoDock and X-Score ranks (R
2 
= 0.7), the top 
rankings still vary significantly between scoring functions. An mRNA-5’-cap analogue 
inhibitor (7-methyl GTP) bound to a RNA-binding translation initiation protein (1L8B 
Kd = 0.14 μM) [179] was ranked 4
th
 and 8
th
 by ITScore+tor and AutoDock, respectively. 
Meanwhile, DOCK4+tor and X-Score ranked it 16
th
 and 99
th
, respectively. The 
inhibitor’s high potency is attributed to favorable stacking of the guanine moiety and 
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extensive hydrogen bonding through the phosphate groups. The torsional entropy 
penalties for the ligand did not significantly affect the rankings.   
Assessing the well-scored invalids can be an enlightening exercise because it can 
reveal caveats in a given scoring function. Most importantly, we expect that 
opportunistic invalids should score well if they are similar to a valid ligand and they are 
bound in the true active site. These are “acceptable failures” where a good score and 
rank is desirable, despite the lack of clear functional significance for the binding. Of the 
71 invalids, 15 were observed to bind in active sites, and 3 of those appeared in the top-
ranked invalid lists (Table V-5).  
Overall, each of the scoring functions ranked a similar list of invalids highly (Table 
V-5) but not the rank itself or the order of ranking. Chemically the top-scoring invalids 
include a variety of molecules, such as common detergents (N-octanoyl-sucrose in 1IZ2, 
n-octane in 1APM), buffers (tartarate in 1D5R, DTT in 1N2F, HEPES in 1RJM), other 
small organic compounds. Most of the invalids were bound to enzymes, although not all.  
Three of the four scoring functions ranked 1D5R and 1IZ2 as high-scoring invalids. 
Structure 1D5R has a buffer tartrate molecule bound in an active site of a PTEN tumor 
suppressor. The tartrate makes many similar contacts to those expected for the natural 
substrate – inositol (1,3,4,5)-tetrakisphosphate, but it has no known biological activity 
with respect to PTEN phosphatase function [180]. Meanwhile, 1IZ2 shows an N-
octanyl-sucrose (SUM) detergent additive bound to an alpha1-antitrypsin. The detergent 
molecule’s hydrophobic tail is partially inserted into a protein cavity away from the 
known active site, and a quarter of the ligand surface area remains exposed to solvent.   
Another interesting structure is 1URM, ranked highly amongst invalids by 
ITScore+tor and DOCK4+tor. The structure contains a benzoate molecule which 
unexpectedly binds in the active site of the human peroxiredoxin 5 enzyme, making 
bonds with a critical mutated serine residue (mutated from the catalytic peroxidatic 
cysteine) and multiple hydrophobic contacts through its aromatic ring. The origin of the 
benzoate in the structure is unknown and no known biological function has been 
associated with its binding [181]. However, the molecule was also seen to bind in the 
same pocket of wild-type and homologous crystal structure of the protein, indicating 
that its binding mode might be more than serendipity.   
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In 1RJM, ranked as the top invalid by DOCK4+tor, the ligand is far from an active 
site, wedged in a hole formed by trimer of MenB chains, a lyase from Mycobacterium 
tuberculosis. The ligand’s negatively charged sulfonic-acid head group forms 
interactions with a charged Arg side chain via some well ordered water molecules. 
Highly ranked by X-Score and AutoDock4, 1SHV is a structure of an SHV-1 beta-
lactamase, complexed with a detergent bearing a maltose moiety. The hydrophobic tail 
of the Cymal-6 detergent is wedged between two hydrophobic α-helices on the “top” of 
the protein, while the disaccharide group is hydrogen bonded across the crystal packing 
interface, facilitating intermolecular aggregation. The ligand scores well despite having 
the maltose moiety (which accounts for ~30% of the surface area) exposed to solvent in 
the monomer structure, and it does not appear to have an effect on the catalytic activity 
of the enzyme [182]. Also scored highly by X-Score and AutoDock4 is 2SHP, an SHP-
2 tyrosine phosphatase with a detergent-like ligand - CAT. The CAT’s tail is nicely 
buried between a trio of hydrophobic α-helices, just shy of the catalytic site but it does 
not appear to form strong bonds with the surrounding residues.  
Although several other invalids are found in the active sites of proteins (1QST, 
2OR7, 1T7V, 1TTO et al.) they aren’t ranked especially high among the invalids by any 
of the scoring functions.  Some of the invalids are identified by modeling molecules 
into unaccounted electron density based on size, shape, and chemical environment. 
Usually the molecule is readily identified as a component of the crystallization matrix. 
For example, a molecule of polyethylene glycol was modeled to fit the density in the 
δ5-3-ketosteroid isomerase (8CHO) [183]. Other cases exist where the ligand was not 
from the crystallization matrix. Analine (ANL) is seen to bind near a proposed 
phospholipids substrate site in the crystal structure of phospholipase A2 (1PPA). While 
its presence is confirmed by the electron density, its origin is remains a mystery [184]. 
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Table V-4: Top scoring valids. Unique valids in italics, those scored in the top 10 by 2 or more 
functions in plain text. 
Table V-5: Top scoring invalids. Unique valids in italics, those ranked in the top 10 by two or more 
functions in plain text. Invalids found in known binding sites are marked with an asterisk 
 
ITScore + tor 
PDB Ligand Rank %ESA 
1M27 FLC 88 24.5% 
1RTV SRT 95 10.6% 
2RA5 SRT 111 20.8% 
1D5R TLA* 112 5.0% 
1URM BEZ* 119 18.8% 
1IZ2 SUM 120 25.9% 
2INU 2PO 127 36.2% 
2O02 BEZ 135 31.7% 
1ZDY T3A 137 18.9% 
2OK6 BEZ 139 0.2% 
 
DOCK4 + tor 
PDB Ligand Rank %ESA 
1RJM EP1 26 3.6% 
1D5R TLA* 29 5.0% 
2RA5 SRT 35 20.8% 
2B4P MLI* 46 8.3% 
1MRZ CIT 51 34.5% 
1M27 FLC 57 24.5% 
1ZGN MES 69 45.0% 
1HH8 FLC 81 19.7% 
1URM BEZ* 82 18.8% 
2OK6 BEZ 92 0.2% 
AutoDock4 
PDB Ligand Rank %ESA 
2SHP CAT 54 10.4% 
1SHV MA4 60 34.1% 
2OK6 BEZ 64 0.2% 
1IZ2 SUM 68 25.9% 
1D5R TLA* 85 5.0% 
2E50 TRE 91 26.5% 
1JJ0 SUC* 98 30.0% 
1LIH PHN 100 37.2% 
X-Score 
PDB Ligand Rank %ESA 
1SHV MA4 35 34.1% 
2SHP CAT 42 10.4% 
1IZ2 SUM 44 25.9% 
1RJM EP1 95 3.6% 
1Q61 MG8 103 10.4% 
2OK6 BEZ 104 0.2% 
1APM OCT 105 17.8% 
2P4B BOG 106 19.7% 
ITScore + tor 
PDB Ligand Rank %ESA 
1C9C PP3 1 5.9% 
2CER PGI 2 14.0% 
2J7C IDE 3 14.1% 
1L8B MGP 4 36.9% 
1IEX TCB 5 11.5% 
2J7D GI1 6 12.4% 
1VJ5 CIU 7 6.8% 
2J7B NTZ 8 7.3% 
1BR6 PT1 9 20.0% 
2J7G GI4 10 12.4% 
 
DOCK4 + tor 
PDB Ligand Rank %ESA 
1C9C PP3 1 5.9% 
1HG2 IP2 2 69.1% 
1D1Q 4NP 3 12.2% 
2PBW DOQ 4 10.7% 
1NO6 794 5 23.2% 
1H1H A2P 6 60.3% 
1V48 HA1 7 5.0% 
2CCG TMP 8 21.2% 
5GPB GPM 9 16.1% 
2FZG EOB 10 7.1% 
 
AutoDock4 
PDB Ligand Rank %ESA 
1LO0 BC1 1 12.2% 
2HHA 3TP 2 25.8% 
2CER PGI 3 14.0% 
2OYM MNI 4 10.7% 
1Q8U H52 5 61.4% 
1OIT HDT 6 25.2% 
1FDS EST 7 11.8% 
1L8B MGP 8 36.9% 
1VJ5 CIU 9 6.8% 
1K1P MEL 10 24.7% 
 
X-Score 
PDB Ligand Rank %ESA 
1VYQ DUX 1 27.0% 
1VJ5 CIU 2 6.8% 
1FDS EST 3 11.8% 
1OIT HDT 4 25.2% 
1GII 1PU 5 10.6% 
1K1P MEL 6 24.7% 
2CER PGI 7 14.0% 
1LO0 BC1 8 12.2% 
1NO6 794 9 23.2% 
2BU2 TF1 10 28.1% 
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1PPA ANL 101 5.2% 
1N2F DTT 124 16.7% 
 
1JLU OCT 109 17.2% 
2GFC OCT 111 15.5% 
 
5.4 Conclusion 
This study puts forth a new criterion for evaluating scoring functions: the ability to 
discern between opportunistic binding (invalids) and biologically important ligands 
(valids). Accordingly, a new test set is presented, which contains 177 valid and 71 
invalid structures. The invalid and valid structure sets show similar distributions of 
physicochemical properties such as molecular weight, hydrophobicity, solubility and 
BSA. For different scoring functions - representative of knowledge-based, force-field, 
and empirical methods - are used to evaluate the test set with respect to valid/invalid 
discernment. The results show that the four scoring functions are able to tease out 
invalids from valids with a significant success rate, achieving ROC AUC scores of 0.84, 
0.81, 0.79 and 0.78 for ITScore+tor, X-Score, DOCK4+tor, and AutoDock4, 
respectively. Additionally the approximation of ligand torsional entropy in the scoring 
functions was shown to have an important contribution for successful ranking of the 
valids versus invalids among the protein-ligand complexes.  
 This test set has potential to help improve algorithms used in molecular docking 
by providing a different measure for docking success. Its further development will be 
essential to extending scoring functions to new purposes, like cross docking identifying 
unknown protein function, or estimating the druggability of a surface pocket. 
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CHAPTER VI  
 
Overcoming Sequence Misalignments with Weighted Structural 
Superposition 
6.1 Introduction 
Evolutionarily related proteins generally retain a tertiary fold that is more conserved 
than the amino acid sequence [185, 186]. Structure is related to function; hence, 
proteins with similar structures may also share a common biological activity [187]. As a 
result, the identification of a homolog is a very useful means to infer the function and/or 
predict the structure of an uncharacterized protein. Many databases exist that classify 
proteins into families by their structures, including but not limited to SCOP [188], 
CATH [189], DaliDB [190], PASS2 [191], MMDB [192], ASTRAL [193], 
HOMSTRAD [194], and LPFC [195]. A review from Orengo and Thorton provides a 
very thorough discussion of protein evolution from a structural standpoint [196], and 
another recent review stresses that the classification in an evolutionary context is still an 
open problem [197].  
An appropriate structural superposition provides a means to compare the similarity 
or dissimilarity between protein structures. However, in order to perform a structural 
comparison, the corresponding residues (atom pairs) between the proteins must be 
determined. This task can be accomplished 1) in a sequence-dependent manner using an 
initial sequence alignment or 2) solely through structural information in a sequence-
independent manner. Sequence-based techniques can miss similarity between 
homologous proteins with intermediate to low sequence identity (twilight zone). Fold-
based methods can identify structural similarity, even between homologs with divergent 
sequences, but they may be misleading in the case of flexible proteins. A technique that 
combines the two approaches and overcomes limitations caused by the protein 
flexibility would be an ideal choice for superimposing homologs. In 2005, a thorough 
evaluation [198] of six structural comparison techniques – SSAP [199], STRUCTAL 
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[200, 201], DALI [202], LSQMAN [203], CE [204], and SSM [205] - demonstrated 
many strengths and limitations of current approaches and the caveats of metrics used for  
evaluation and comparison. A more recent review with similar scope indicated room for 
improvement of alignments, especially in proteins with extensive conformational 
variability or structural repetitions [206]. Additional reviews of the field call for 
combining techniques and using consensus across several methods to best define a 
structural comparison [185, 207, 208]. Here, we present a structural alignment method 
that accounts for protein flexibility and utilizes a superposition-driven approach to 
capture structural similarity in a more systematic and intuitive way. 
Previously, we introduced a superposition technique that overcomes the limitations 
of protein flexibility [7] by implementing a Gaussian-weighting term into the RMSD-fit 
algorithm determined by Kabsch [209]. The calculated weight is directly related to the 
distance between two atoms in space. Consequently, atom pairs in close proximity have 
a greater weighting than those further apart, biasing the superposition toward the 
regions that remain relatively rigid between conformations. Our method is the reverse 
of techniques used for the last 20 years, which perform two steps: 1) identify related 
subsets of Cα and 2) overlay those related subsets by a standard RMSD fit (sRMSD; 
Figure VI-1). Using our technique, the overlay defines the domains, rather than the 
domains defining the overlay. The resulting weights identify the domains. As illustrated 
in Fig. 1B, the backbones of two protein conformations are well superimposed in the 
blue, high-weight regions but can be seen separately in the red, low-weight regions. 
Each solution is based on a unique domain of the protein and each is an equally valid 
overlay. Complete mathematical details of the weighted RMSD (wRMSD) procedure 
can be found in our original work [7], and an abbreviated presentation is provided in the 
Appendix. 
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Figure VI-1 : A) Most methods for superimposing flexible proteins are based on two steps, which 
involve determining a subset of related atoms and overlaying the subset using a standard RMSD-fit 
procedure. Each technique differs in the way that it identifies the related subsets, but in the 
superposition step, all of the techniques designate each Cα as “in” or “out” of the calculated fit. B) 
Our weighted superposition is based on all Cα. Multiple solutions can be found where the domains 
are reflected in the resulting weights and superpositions. Blue and green regions have high weights, 
align well, and define a domain. Red regions have low weights and poor agreement in the overlay. 
 
In this work, we have coupled our wRMSD technique with basic sequence 
alignment algorithms from the EMBOSS package [210] to provide initial alignment of 
homologous sequences. In our previous work, we were able to show an improved 
superposition of two conformations of the chaperonin protein GroEL, which undergoes 
a large conformational change between the bound and apo forms (PDB [2] codes 1AON 
[211] and 1OEL [212], respectively). In Figure VI-2, we use this system again to 
demonstrate the potential difficulties of fitting homologous, flexible proteins. With our 
technique, either conformation of GroEL can be appropriately superimposed to the 
bound form of its archaeal homolog, the thermosome (1A6E [213]). The easier case of 
fitting the two bound conformations is shown in Figure VI-2A, and Figure VI-2B shows 
the more difficult comparison of the bound form of the thermosome to the apo form of 
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GroEL. The superpositions are colored by weight of the aligned pairs of Cα atoms, with 
higher weights indicating closer proximity, and higher average weight (wSUM) 
indicating stronger structural similarity. Fold-based techniques can identify the 
homologous regions from the similar bound conformation in regions of very low 
sequence similarity, but in cases where the structures of homologs are only available in 
alternate conformations, those same techniques may have difficulty. Our method is able 
to overcome errors from the initial atom pairing due to low sequence identity and large 
conformational differences by only weighting regions of the protein in good structural 
agreement. 
Figure VI-2: Chaperonin family (20.8% ID). Most techniques would readily identify the similarity 
between the thermosome and GroEL in the similar the bound conformation, but they may not 
identify its similarity with the apo conformation of GroEL. A) wRMSD superposition of the bound 
conformation of GroEL (thick, colored lines) onto the homologous thermosome (thin, black lines). 
Light gray regions of GroEL indicate residues within gaps in the alignment. B) wRMSD fit of the 
apo conformation of GroEL (thick, colored lines) onto its homolog thermosome (thin, gray lines). 
The wSUM gives the average weights of all paired residues, showing that the two bound 
conformations in A have greater similarity than the two conformations in B. 
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Once a sufficient overlay is established, the seed extension (SE) structural alignment 
algorithm[214] lets the wRMSD superposition dictate a new and improved sequence 
alignment. The SE method extends the alignment of residue pairs in very close 
proximity (seeds) along the protein chain.  Many modern structural alignment methods, 
such as CE, combine sequence and structure data in their alignment procedure. CE uses 
blocks of aligned fragment pairs to perform a combinatorial extension, considering both 
sequence and structural similarity as part of an optimal alignment determination. In 
contrast, our method is modular and allows the structural information to dominate the 
superposition producing a consistent structural alignment solution. The SE algorithm 
allows us to then convert the information from the structural alignment into an equally 
consistent sequence alignment. Below, we demonstrate the robustness of the procedure 
with respect to initial sequence alignment, and the ability to correct misalignments in 
the initial alignment. We then compare alignment performance to that of several 
popular structure alignment programs.  
6.2 Methods 
Homologous protein pairs were obtained from the HOMSTRAD database [194]. 
The protein coordinates were downloaded from the PDB [2], and the specific protein 
chains used were dictated by the pairings listed on the HOMSTRAD website. For this 
study, we chose to focus on the more difficult cases of homologous proteins with lower 
sequence identities (ID) (39-16%). We examined homolog pairs with <16% ID, but the 
sequence alignment algorithms used to obtain an initial alignment failed, giving 
nonsensical alignments. The other structural alignment programs used in this study also 
failed with these cases, making <16% ID a relatively universal cutoff for current 
methods.  
Our technique is performed using Cα coordinates, but it is easily extended to any 
atom subset. The HwRMSD procedure consists of 4 sequential steps:  
1. Use a simple sequence alignment to determine an initial list of paired residues. 
2. Calculate an initial sRMSD alignment (non-weighted) to overlay the centers of 
mass and provide a rough initial orientation for the proteins.  
3. Conduct iterative wRMSD fitting until convergence is reached. 
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4. Obtain a corrected sequence alignment from the structural superposition using SE.  
The program needle, an implementation of the Needleman-Wunsch (NW) global 
alignment from the EMBOSS [210] package was used to generate the pair-wise 
sequence alignment. This alignment determines the residue correspondence between the 
two proteins, which is then used to guide the initial structural superposition.  
To obtain a sequence alignment from the structural superposition, SE is used with 
default parameters [214]. Briefly, SE finds “seed” pairs of structurally equivalent 
residues from overlaid structures based on their physical proximity and chemical 
similarity. Consecutive triplets of seeds are then extended along the alignment matrix in 
both directions, using distance and amino acid similarity to resolve conflicts which arise 
during the extension of more than one diagonal.  
To test the robustness of the method with respect to initial sequence alignments, 
water, an implementation of the local Smith-Waterman (SW) sequence alignment from 
EMBOSS [210], was also used. The four different scoring matrices used were 
BLOSUM50, BLOSUM62, PAM120, and PAM250, Each employed its optimal gap-
open and gap-extension penalty parameters: (-10,-2), (-7,-1), (-16,-4), and (-10,-2), 
respectively. The optimal parameters for each scoring matrix were recommended by the 
European Bioinformatics Institute [215].   
For each protein pair, the pair-wise distances between the superpositions obtained 
with the same sequence alignment algorithm were calculated, and the median of these 
values was chosen to represent the similarity of the solutions. The distances between the 
superpositions were calculated using a simple all-atom RMSD.  In cases such as the 
PHBD-like proteins (1FOH [216] and 1PBE [217]) and several others, the initial 
sequence alignment was altogether too small to be considered a reasonable solution 
when using certain sequence alignment parameter sets. To avoid such invalid outliers, 
any solution with an alignment length of less than 10 residue pairs was discarded, and 
the median distance was calculated between the 2 or 3 remaining solutions. Such cases 
were mostly in the range of low sequence identity (< 20% ID), and they illustrate the 
practical limits of the current approach. For comparing our results to other tools, we 
used the EMBOSS-wrapped implementations of CE [204], FATCAT (flex) [218], and 
the native SSM [205] and DaliLite [190] servers. Default parameters were used for all 
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structural alignment methods. For SSM and DaliLite, only the best alignment solution 
was considered, based on highest Q-Score or Z-Score, respectively. To obtain consistent 
weighing for alignments from different software packages, a weighting constant of c=5 
was used for any wRMSD or %wSUM calculations (in the default wRMSD method this 
constant is set to the value of the initial sRMSD superposition). 
PyMOL [116] was used for various visualization purposes and the creation of 
figures in this paper. 
6.3 Results and Discussion 
6.3.1 Overcoming Variation in the Initial Sequence Alignment 
Aligning proteins with high sequence identity is straightforward, so for this study, 
we chose to focus on the more difficult cases of homologous proteins in the low to 
intermediate range (39-16% ID), as listed in Table VI-1. We first examined the 
robustness of the HwRMSD protocol with respect to a variety of sequence alignments. 
We chose the canonical implementation of global Needleman-Wunsch (NW) and local 
Smith-Waterman (SW) algorithms to perform the initial sequence alignments and varied 
their parameters by using four different scoring matrices and their respective optimal 
gap penalty values. For each test case, each of the sequence alignments was used to 
generate a standard and weighted superposition. The similarity of the superpositions per 
test case was then evaluated by computing all-atom RMSD distances among the 
superpositions generated from each of the sequence alignment algorithms (note that this 
use of RMSD is simply a measure of the difference in two sets of coordinates, not a 
fitting procedure). 
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Table VI-1: Median RMSD differences (in Å)* between the structural superpositions generated 
utilizing sequence alignments with different parameters; using global (Needleman-Wunsch) or local 
(Smith-Waterman) sequence alignment algorithm, and standard or weighted superposition 
algorithm. 
Homolog Proteins and PDB IDs %ID Smith-Waterman Needlman-Wunsch 
 
 Standard Weighted Standard Weighted 
Serine/Threonine Phosphatase 
1FJM & 1TCO 
39% 0.42 0.07 0.72 0.02 
Glutathione Synthase 
1M0W & 2HGS 
37% 0.27 0.06 0.27 0.07 
Interferon 
1AU1 & 1ITF 
35% 1.48 0.12 1.43 0.17 
Adenosylmethionine Decarboxylase 
1I7B & 1MHM 
33% 0.25 0.09 0.24 0.03 
Clostridial Neurotoxin Zinc Protease 
1EPW & 3BTA 
31% 0.64 0.08 0.69 0.09 
Sulfatase 
1AUK & 1FSU 
29% 0.91 0.24 0.54 0.09 
Translation Initiation Factor 
1AP8 & 1EJH 
29% 0.97 0.22 0.23 0.05 
Protocatechuate-3,4-Dioxygenase 
3PCG (chain A) & 3PCG (chain M) 
28% 0.76 0.05 0.49 0.04 
Aminotransferase 
1A3G & 5DAA 
27% 1.38 0.45 1.22 0.13 
SpoU rRNA Methylase 
1IPA & 1GZ0 
26% 5.83 1.30 2.59 0.23 
FMN Oxidoreductase 
1OYC & 2TMD 
25% 2.26 0.73 0.30 0.08 
Queuine tRNA-Ribosyltransferase 
1IQ8 & 1K4G 
25% 0.76 0.50 0.34 0.08 
tRNA Synthestase 
1GLN & 1QTQ 
24% 4.96 1.86 3.01 0.15 
DNA Methylase 
1BOO & 2ENT 
23% 3.31 0.36 2.73 0.19 
DNA Topoisomerase 
1AB4 & 1BJT 
22% 1.46 0.55 0.48 0.43 
Pyridoxal-Phosphate Enzymes 
1TDJ & 2TYS 
21% 6.89 4.91 5.54 2.59 
Iron/Ascorbate Oxidoreductase 
1BK0 & 1DCS 
20% 11.08 1.77 0.92 0.51 
Molybdopterin Dehydrogenase 
1FFV & 1FO4 
19% 1.21 0.66 1.08 0.49 
Splicesomal Protein, Internalin B 
1A9N & 1D0B 
19% 2.33 0.56 7.85 8.81 
Asp/Glu/Hydontoin Racemase 
1B74 & 1JFL 
18% 1.52 0.51 1.36 0.22 
Polysaccharide Lyase 
1CB8 & 1EGU 
18% 1.32 0.68 1.27 0.20 
PHBH-like Proteins 
1FOH & 1PBE 
17% 5.44 4.72 4.83 2.63 
Adaptin, Clathrin Appendage Domain 
1E42 & 1QTS 
16% 5.51 3.98 3.94 0.47 
*The sequence alignments were altered by varying the similarity matrix and gap penalties. The variation across the 
superpositions was measured by pair wise RMSD (Å) between all the solutions. Median differences are reported, but all calculated 
pair-wise RMSDs are included in the supplementary material. Smaller value denotes a greater agreement between the 
superpositions. 
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For each test case except one, the use of weighted superposition overcomes the 
variation in atom-pairing arising from the different sequence-alignment parameters to 
give a more consistent structural comparison. Figure VI-3 shows how the standard 
superpositions resulted in more variation across the solutions for a pair of proteins; the 
median RMSD ranged from 0.23 – 7.84 Å with roughly half of the test cases having 
variation of greater than 1 Å. In contrast, for the weighted fit, the median RMSD of the 
solutions ranged from 0.02 – 8.8 Å with only 9 out of 46 cases (3 for global and 6 for 
local) having greater than 1 Å variation. Both global NW and local SW sequence 
alignments resulted in similar variation in superpositions. Protein pairs with lower 
sequence identity showed greater variation (bubble size in Figure VI-3 is proportional to 
sequence identity, and the small bubbles are in the upper right quadrant).   
Figure VI-3: Median RMSD distances (measures of agreement, not overlay fit) between 
superpositions obtained from varying sequence alignment parameters. Standard superposition 
values on the x-axis are higher than the weighted superposition values on the y-axis, indicating 
greater variation in solutions for the sRMSD superpositions and better agreement across the 
wRMSD superpositions. Blue bubbles represent medians of superpositions obtained from global 
Needleman-Wunsch alignments; red bubbles are from local Smith-Waterman alignments. The size 
of the bubbles is proportional to sequence identity of the aligned protein pairs (39% to 16%) with 
smaller bubbles indicating less similarity. In general, the smaller bubbles show higher variation due 
to difficulty of obtaining a consistent initial sequence alignment. 
 
130 
Standard superposition is sensitive to the initial alignment, and incorrectly paired 
residues skew the result even in cases where large structure similarity in a protein 
domain is visually obvious. The weighted superposition converges to a consistent result 
even when a wide variety of initial alignments are used, allowing regions of the 
structure in closest proximity – such as large similar domains – to drive the 
superposition. Figure VI-4 uses DNA methylase homologs [219] (23% ID) to visually 
show how the standard superpositions are noticeably different when varying the 
methods and parameters for sequence alignment (Figure VI-4A). For this example, the 
median difference was 3.69 Å among the SW alignments and 2.85 Å among the NW 
alignments. These variations in the superpositions result in different “corrected” 
sequence alignments from SE. Conversely, the weighted superpositions are 
indistinguishable by eye (Figure VI-4B); the median difference of the weighted 
superpositions is only 0.35 Å for the SW alignments and 0.16 Å for the NW. All the 
weighted superpositions generate the same corrected sequence alignment with SE. Most 
importantly, the weighted superpositions resulted in an improved fit over the standard 
superpositions, particularly in the core region which is structurally conserved between 
the homologous proteins. After all, a consistent superposition is only useful if it is also 
an improved superposition! 
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Figure VI-4: DNA methylase family (23% ID). Weighted structural superpositions are nearly 
independent of the sequence alignment method, but standard superpositions are greatly affected.  
A) Overlays of 2ENT (black ribbon) to 1BOO[219] (colored ribbons) from standard superpositions 
based on seven different sequence alignments. B) The seven weighted superpositions of 2ENT
 
to
 
1BOO, based on the same varied sequence alignment routines collapse into a single converged 
solution. 
 
There were several test cases where the weighted solutions of the SW and NW 
alignments were not a significant improvement over standard solutions. For example, in 
the case of spliceosomal protein [220] and internalin B [221] (1A9N and 1D0B) the 
NW PAM120 alignment produced a significantly different superposition, (median 
distance 15 Å from other solutions) skewing the median of both standard and weighted 
solutions. Similarly in the case of the adaptin [222] and clathrin [223] appendage 
domains (1E42 and 1QTS) the SW PAM120 alignment produced an outlier 
superposition (distances of 7 Å from other solutions). The PAM120 alignment 
parameter set has the most severe gap penalty of the four matrices tested (-16), and it 
produced alignments with very few gaps when used with the global NW method, and 
extremely short alignments with the local SW method. Both of these cases are in the < 
20% sequence identity range and exemplify the current practical limits of the method, 
which requires at least a reasonable initial sequence alignment. A list of all the pairs 
used in the median RMSD calculations and the pair-wise distances of their respective 
superposition solutions is available in the Supplementary Materials. 
132 
We found that wRMSD is more sensitive to the initial sequence alignment 
parameters – matrix, gap open penalty and gap extend penalty – rather than the choice 
of alignment algorithm or alignment length. As long as a reasonably long gapped 
alignment is provided, the weighted superposition technique can produce a consistent 
structural superposition. The NW alignment with a BLOSUM50 matrix produced the 
most appropriate alignments over all the test cases (the rest were too short or failed), 
and similar alignments were also obtained from BLOSUM62 and PAM250 with both 
NW and SW. Given its reliable performance, the NW BLOSUM50 alignment has been 
defined as the default initial alignment for our HwRMSD method and for the 
comparison to other methods below.   
Of course, there may be situations where it is difficult to obtain an appropriate 
superposition with the weighted fitting, e.g., when a protein is large and has multiple 
domains. If two different initial sequence alignments obtain residue pairings each 
focused on a different domain, rather than spanning entire protein structure, then the 
weighted superpositions may not converge to the same solution. Another such case is 
when there is too little sequence or structural similarity, but this is when most 
comparison methods breakdown. For the test cases employed in this study, the sequence 
alignment tools broke down at ~16% ID, returning sporadic aligned segments that were 
too short and too infrequent. Homologs with so little sequence similarity are notoriously 
difficult to align [224], but it may be possible in some cases to compare them using 
methods based on structural information such as geometric comparisons of folds [225]. 
However, these techniques would be successful only when there is little structural 
variation or flexibility. Techniques such as wRMSD are absolutely required for large 
structural variation. 
6.3.2 Correcting Sequence Misalignments 
Residue pairings in regions of good structural agreement will be heavily weighted in 
the wRMSD calculation. Protein regions that have been brought into close spatial 
proximity, but have a low weighting with respect to the initial sequence alignment, 
indicate potentially incorrect pairings of residues. In Figure VI-5, we visually 
demonstrate how the spatial proximity of structures after a weighted superposition 
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corrects a sequence alignment by using two homologs from the SpoU rRNA methylase 
family with 26% ID (1GZ0 and 1IPA) [226, 227]. 
Figure VI-5: SpoU rRNA methylase family (26% ID). A) NW sequence alignment of 1IPA and 
1GZ0 using default parameters. Lower case represents sequence dis-similarity, and gaps are shown 
with dashes. The underlined region notes domain 1, yellow represents α-helices, purple represents 
β-sheets, and boxes represent misaligned residues corresponding to the labeled α-helix and β-sheet 
in B and C. Atom pairs with a weighting of 50% or greater in the wRMSD calculation are noted 
with asterisks. B) Standard superposition superpositions of 1GZ0 (colored ribbon) onto 1IPA 
(black ribbon) obtained using the initial alignment (from A), colored by weight.  C) Weighted 
superposition obtained from the initial standard superposition. D) SE sequence alignment based on 
the wRMSD superposition, which now corrects the alignment of the secondary structure elements 
based on their spatial proximity in C. 
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Figure VI-5A shows the initial global NW sequence alignment using default 
parameters (BLOSUM50), and the resulting standard and weighted superpositions are 
provided in Figure VI-5B and C. The final alignment generated by SE is shown in 
Figure VI-5D. Any residue pairs that received a weight of 0.5 or greater from the 
wRMSD calculation are noted with an asterisk. The underlined region of the sequence 
alignment in Figure VI-5A and D corresponds to a flexible domain between the 
proteins; as would be expected, none of these residues were significantly weighted to 
contribute to the superposition. The black boxes in Figure VI-5A indicate two regions 
of incorrect atom pairing. The first is due to an erroneous gap placement (in 1IPA) and 
corresponds to the residues of the denoted H8 α-helix in Figure VI-5B and C. The 
residues of the α-helix were not aligned properly, and hence, the appropriate Cα atoms 
were not paired together. However, after the weighted superposition, they are brought 
into close spatial proximity, and the final sequence alignment obtained by SE eliminates 
the gap to produce a correct pairing as evidenced by the high weights (Figure VI-5C). 
The β-sheet, noted in Figure VI-5B and C, is also a misalignment that is overcome by 
the wRMSD superposition. This initial error is caused by the default behavior of the 
Biopython parser [228], used to pull sequence information from the coordinates in the 
PDB files, which omits a modified methionine residue. While this is easily rectified 
programmatically, we allow the omission to serve as an example of parser error.  Some 
parsers ignore non-standard amino acids (listed as HETATMs), and in the 1GZ0 
structure, the methionines have been replaced with selenomethionine to aid in solving 
the structure. Once again, the structural superposition overrides the ambiguity, and the 
final alignment correctly pairs the beta sheet residues (with selenomethionine present 
this time due to the smarter parsing inherent to SE). 
Correction of an alignment is made possible by the powerful combination of 
wRMSD-generated superposition and the “seed extension” algorithm used by SE to 
obtain a sequence alignment from a pair of protein structures. The SE method makes no 
inference about secondary structure elements of the aligned structures and considers 
residue similarity only in tie-breaking situations (using the BLOSUM62 scoring matrix 
to break ties). Additionally, the algorithm extends from a number of small “seed” 
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pairings, so there are no gap penalties and no global cost optimization – two factors that 
are present in many structural alignment algorithms. The absence of these heuristics 
makes the SE algorithm a true What-You-See-Is-What-You-Get method for translating 
a structural superposition into a sequence alignment, and thus, it is a perfect fit for the 
HwRMSD protocol.   
6.3.3 Comparison to Other Structural Alignment Methods 
We compared the performance of our HwRMSD method against several leading 
structural alignment programs based on several benchmarks. First, we used the 
sequence alignments and structure solutions generated by structural alignment programs 
CE, FATCAT, DaliLite, and SSM to perform a robustness analysis similar to that 
performed with global and local sequence alignment methods described earlier. We then 
used the traditional raw RMSD metric and the previously described wSUM metric to 
directly compare the results of the programs to the final HwRMSD structural 
superpositions and structural alignments.  
For the robustness analysis, we used the superposition and the final sequence 
alignment of a structural alignment program as the starting point for a weighted 
superposition (instead of the NW/SW sequence alignment and the standard 
superposition used earlier). As done previously, we computed the pair-wise RMSDs 
between the original solutions of CE, FATCAT, DaliLite, and SSM for each test pair of 
proteins before, and after, the weighted superposition. The median RMSDs for the 
original solutions ranged from 0.43 Å to 8.08 Å with 10 cases >1 Å, and the median 
RMSDs for the weighted alignments ranged from 0.021 Å to 8.46 Å with 6 cases >1 Å. 
Again, in most cases, the weighted fit had significantly lower median distance and was 
able to “collapse” the various solutions to one (or sometimes two very similar) 
consensus superpositions. Several of the test cases did not show a significant change in 
median distance between original and weighted solutions (Figure VI-3). In the cases of 
protocatechuate-3,4-dioxygenase[229] (3PCG), DNA topoiomerases [230, 231] (1AB4 
and 1BJT), and the appendage domain pair [222, 223] (1E42 and 1QTS), the FATCAT 
program altered the solution structure by including a twist of a domain. This is an 
inherent functionality of the algorithm, which produced a structural superposition 
136 
distinct from that of other algorithms. In the case of spliceosomal protein [220] and 
internalin B [221] (1A9N and 1D0B), the DaliLite algorithm produced an alternate, but 
quite reasonable solution, as the top result. This solution was equally far from the three 
other alignments, and thus, it increased the average distance. SSM also provided such 
an outlying solution in the case of the interferon homologs [232, 233] (1ITF and 1I7B). 
In each described case, removing the outlier solution greatly reduces the median 
distance between the remaining alignments, with the weighted solutions having a much 
smaller median distance. We chose to keep such solutions to demonstrate the variability 
of the results and the limits of any structural alignment approach. Again, this analysis 
does not indicate whether the final result of an HwRMSD alignment is better or worse 
than the other structural alignment programs; it is merely another illustration of the 
robustness of the weighted superposition method with respect to varied initial sequence 
alignments and superpositions. 
A pair-wise RMSD score has long been used as a standard way to compare 
structural alignment solutions from different algorithms. While some structural 
alignment programs are tuned to minimize the final global RMSD, the HwRMSD 
method lets the structure dictate the alignment, so the distance between large similar 
domains is minimized. However, this is oftentimes accomplished at the expense of other, 
more flexible or more distantly related regions of the protein, thereby increasing the 
overall final RMSD measurement [7]. Figure VI-6A demonstrates the RMSD values of 
the final alignment solutions from CE, FATCAT, Dalilite, SSM, and wRMSD. Overall, 
the wRMSD solutions resulted in higher RMSD values as compared to the other tools in 
this study; however, aside from the half a dozen cases in which domain flexibility 
inflated the RMSD values, the wRMSD results were comparable to those of FATCAT 
and SSM. In our test cases, the CE solutions performed the best in terms of raw RMSD, 
but had slightly smaller alignment coverage than other methods in many of the cases 
(Figure VI-6). 
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Figure VI-6: Alignment results of HwRMSD (using BLOSUM50 global NW alignment) compared 
to other structural alignment programs using the RMSD A) and the wSUM B) metrics. Lower 
values of RMSD and higher values of wSUM represent a better alignment. Sequence similarity of 
the protein pairs decreases from left to right. Thin lines in A) indicate alignment coverage i.e. the 
number of residue pairs aligned with respect to the shortest protein chain.  
 
 
 
Recent studies have pointed out the weakness of using the RMSD metric in cases 
where flexible or distantly related structures are considered [198, 199] and multiple 
alternate geometry-based scores have been proposed [198]. We chose to also compare 
HwRMSD to CE, FATCAT, DaliLite, and SSM using the previously described wSUM 
metric [7], which is the average weight of the paired residues. The weight is directly 
related to Cα-Cα distance via a scaling constant (set to 5 for all the comparative 
calculations); thus it represents an average similarity measure (see Appendix for more 
details). The wSUM metric is more informative for structural alignments than a pure 
A 
B 
A 
B 
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RMSD because it measures the extent of the ‘best aligned’ regions of a protein pair, 
rather than just the distance of all the paired atoms. If all the aligned residue pairs of 
two structures overlapped perfectly, the wSUM would be 1.0. For each of our test cases, 
the different programs generated very similar alignment lengths (Figure VI-6A), so 
even though the weights are normalized by the alignment length, the wSUM values are 
comparable among the methods.   
CE, FATCAT, SSM, and HwRMSD all perform quite well (Figure VI-6B) with 
wSUM values ranging from 0.8 to 0.1. Values decreased as the %ID of the protein pairs 
decreased. DaliLite superpositions result in lowest wSUM values in general, with 
FATCAT, CE, and HwRMSD performing similarly well. Of course, the HwRMSD 
algorithm is built to minimize wRMSD which increases the weights, so we do not 
expect other structural alignment programs to get an optimal value in this metric.  
Rather, as seen here, we expect the HwRMSD result to be on par with other software in 
closely aligning a large portion of the protein in a structurally valid way. The wSUM 
performance provides confidence that the wRMSD algorithm and the HwRMSD 
protocol overall, not only overcomes the initial sequence alignment errors, but also 
produces structural superpositions that generate improved and valid alignments.  
6.3.4 Local Alignments  
 Some alignment problems may have multiple solutions, especially if there are 
multiple similar domains that move relative to one another between the two structures 
being aligned (such as in the case of an apo vs. holo structure). The wRMSD algorithm 
can explore alternate multiple alignments by using a “local” alignment where sub-sets 
of the initial sequence alignment are used to produce multiple initial standard 
superpositions and, hence, multiple weighted superpositions. By using only small 
segments of the sequence alignment, the weighing is restricted to only a portion of the 
structure, allowing structural similarities that would have been washed out in the global 
alignment to drive the weighted superposition. The alternate solutions can then be 
ranked by wSUM to choose the best of these “local” alignments. The local alignment 
option is built into the current implementation of HwRMSD. The local alignment 
functionality is extensively described in the previous wRMSD publication [7]. 
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6.4 Conclusion 
We have now coupled our wRMSD method with a sequence alignment and seed 
extension (SE) algorithm. Our method is capable of preferentially selecting out the 
regions with the best structural agreement between homologous proteins and generating 
a superposition that can identify significant similarities and differences. The SE 
algorithm then generates a “corrected” sequence alignment based on the improved 
superposition. This algorithm combination, referred to as HwRMSD, provides a flexible 
and transparent structure alignment method. The HwRMSD technique can be used to 
superimpose homologs with low sequence identity and large conformational differences, 
an area where both sequence-based and structure-based methods may fail.  
Employing homologs in the range of intermediate to low sequence identity, we have 
shown that applying a weighting term can overcome the dependence of a structural 
superposition on the initial sequence alignment used to determine the appropriate Cα 
pairs. The wRMSD superpositions are not significantly affected by the choice of the 
sequence alignment method or the employed parameters, but the sRMSD fits are highly 
dependent on both. The conserved regions of the structures are heavily weighted; thus, 
errors made in the initial sequence alignment are relatively discounted. The calculated 
weights can be used to determine potential mis-assignments in the initial sequence 
alignments. The wRMSD technique does not require prior knowledge of any protein 
system, and it removes the need to determine the best alignment method or parameters 
for each application. However, we must note that our tool, like any other, will 
breakdown when sequence or structural similarity is too low. Next, we aim to use this 
technique to align protein structures in our Binding MOAD database [108] to 
characterize ligand recognition across homologous families of protein structures. 
The Appendix provides a short mathematical description of the technique and all 
calculated RMSD values used to determine the medians in Table VI-1 and Figure VI-3.  
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CHAPTER VII  
 
Conclusion and Future Directions 
 
The Binding MOAD database is the largest currently available source of protein-
ligand binding sites with annotated ligand class and binding data. It is one of only 
several datasets cross-referenced by the PDB to provide binding data for individual 
protein-ligand complexes. However, the data in Binding MOAD is meant for more than 
a simple look-up of binding parameters. With proper mining and analysis, the database 
provides the scientific community with large, high-quality datasets for improving 
structure-based drug design methods. Regular updates to the data and the development 
of new functionalities can maintain Binding MOAD’s relevance as a powerful scientific 
tool for exploring binding sites. 
This thesis extends Binding MOAD to incorporate structural details of the binding 
sites currently annotated in the database. A robust relational-object model and efficient 
statistical routines were developed for mining this structural data in a dynamic and 
flexible way. Going forward, these extensions will be incorporated into the 
bindingmoad.org web server to make them available for public use. The binding-site 
data will be presented alongside the currently available information, and it will provide 
a user-friendly way to conduct binding-site composition analysis of the sort presented in 
Chapters III and IV of this thesis. These analyses can range from a simple display of 
residues contained in a single site to the calculation of residue propensities for a query-
set of binding sites, with confidence intervals determined by sampling.  
Specifically, the kinds of data views that will be available to the users are discussed 
below. Identities of residues contained in a specific binding site will be displayed, along 
with information about relative surface-accessibility of these residues. Visualization of 
a binding site will be provided either through an exportable PyMol script or through the 
Eolus Viewer that currently displays binding-site volume information. From an 
141 
individual binding site, the user will be able to retrieve binding sites similar in 
composition, as determined by comparison of residue counts. This search can also be 
generalized to look for binding sites with custom patterns specifying the desired 
numbers of residues to be present.   
A unique feature of Binding MOAD will be the ability to generate residue 
frequencies and propensities for an arbitrary set of binding sites. For example, a user 
may wish to see the propensities of residues for binding sites in a specific protein class 
or in proteins that bind the same ligand. Residue frequencies and propensities can be 
graphically and/or textually presented for any query returning a set of protein structures 
or for existing protein families and EC classes. The leave-10%-out sampling for proper 
interpretation of the propensities will be implicitly included in any such calculation. If 
desired, error bounds with respect to randomly-sampled propensities would be provided 
for any propensity calculation to let users to qualify the trends they obtained with their 
custom query. Of course, any query against the database will be subject to the various 
filtering criteria available based on Binding MOAD annotations. Current criteria 
include EC number, protein-source organism, ligand redundancy, resolution, and the 
presence of binding data. With respect to residue propensities the search criteria can be 
extended to include type of interaction (side chain or backbone), residue type, surface-
accessibility, and/or binding-site size.   
These features are only a few possible use cases for reporting binding-site data. 
Further work on the statistics of residue composition and propensities could allow 
Binding MOAD users to “drill down” into the data for more comparative analyses.  The 
assessment of propensity variation with respect to ligand bias, and the significance of 
comparing binding-site composition are focus areas in need of further exploration. 
Using the structural data obtained from Binding MOAD, the analysis of binding 
sites presented in this thesis reveals the broad trends in residue composition. In the spirit 
of a true top-down approach, a broad separation of binding sites is made using the 
biological relevance of the ligand as annotated in Binding MOAD. While further 
analyses of binding-site or ligand sub-classes are possible, we look to the broad trends 
of residue composition to give a backdrop for such classification analyses. We find that 
certain residues are over-represented in binding sites of biologically relevant “valid” 
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ligands versus the sites of spurious “invalid” crystallographic additives. Trends like the 
over-representation of Arg in invalid ligand binding sites, or the relative scarcity of Lys 
in valid sites, stand up to tests that randomly shuffle the site labels. Examining the bias 
to propensity imparted by the types of ligands present in the PDB shows that 
propensities for valid sites retain overall trends even if the 20 most-frequent ligands are 
omitted from the calculation. The invalid ligand sets is much smaller and less diverse, 
and the omission of its most-frequent ligands from propensity calculations drastically 
alters the trends. We believe that valid binding-site propensities obtained by our 
analysis can help guide structure-based drug design in a way similar to previously-
determined propensities of catalytic residues or protein-protein binding sites.  
To examine the generality of the established propensity trends, their variation is 
explored systematically in random subsets of the data set.  We observe that propensities 
for valid binding sites converge quicker than invalid due to the larger number of 
residues present in those sites. Moreover, we recommend that at least 1000 diverse 
protein complexes are needed for significant general conclusions for biologically 
relevant binding sites. While calculating propensities for sets below this size is 
appropriate for certain applications (e.g., those that focus on specific drug-binding sites 
or the analysis of a functional protein class), such calculations will not represent general 
trends of binding-site composition, given currently available structural data. Examining 
the propensity variation gives context to past and future studies attempting to calculate 
residue composition of protein surfaces. As the number of protein-ligand complexes in 
the PDB continues to grow, the available data for binding-site composition may 
strengthen or change the general trends. However, the propensity analysis presented in 
this thesis will still be applicable to evaluate the internal consistency of the trends in 
that data.  
The scoring of binding-site predictions using residue-propensity data is one of the 
direct applications of general trends in binding-site composition. Geometry-based 
methods for binding-site prediction often make no assumption about the composition of 
the predicted pocket. The incorporation of a propensity-based score into the scoring 
schemes used to rank-order their predictions can help these methods identify potential 
pockets that contain residues frequently seen in biologically-relevant binding sites. This 
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is a middle-of-the-road approach between de novo methods, based on pure geometry or 
energy criteria, and knowledge-based methods that explicitly compare predicted pockets 
to known binding sites. Chapter IV of this thesis demonstrates that a propensity-based 
score can perform as well as a native score of a binding-site prediction algorithm in 
ranking successful predictions. Moreover, for large proteins, where geometry-based 
algorithms may find several large binding-site-like pockets, a propensity-based or 
consensus score can significantly out-perform the native score in the success of top-
ranked predictions. 
Despite the success of propensity-based scoring for binding-site prediction, we find 
that the geometry-based algorithm we tested relied too heavily on the size of the binding 
site. The size of the predicted site was such an important factor for a successful 
prediction that the propensities only had impact in a limited number of cases. A better 
application of general residue propensities may lie in methods that rely on sub-structure 
matching for predicting protein regions relevant for ligand binding. For example, 
ProBiS [83]  matches triplets of residue fragments from a query protein to a database of 
known sites, and it combines highly-conserved triplets to delineate potential binding 
sites. Since structurally-conserved residues may often appear outside of functional sites 
(such as surface patches repeatedly seen to bind invalid ligands with no known 
function), binding-site propensities can provide heuristics for weighing subs-structures 
containing residues known to preferentially participate in ligand binding. Using 
propensity-based scores or weights to improve the ProBiS algorithm is a potential future 
application of the general propensity trends. The aim will still be to discern binding-
site-like regions from the rest of the protein surface, but the confounding effect of an 
additive score seen in the current study will be avoided.  
Other knowledge-based algorithms for predicting binding sites may also benefit 
from binding-site composition information. Comparison of residue composition 
between a predicted site and propensities of classes of known sites is complementary to 
sequence-based motif-searching methods or geometric coordinate-matching methods 
employed by some current tools. However, more work needs to be done on the statistics 
involved in comparing propensities for small sets of binding sites, as well as the bias 
that ligand or protein similarity introduces into such comparisons. Proper comparisons 
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to avoid system bias in ligands and/or proteins require careful statistical analysis and 
appropriate null scenarios for comparison. Also, a rigorous statistical framework will be 
required for establishing the significance of a residue-composition search against a 
database of known sites or sets of propensities. These are just some of the challenges 
that would be involved in shifting from general propensity trends to the comparison of 
propensities among small subsets of binding sites within the framework of the Binding 
MOAD database.  
This thesis provides a framework and several guiding principles for the processing 
and analysis of binding sites in the Binding MOAD database. It takes a first step 
towards the understanding of trends of residue occurrence on protein surfaces and 
protein-ligand binding sites. Potential applications of these trends include, but are not 
limited to, the improvement of binding-site prediction methods and possibly binding-
site comparison algorithms. The propensity trends and their applications are valuable 
contributions to the overarching goal of structure-based drug design; which hinges upon 
a thorough understanding of the general principals of protein-ligand binding.   
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Appendix  
 
Supplementary Information for Chapter VI 
A1. Additional Details of the HwRMSD procedure (see also: Damm & Carlson. 
2000;49:457-466) 
Given two proteins, X and Y, the two PDB files are parsed to compile a list of 
resolved residues in each crystal structure. Needle (EMBOSS) is used to align the 
sequences of X and Y. From the alignment, pairs of residues are matched and used in 
the overlay process. The superposition is based on paired Cα, but the code can easily be 
modified to incorporate more atoms if the user wishes. 
First, the centers of mass of both proteins are placed at the origin, and a standard 
RMSD fit is used to give a rough, initial orientation for the overlay. Without this first 
step, the proteins would be too far apart and all weights would be zero. X and Y have n 
residues paired, and we calculate a Gaussian-weighting factor (wn) for each pair, based 
on the distance between them. 
    
     
            (1) 
where c is an arbitrary scaling factor and dn is determined as 
          
 
   
        
 
   
 
       
 
   
  
 
 
   (2) 
The scaling factor, c, was set to the RMSD of the initial sRMSD the weights need to 
have sufficient power to overcome the initial differences in the superposition. When the 
weights were calculated for alignments of other programs a scaling factor of c = 5 was 
used for consistency. 
A wRMSD fit is an iterative process: after a rotation is applied to a protein, the 
distances between the residues change, which in turn changes the weights, which 
requires a recalculation. Convergence is straightforward. Each iteration starts by placing 
the Gaussian-weighted center of mass (wCM) of each protein at the origin. 
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   and       
        
    
    (3) 
Weighting terms are used in the RMSD fit by simply incorporating them to the 3x3 
covariance matrix (rij). 
                      (4) 
At this point, the rotation of the protein X onto Y is determined via the eigenvalues 
and eigenvectors of the square of the covariance matrix, as is standard practice. Rather 
than minimizing the sum of dn
2
, as is done in a standard RMSD fit, a wRMSD fit 
minimizes the sum of wndn
2
. 
The goodness of fit can be measured in a sum of all weights. The maximum value 
occurs when all weighs are 1.0 and the sum is n (all atom pairs are perfectly overlaid). 
We write the sum of all weights (wSUM), normalized for the number of paired residues, 
as 
     
 
 
            (5) 
A2. Raw distances used to calculate medians for Table VI-1. 
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Needleman-Wunsch (NW) Global Alignment Standard Fit 
 
Needleman-Wunsch (NW) Global Alignment Standard Fit 
 
1FJM & 1TCO 1.16 0.11 0.29 1.18 1.24 0.18 0.72 0.01 0.00 0.03 0.01 0.03 0.04 0.02 
1M0W & 2HGS 0.20 0.27 0.27 0.35 0.34 0.07 0.27 0.06 0.07 0.06 0.09 0.10 0.03 0.07 
1AU1 & 1ITF 1.46 1.74 1.41 1.28 1.46 0.55 1.43 0.12 0.33 0.15 0.21 0.08 0.20 0.17 
1I7B & 1MHM 0.33 0.10 0.15 0.38 0.37 0.13 0.24 0.02 0.02 0.04 0.04 0.06 0.03 0.03 
1EPW & 3BTA 0.43 0.71 0.76 0.66 0.77 0.18 0.69 0.14 0.03 0.04 0.16 0.13 0.06 0.09 
1AUK & 1FSU 0.23 0.71 0.34 0.72 0.39 0.69 0.54 0.09 0.11 0.11 0.03 0.08 0.10 0.09 
1AP8 & 1EJH 0.00 0.23 0.23 0.23 0.23 0.00 0.23 0.00 0.05 0.05 0.05 0.05 0.00 0.05 
3PCG & 3PCG 0.68 0.34 0.18 0.72 0.63 0.22 0.48 0.04 0.04 0.06 0.03 0.06 0.05 0.04 
1A3G & 5DAA 0.58 0.61 1.90 1.01 2.18 1.43 1.22 0.12 0.07 0.17 0.13 0.07 0.15 0.12 
1GZ0 & 1IPA 3.10 
 
0.72 
 
2.59 
 
2.59 0.10 
 
0.23 
 
0.27 
 
0.23 
1OYC & 2TMD 0.30      0.30 0.08      0.08 
1IQ8 & 1K4G 0.28 0.41 0.30 0.30 0.46 0.37 0.34 0.06 0.05 0.11 0.05 0.16 0.14 0.08 
147 
1GLN & 1QTQ 1.20 
 
3.99 
 
3.01 
 
3.01 0.08 
 
0.18 
 
0.15 
 
0.15 
1BOO & 1EG2 2.38  2.73  3.44  2.73 0.10  0.19  0.21  0.19 
1AB4 & 1BJT 0.48      0.48 0.43      0.43 
1TDJ & 2TYS 1.51 7.32 4.08 7.00 3.68 8.50 5.54 0.17 4.94 0.74 4.91 0.77 4.41 2.59 
1BK0 & 1DCS 0.92 
     
0.92 0.51 
     
0.51 
1FFV & 1FO4 1.08  0.29  1.14  1.08 0.49  0.18  0.65  0.49 
1A9N & 1D0B 2.85 13.60 0.83 12.81 2.88 13.25 7.85 3.56 15.00 1.19 13.22 4.39 15.93 8.81 
1B74 & 1JFL 0.71  1.36  1.53  1.36 0.13  0.22  0.28  0.22 
1CB8 & 1EGU 1.27 
 
0.55 
 
1.38 
 
1.27 0.20 
 
0.17 
 
0.30 
 
0.20 
1FOH & 1PB3 4.83  2.21  5.38  4.83 1.83  2.63  3.59  2.63 
1E42 & 1QTS 2.24  3.94  5.85  3.94 0.28  0.48  0.47  0.47 
               
 
Smith-Waterman (SW) Local Alignment Standard Fit 
 
Smith-Waterman (SW) Local Alignment Weighted Fit 
 
1FJM & 1TCO 0.32 0.04 0.52 0.33 0.61 0.51 0.42 0.07 0.02 0.07 0.08 0.01 0.08 0.07 
1M0W & 2HGS 0.19 0.27 0.28 0.34 0.34 0.06 0.27 0.06 0.06 0.06 0.10 0.10 0.02 0.06 
1AU1 & 1ITF 0.00 1.57 1.48 1.57 1.48 0.28 1.48 0.00 0.11 0.18 0.11 0.18 0.13 0.12 
1I7B & 1MHM 0.33 0.12 0.15 0.29 0.37 0.21 0.25 0.02 0.13 0.04 0.14 0.06 0.11 0.08 
1EPW & 3BTA 0.43 0.62 0.64 0.64 0.65 0.91 0.64 0.14 0.04 0.04 0.11 0.13 0.05 0.08 
1AUK & 1FSU 0.39 1.64 0.34 1.43 0.31 1.57 0.91 0.03 0.37 0.10 0.39 0.09 0.45 0.24 
1AP8 & 1EJH  0.58 0.97 0.58 0.97 1.57 0.97 0.00 0.08 0.36 0.08 0.36 0.44 0.22 
3PCG & 3PCG 0.19 1.37 0.18 1.33 0.17 1.37 0.76 0.03 0.06 0.06 0.03 0.05 0.05 0.05 
1A3G & 5DAA 0.58 0.86 1.90 0.67 2.08 2.23 1.38 0.11 0.86 0.12 0.78 0.04 0.78 0.45 
1GZ0 & 1IPA 3.30 7.54 7.54 5.83 5.83 5.83 5.83 0.10 1.31 1.31 1.30 1.30 1.30 1.30 
1OYC & 2TMD 0.32 2.89 2.25 2.97 2.28 1.73 2.26 0.08 1.39 0.10 1.34 0.13 1.36 0.73 
1IQ8 & 1K4G 0.29 1.16 0.30 1.22 0.48 1.05 0.76 0.07 0.85 0.11 0.83 0.17 0.92 0.50 
1GLN & 1QTQ 0.46 4.96  5.30   4.96 0.14 1.95  1.86   1.86 
1BOO & 1EG2 2.77 4.57 2.68 2.46 3.85 5.84 3.31 0.07 0.56 0.15 0.59 0.14 0.60 0.36 
1AB4 & 1BJT 0.54 1.84 0.67 1.94 1.08 2.32 1.46 0.45 0.71 0.24 0.88 0.44 0.64 0.55 
1TDJ & 2TYS 0.87 7.32 
 
6.89 
  
6.89 0.26 4.91 
 
4.92 
  
4.91 
1BK0 & 1DCS 9.84 12.37 20.07 4.08 12.32 9.25 11.08 2.07 1.73 0.11 1.43 2.08 1.80 1.77 
1FFV & 1FO4 0.65 1.59 0.77 1.81 0.84 1.76 1.21 0.60 0.73 0.28 1.18 0.82 0.48 0.66 
1A9N & 1D0B 2.23 2.91 1.52 2.49 2.07 2.43 2.33 0.32 0.96 0.11 0.80 0.32 0.97 0.56 
1B74 & 1JFL 1.11 1.52 0.85 2.14 1.51 1.73 1.52 0.07 0.76 0.33 0.76 0.30 0.70 0.51 
1CB8 & 1EGU 1.30 2.02 0.73 1.14 1.34 1.91 1.32 0.24 1.01 0.25 0.92 0.43 1.07 0.68 
1FOH & 1PB3 4.18 8.93 3.34 5.59 5.29 9.69 5.44 7.28 9.16 7.33 2.16 0.51 2.01 4.72 
1E42 & 1QTS 2.03 6.90 2.80 7.73 4.12 6.91 5.51 0.45 7.51 0.15 7.76 0.39 7.53 3.98 
 
A3. Raw RMSD and wSUM values used in Figure VI-6 for comparison of HwRMSD 
to other structural alignment programs. 
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Pair-wise RMSD (in Å) and wSUM* of HwRMSD and other Structural Alignment Program solutions 
 
 wRMSD  CE  FATCATflex DaliLite SSM 
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1FJM & 1TCO 
39% 5.74 0.77 1.69 0.75 1.75 0.78 3.79 0.69 1.90 0.79 
1M0W & 2HGS 37% 3.36 0.61 2.07 0.65 3.09 0.62 3.06 0.61 3.08 0.64 
1AU1 & 1ITF 35% 3.99 0.52 2.52 0.55 3.06 0.51 4.32 0.41 3.50 0.28 
1I7B & 1MHM 33% 2.44 0.70 1.83 0.71 2.32 0.69 2.65 0.55 2.42 0.70 
1EPW & 3BTA 31% 3.60 0.55 2.81 0.51 3.12 0.50 3.02 0.46 3.06 0.55 
1AUK & 1FSU 29% 5.98 0.59 2.30 0.62 3.06 0.59 4.51 0.56 4.44 0.58 
1AP8 & 1EJH 29% 8.39 0.35 3.88 0.27 3.70 0.33 3.92 0.28 4.41 0.36 
3PCG (A) & 3PCG 
(M) 
28% 10.22 0.60 2.44 0.56 6.68 0.57 6.76 0.36 7.30 0.63 
1A3G & 5DAA 27% 1.44 0.76 1.44 0.76 1.43 0.76 1.71 0.66 1.39 0.77 
1IPA & 1GZ0 26% 11.50 0.46 3.32 0.31 3.52 0.35 8.19 0.37 3.42 0.33 
1OYC & 2TMD 25% 4.48 0.54 2.42 0.56 3.10 0.50 2.89 0.52 2.98 0.45 
1IQ8 & 1K4G 25% 2.69 0.57 2.27 0.57 2.39 0.57 2.57 0.49 2.44 0.57 
1GLN & 1QTQ 24% 3.38 0.52 2.27 0.56 3.00 0.51 3.18 0.50 3.12 0.54 
1BOO & 2ENT 23% 7.03 0.62 1.88 0.69 4.02 0.59 5.80 0.52 6.78 0.63 
1AB4 & 1BJT 22% 5.40 0.39 3.03 0.41 3.95 0.45 4.90 0.32 4.12 0.41 
1TDJ & 2TYS 21% 5.66 0.43 2.70 0.47 4.12 0.43 3.85 0.43 4.32 0.45 
1BK0 & 1DCS 20% 4.77 0.42 2.81 0.44 3.20 0.43 3.73 0.41 4.68 0.44 
1FFV & 1FO4 19% 2.97 0.54 2.23 0.54 2.48 0.53 2.59 0.44 2.59 0.54 
1A9N & 1D0B 19% 8.77 0.42 3.69 0.37 6.16 0.47 5.87 0.32 6.43 0.43 
1B74 & 1JFL 18% 4.96 0.39 3.75 0.31 3.90 0.38 4.57 0.29 3.54 0.43 
1CB8 & 1EGU 18% 3.78 0.45 2.37 0.48 2.46 0.48 2.73 0.41 2.96 0.48 
1FOH & 1PBE 17% 4.18 0.42 3.02 0.39 2.63 0.52 3.23 0.46 3.11 0.50 
1E42 & 1QTS 16% 14.38 0.27 4.35 0.18 4.74 0.37 5.15 0.09 4.62 0.24 
*wSUM is the sum of distance-dependent weights for all the corresponding atom pairs in a 
structural alignment solution. Higher values indicate a higher fraction of pairs aligned, with the 
value of 1 signifying all atom pairs perfectly overlaid.  
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